ANTI OBESITY

/ Uncategorized / By
  1. Possible anti-obesity therapeutics from nature–A review
  2. Anti-obesity drugs: past, present and future
  3. Anti-obesity drugs: a review about their effects and safety
  4. Anti-obesity action of oolong tea
  5. Anti-obesity therapies
  6. The obesity pipeline: current strategies in the development of anti-obesity drugs
  7. The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
  8. Anti-obesity drugs: a review about their effects and their safety
  9. Treatment of obesity: an update on anti‐obesity medications
  10. A systematic review of anti-obesity medicinal plants-an update
  11. Anti‐obesity effects of green tea: from bedside to bench
  12. Food ingredients as anti-obesity agents: a review
  13. The anti-obesity potential of sigmoidin A
  14. Natural products in anti-obesity therapy
  15. Mechanisms underlying current and future anti-obesity drugs
  16. Rise and fall of anti-obesity drugs
  17. The utility of animal models to evaluate novel anti‐obesity agents
  18. Screening of crude plant extracts with anti-obesity activity
  19. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model
  20. Are medical students aware of their anti-obesity bias?
  21. Orlistat: its current status as an anti-obesity drug
  22. Food components with anti-obesity effect
  23. Anti-obesity effects of tea catechins in humans
  24. Vegetables containing phytochemicals with potential anti-obesity properties: A review
  25. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats
  26. Antidiabetes and Anti-Obesity Activity of Lagerstroemia speciosa
  27. Do we need anti‐obesity drugs?
  28. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732
  29. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
  30. Propionate. Anti-obesity and satiety enhancing factor?
  31. Anti-obesity and antihyperlipidaemic effect of Hunteria umbellata seed extract in experimental hyperlipidaemia
  32. PYY3‐36 as an anti‐obesity drug target
  33. Efficacy and safety of anti‐obesity drugs in children and adolescents: systematic review and meta‐analysis
  34. Anti-obesity drugs: a critical review of current therapies and future opportunities
  35. Anti-obesity drugs and neural circuits of feeding
  36. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
  37. Sibutramine: a review of the pharmacology of a novel anti-obesity agent.
  38. Anti-obesity effects of natural products
  39. Gluttony or sloth’: Critical geographies of bodies and morality in (anti) obesity policy
  40. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor
  41. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways
  42. Disability and the anti‐obesity offensive
  43. Anti-obesity compounds in green leaves of Eucommia ulmoides
  44. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
  45. Phenolic compounds and plant extracts as potential natural anti-obesity substances
  46. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice
  47. Anti‐obesity effects of long‐chain omega‐3 polyunsaturated fatty acids
  48. Mechanisms of hypolipidemic and anti‐obesity effects of tea and tea polyphenols
  49. Anti-diabetes and anti-obesity medications: effects on weight in people with diabetes
  50. The discovery and status of sibutramine as an anti-obesity drug
  51. Current strategies in the development of anti-obesity drugs and their safety concerns
  52. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
  53. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice
  54. Measuring fatness, governing bodies: The spatialities of the Body Mass Index (BMI) in anti‐obesity politics
  55. Chemical constituents from Nelumbo nucifera leaves and their anti-obesity effects
  56. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.
  57. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice
  58. A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model
  59. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes
  60. Anti‐obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid
  61. Anti-obesity potential of Clerodendron glandulosum. Coleb leaf aqueous extract
  62. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase
  63. Vascular targeting of adipose tissue as an anti-obesity approach
  64. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice
  65. DGAT1 inhibitors as anti-obesity and anti-diabetic agents.
  66. Anti-obesity and hypolipidemic effects of black soybean anthocyanins
  67. Selection of patients for anti-obesity surgery
  68. Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials
  69. NPY receptors as potential targets for anti‐obesity drug development
  70. Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice.
  71. Saffron: a natural potent antioxidant as a promising anti-obesity drug
  72. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity
  73. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice
  74. Serotonergic anti-obesity agents: past experience and future prospects
  75. Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone
  76. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice
  77. An assessment of the safety and efficacy of sibutramine, an anti‐obesity drug with a novel mechanism of action
  78. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice
  79. Ghrelin as a potential anti-obesity target
  80. Anti-obesity effect of Morus bombycis root extract: anti-lipase activity and lipolytic effect
  81. Screening of polyphenolic plant extracts for anti‐obesity properties in Wistar rats
  82. Evaluation of anti-obesity effect of Aegle marmelos leaves
  83. An improved synthesis of rimonabant: anti-obesity drug
  84. Anti-obesity Effect of Dioscorea nipponica Makino with Lipase-inhibitory Activity in Rodents
  85. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
  86. New advances in models and strategies for developing anti-obesity drugs
  87. Anti-obesity activity of Lactobacillus fermented soy milk products
  88. Substance P as a novel anti-obesity target
  89. Beta3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans
  90. Anti-obesity and anti-diabetic effects of acacia polyphenol in obese diabetic KKAy mice fed high-fat diet
  91. Apolipoprotein A‐I possesses an anti‐obesity effect associated with increase of energy expenditure and up‐regulation of UCP1 in brown fat
  92. Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesity
  93. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review
  94. Diacylglycerol: Efficacy and mechanism of action of an anti‐obesity agent
  95. Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat
  96. Anti-obesity actions of mastication driven by histamine neurons in rats
  97. Anti-obesity drug development
  98. A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol
  99. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin
  100. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte
  101. Anti-obesity and Antidiabetic Effects of Deep Sea Water on ob/ob Mice
  102. What is the prognosis for new centrally-acting anti-obesity drugs?
  103. Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis
  104. Anti‐obesity and hypolipidemic effects of Fuzhuan brick tea water extract in high‐fat diet‐induced obese rats
  105. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status
  106. Anti‐obesity actions of green tea: possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis‐related transcription factors
  107. Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28
  108. Screening of selected Asian spices for anti obesity-related bioactivities
  109. Anti‐obesity action of Salix matsudana leaves (Part 2). Isolation of anti‐obesity effectors from polyphenol fractions of Salix matsudana
  110. Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet
  111. Anti-obesity effects of onion extract in Zucker diabetic fatty rats
  112. Anti-obesity and hypotriglyceridemic properties of coffee bean extract in SD rats
  113. On the site and mechanism of action of the anti-obesity effects of interleukin-6
  114. Novel anti-obesity drugs
  115. Anti-obesity effect of Pinellia ternata extract in Zucker rats
  116. Ethnobotanical study of medicinal plants used as anti-obesity remedies in Nkonkobe Municipality of South Africa
  117. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet
  118. Hoodia gordonii: an up-to-date review of a commercially important anti-obesity plant
  119. Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats
  120. Screening of anti-obesity agent from herbal mixtures
  121. Erythropoietic and anti‐obesity effects of Garcinia cambogia (bitter kola) in Wistar rats
  122. Plasma proteome analysis for anti‐obesity and anti‐diabetic potentials of chitosan oligosaccharides in ob/ob mice
  123. Potential anti-obesity and lipid lowering natural products: a review
  124. Nomilin as an anti-obesity and anti-hyperglycemic agent
  125. Bioactive anti-obesity food components
  126. Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet
  127. Anti‐obesity action of Salix matsudana leaves (Part 1). Anti‐obesity action by polyphenols of Salix matsudana in high fat‐diet treated rodent animals
  128. Anti-obesity and anti-diabetic effects of CL 316, 243, a highly specific β3-adrenoceptor agonist, in yellow KK mice
  129. Anti‐obesity role of adzuki bean extract containing polyphenols: in vivo and in vitro effects
  130. Anti-obesity effects of the methanolic extract and chakasaponins from the flower buds of Camellia sinensis in mice
  131. Rimonabant: more than an anti‐obesity drug?
  132. Anti-obesity effects of small molecule melanin-concentrating hormone receptor1 (MCHR1) antagonists
  133. Lotus seed epicarp extract as potential antioxidant and anti-obesity additive in Chinese Cantonese Sausage
  134. Potential risks associated with the use of herbal anti-obesity products
  135. Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats
  136. Gut hormones as peripheral anti obesity targets
  137. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and obese middle-aged female Zucker rats.
  138. Anti-Obesity and Antioxidative Effects of Purple Sweet Potato Extract in 3T3-L1 Adipocytes In Vitro
  139. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141
  140. Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism
  141. Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
  142. A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant
  143. Anti‐obesity effect of kimchi fermented with Weissella koreensis OK1‐6 as starter in high‐fat diet‐induced obese C57BL/6J mice
  144. “Weighing in” on synergy: preclinical research on neurohormonal anti-obesity combinations
  145. Anti-obesity drugs
  146. Anti-obesity and hypolipidemic effects of a proprietary herb and fiber combination (S&S PWH) in rats fed high-fat diets
  147. Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism
  148. Hypocholesterolemic and Anti‐Obesity Effects of Saponins from Platycodon grandiflorum in Hamsters Fed Atherogenic Diets
  149. Anti-obesity effects of glabridin-rich supercritical carbon dioxide extract of licorice in high-fat-fed obese mice
  150. Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes
  151. The anti-obesity effect of natural vanadium-containing Jeju ground water
  152. The anti-obesity effect of Lethariella cladonioides in 3T3-L1 cells and obese mice
  153. Evaluation of the amine derivatives of Monascus pigment with anti-obesity activities
  154. Anti-obesity effects of germinated brown rice extract through down-regulation of lipogenic genes in high fat diet-induced obese mice
  155. Anti-obesity effects of epigallocatechin-3-gallate, orange peel extract, black tea extract, caffeine and their combinations in a mouse model
  156. Anti-obesity effect of Gymnema sylvestre extract on high fat diet-induced obesity in Wistar rats
  157. Dehydroepiandrosterone: An anti‐obesity and anti‐carcinogenic agent
  158. Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists
  159. Optimization of the preparation of fish protein anti-obesity hydrolysates using response surface methodology
  160. Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG)
  161. Leptin potentiates the anti-obesity effects of rimonabant
  162. Anti-obesity and lipid-lowering properties of alpha-lipoic acid
  163. Radical scavenging and anti-obesity effects of various extracts from turmeric (Curcuma longa L.)
  164. Anti-obesity effects of protopanaxdiol types of ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet
  165. Anti-obesity effect of standardized ethanol extract of Embelia ribes in murine model of high fat diet-induced obesity
  166. Antitumoral actions of the anti-obesity drug orlistat (Xenical™) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and …
  167. … receptor 1 as an anti-obesity target? A wave of terminations of development programmes for cannabinoid receptor 1 blockers for obesity indicates the demise of a …
  168. A systematic review of the antioxidant, anti-diabeticand anti-obesity effects and safety of triphala herbalformulation
  169. The Water Extract of Adlay Seed (Coix lachrymajobi var. mayuen) Exhibits Anti-Obesity Effects Through Neuroendocrine Modulation
  170. Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents
  171. Mechanism of the anti‐obesity effects induced by a novel melanin‐concentrating hormone 1‐receptor antagonist in mice
  172. Water extract of Houttuynia cordata Thunb. leaves exerts anti-obesity effects by inhibiting fatty acid and glycerol absorption
  173. Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
  174. Effect of phillyrin on the anti-obesity in nutritive obesity mice
  175. Anti-obesity activity of a novel lipid synthesis inhibitor.
  176. A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects
  177. Anti-obesity effect of grape skin extract in 3T3-L1 adipocytes
  178. Simultaneous determination of anti‐diabetes/anti‐obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MS
  179. Anti-obesity activity of Allium fistulosum L. extract by down-regulation of the expression of lipogenic genes in high-fat diet-induced obese mice
  180. Anti-Obesity and Hypolipidemic Effects of Ethanolic Extract from Alpinia officinarum Hance (Zingiberaceae) in Rats Fed High-Fat Diet
  181. Anti‐obesity activities of fermented soygerm isoflavones by Bif idobacterium breve
  182. Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose …
  183. Radical scavenging activity and anti-obesity effects in 3T3-L1 preadipocyte differentiation of Ssuk (Artemisia princeps Pamp.) extract
  184. The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen
  185. NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs
  186. Anti-obesity effect of phosphatidylinositol on diet-induced obesity in mice
  187. Sibutramine: current status as an anti-obesity drug and its future perspectives
  188. Use of anti-obesity drugs among college students
  189. Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice
  190. Anti-Obesity Effect of Blumea balsamifera Extract in 3T3-L1 Preadipocytes and Adipocytes
  191. Mono-and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs
  192. Anti-obesity and anti-diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet
  193. Involvement of protein tyrosine phosphatases in adipogenesis: New anti-obesity targets?
  194. Pregnancy and lactation have anti‐obesity and anti‐diabetic effects in Ay/a mice
  195. Neuromodulation by soy diets or equol: anti-depressive & anti-obesity-like influences, age-& hormone-dependent effects
  196. Advances in anti-obesity therapeutics
  197. Anti-obesity effects of hot water extract and high hydrostatic pressure extract of garlic in rats fed a high-fat diet
  198. Characterization of taurine as anti-obesity agent in C. elegans
  199. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity
  200. Anti-obesity and hypoglycemic effect of ethanolic extract of Murraya koenigii (L) leaves in high fatty diet rats
  201. Tremor and the anti‐obesity drug BRL 26830A.
  202. Anti-Obesity Effects of Salted and Unsalted Doenjang Supplementationin C57BL/6J Mice Fed with High Fat Diet
  203. Anti-Obesity Effect on Rodents of the Traditional Japanese Food, Tororokombu, Shaved Laminaria
  204. Isoxazol‐5(4H)one Derivatives as PTP1B Inhibitors Showing an Anti‐Obesity Effect
  205. Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor
  206. Gene expression analysis of the anti-obesity effect by apple polyphenols in rats fed a high fat diet or a normal diet
  207. Ghrelin—a novel generation of anti‐obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues
  208. Anti-obesity effect of PM-F2-OB, an anti-obesity herbal formulation, on rats fed a high-fat diet
  209. Anti‐obesity efficacy of LH‐21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet‐induced obese rats
  210. NESS038C6, a novel selective CB1 antagonist agent with anti-obesity activity and improved molecular profile
  211. Anti-obesity effects of xanthohumol plus guggulsterone in 3T3-L1 adipocytes
  212. An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex
  213. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment
  214. Anti-obesity and anti-diabetic activities of algae
  215. Anti-obesity activity of methanol extract from hot pepper (Capsicum annuum L.) seeds in 3T3-L1 adipocyte
  216. Medohara and Lekhaniya dravyas (anti-obesity and hypolipidemic drugs) in Ayurvedic classics: A critical review
  217. Anti‐obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes
  218. Anti-obesity effects of hot water extract from Wasabi (Wasabia japonica Matsum.) leaves in mice fed high-fat diets
  219. H3 receptor antagonists/inverse agonists as anti-obesity agents.
  220. Anti-obesity effects of Geranium thunbergii extract via improvement of lipid metabolism in high-fat diet-induced obese mice
  221. The psychopharmacology of appetite: targets for potential anti-obesity agents
  222. Ending Fat Stigma: Precious, Visual Culture, and Anti-Obesity in the “Fat Moment”
  223. Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes
  224. Attitudes and reported practice for obesity management in Korea after introduction of anti-obesity agents
  225. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
  226. Anti-obesity effect and action mechanism of Adenophora triphylla root ethanol extract in C57BL/6 obese mice fed a high-fat diet
  227. Anti‑obesity effects of Actinidia polygama extract in mice with high‑fat diet‑induced obesity
  228. Anti-obesity drugs: are they worth it?
  229. Anti-obesity effect of monascus pilosus mycelial extract in high fat diet-induced obese rats
  230. Uncoupled protein 3 and p38 signal pathways are involved in anti-obesity activity of Solanum tuberosum L. cv. Bora Valley
  231. Anti-obesity effect of HT048, a herbal combination, in high fat diet-induced obese rats
  232. Anti-obesity effects of highly polymeric proanthocyanidins from seed shells of Japanese horse chestnut (Aesculus turbinata Blume)
  233. Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3
  234. Anti-obesity drug use before professional treatment in Taiwan
  235. Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition
  236. Regulation of adipocyte autophagy—The potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-I
  237. Targeting thermogenesis and related pathways in anti-obesity drug discovery
  238. Anti-oxidative and anti-obesity activities of Tetrapanax papyriferus and Siegesbeckia pubescens extracts and their synergistic anti-obesity effects
  239. Fat politics in Europe: theorizing on the premises and outcomes of European anti-“obesity-epidemic” policies
  240. Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.
  241. Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus
  242. Anti-obesity effects of mogrosides extracted from the fruits of Siraitia grosvenorii (Cucurbitaceae)
  243. Cyanidin 3-O-β-D-glucoside-rich blackberries modulate hepatic gene expression, and anti-obesity effects in ovariectomized rats
  244. Putting facts over fears: examining childhood anti-obesity initiatives
  245. Anti-obesity Effect of Carbon Dioxide Supercritical Fluid Extracts of Panax Ginseng CA Meyer
  246. Clinical evaluation of anti-obesity drugs
  247. Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism
  248. Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol, on mice
  249. Gastric emptying after a new, more physiological anti-obesity operation: the Magenstrasse and Mill procedure
  250. SH21B, an anti-obesity herbal composition, inhibits fat accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through the modulation of the …
  251. Abietic acid has an anti-obesity effect in mice fed a high-fat diet
  252. Time to Cut the Fat: The Case for Government Anti-Obesity Legislation
  253. Anti-obesity effect of Stellaria media methanolic extract in the murine model of cafeteria diet induced obesity
  254. In vivo anti-obesity effect of the agonist for receptor VPAC1.
  255. Impact of weight-loss medications on the cardiovascular system: focus on current and future anti-obesity drugs
  256. Lipase catalytic synthesis of diacylglycerol from tuna oil and its anti-obesity effect in C57BL/6J mice
  257. National trends in the use and costs of anti-obesity medications in England 1998–2005
  258. Anti-obesity effect of alkaline reduced water in high fat-fed obese mice
  259. Patent focus on new anti-obesity agents: September 1999-February 2000
  260. Enhanced anti-obesity activities of red mold dioscorea when fermented using deep ocean water as the culture water
  261. Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark
  262. Analysis of main single medicinal herbs for anti-obesity
  263. Anti-obesity effects of Rapha diet® preparation in mice fed a high-fat diet
  264. Evaluation of the Influence of thiosemicarbazone–triazole hybrids on genes implicated in lipid oxidation and accumulation as potential anti-obesity agents
  265. Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities
  266. Anti-Obesity and Antihyperglycemic Effects of Crataegus aronia Extracts: In Vitro and in Vivo Evaluations
  267. Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia
  268. α-Lipoic acid, an anti-obesity agent?
  269. Anti-obesity activity of diglyceride containing conjugated linoleic acid in C57BL/6J ob/ob mice
  270. Anti-obesity, fat lowering and liver steatosis protective effects of Ferula asafoetida gum in type 2 diabetic rats: possible involvement of leptin
  271. Evaluation of antilipidemic and anti-obesity efficacy of Bauhinia purpurea bark extract on rats fed with high fat diet
  272. Anti-obesity effect of berberine in mice fed a high fat diet
  273. Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification
  274. A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders
  275. An ethanolic extract from licorice (glycyrrhiza glabra) exhibits anti-obesity effects by decreasing dietary fat absorption in a high fat diet-induced obesity rat model
  276. Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts
  277. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats
  278. Anti-obesity effects of fermented Samjung-hwan in hign fat diet rats
  279. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice
  280. Synthesis and structure–activity relationship of novel RXR antagonists: Orally active anti-diabetic and anti-obesity agents
  281. Anti-obesity and hypolipidemic effects of dietary levan in high fat diet-induced obese rats
  282. Anti-obesity and hypolipidemic effects of a functional formula containing Prumus mume in mice fed high-fat diet
  283. A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity
  284. Fermented Kochujang supplement shows anti-obesity effects by controlling lipid metabolism in C57BL/6J mice fed high fat diet
  285. Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine
  286. Evidence-based clinical research of anti-obesity supplements in Japan
  287. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells Corrigendum in/10.3892/ijo …
  288. Anti-obesity (Pancreatic lipase inhibitory) activity of Everniastrum cirrhatum (Fr.) Hale (Parmeliaceae)
  289. Ischemic colitis after mesotherapy combined with anti-obesity medications
  290. Conformational analysis of the anti‐obesity drug lorcaserin in water: how to take advantage of long‐range residual dipolar couplings
  291. Anti-obesity and anti-diabetic effects of CL316, 243, a highly specific β3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling …
  292. Anti-obesity, antiatherogenic, anti-diabetic and antioxidant activities of J. montana ethanolic formulation in obese diabetic rats fed high-fat diet
  293. Anti-obesity effect of CL 316,243, a highly specific β3-adrenoceptor agonist, in mice with monosodium-l-glutamate-induced obesity
  294. Thermal stability of yeast hydrolysate as a novel anti-obesity material
  295. End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion
  296. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: Possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent …
  297. Anti-obesity and hypolipidemic effects of chufa (Cyperus esculentus L.) in mice fed a high-fat diet
  298. The anti-obesity effect of the palatinose-based formula Inslow is likely due to an increase in the hepatic PPAR-α and adipocyte PPAR-γ gene expressions
  299. Pre–clinical evolutionary study of Clerodendrum phlomidis as an anti–obesity agent against high fat diet induced C57BL/6J mice
  300. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs. II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic …
  301. Anti-obesity effects of poly-γ-glutamic acid with or without isoflavones on high-fat diet induced obese mice
  302. Behavioral intervention and anti-obesity drug therapy
  303. The toxicological assessment of two anti-obesity drugs in C. elegans
  304. Effect of dietary intake of Salicornia herbacea L. hot water extract on anti-obesity in diet-induced obese rats
  305. Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity
  306. Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet …
  307. Anti-obesity pharmacotherapy: Future perspectives utilising 5-HT2C receptor agonists
  308. Anti-Obesity Effects of Boussingaulti gracilis Miers var. pseudobaselloides Bailey via Activation of AMP-Activated Protein Kinase in 3T3-L1 Cells
  309. Discovery of potent, non-steroidal and highly selective glucocorticoid receptor antagonists with anti-obesity activity
  310. Anti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet
  311. Anti‐obesity effects of amino acid in high‐fat diet induced obese mice
  312. An alternative perspective to battling the bulge: the social and legal fallout of Japan’s anti-obesity legislation
  313. Anti-obesity effect of wild ginseng complex pharmacopuncture on adipocyte and high fat diet-induced obese C57BL/6J mice
  314. Preliminary research for the anti-obesity effect of Puerariae Flos extract in humans
  315. Cell signaling mechanisms of gustatory perception of lipids: can the taste cells be the target of anti-obesity agents?
  316. Safety and toxicological evaluation of a novel anti-obesity formulation LI85008F in animals
  317. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question.
  318. Psychosis following anti-obesity treatment with rimonabant
  319. Anti-obesity drugs: from animal models to clinical efficacy
  320. RNA interference targeting cytosolic NADP+-dependent isocitrate dehydrogenase exerts anti-obesity effect in vitro and in vivo
  321. Safety Assessment of an Anti-Obesity Drug (Sibutramine) A Retrospective Cohort Study
  322. Screening of drugs for thermogenic anti-obesity properties: antidepressants
  323. Development, regulatory and marketing challenges for novel anti-obesity therapies.
  324. Anti-obesity effects of Eucommia ulmoides leaves
  325. Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs
  326. Patients’ experiences of prescribed anti-obesity drugs and perceptions of support from primary care: a qualitative study
  327. Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents
  328. Does pharmacologically induced weight loss improve cardiovascular outcome? Impact of anti-obesity agents on cardiovascular risk factors
  329. ANTI‐OBESITY AND ANTI‐DIABETIC EFFECTS OF MAZINDOL IN YELLOW KK MICE: ITS ACTIVATING EFFECT ON BROWN ADIPOSE TISSUE THERMOGENESIS
  330. Anti-Obesity Activity of Ethanolic Extract of Moringa oleifera Seeds In Experimental Animals.
  331. Anti-obesity effect of red garlic composites in rats fed a high fat-cholesterol diet
  332. Novel oral anti-obesity agents: new perspectives with lorcaserin?
  333. One pill makes you smaller: the demand for anti-obesity drugs
  334. Appetite and body weight: integrative systems and the development of anti-obesity drugs
  335. Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats
  336. Anti-obesity and anti-diabetic actions of a β3-adrenoceptor agonist, BRL 26830A, in yellow KK mice
  337. Effects of the red garlic extract for anti-obesity and hypolipidemic in obese rats induced high fat diet
  338. The limits of anti-obesity public health paternalism: another view
  339. Anti-Obesity and Hypolipidemic Effects of Lycium chinense Leaf Powder in Obese Rats
  340. Anti-Obesity and Hypolipidemic Effects of Boussingaultia gracilis Miers var. pseudobaselloides Bailey in Obese Rats
  341. The conformational and biological analysis of a cyclic anti‐obesity peptide from the C‐terminal domain of human growth hormone
  342. QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti-obesity agent
  343. A novel l-isoleucine metabolism in Bacillus thuringiensis generating (2S,3R,4S)-4-hydroxyisoleucine, a potential insulinotropic and anti-obesity amino acid
  344. l-Trp and l-Leu-OEt Derivatives of the Monascus Pigment Exert High Anti-Obesity Effects on Mice
  345. Doing more good than harm? The absent presence of children’s bodies in (anti-) obesity policy
  346. Developing countries could derail global anti-obesity plan
  347. Anti-obesity effect of ethyl acetate extracts from Agrimonia pilosa Ledeb. in 3T3-L1 preadipocytes
  348. NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs?
  349. … A-IV expression in Caco-2/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines
  350. Anti-obesity and body weight reducing effect of Docynia indica (Wall.) Decne fruit extract fractions in experimentally obese mice
  351. Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents
  352. Preparation, identification, structure, and in vitro anti-obesity effects of protease inhibitors isolated from potato fruit juice
  353. Mechanism of anti-obesity action of benidipine hydrochloride in mice.
  354. Inhibition of IKK-β: A new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32
  355. Effect of anti‐obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients
  356. Safety pharmacology of sibutramine mesylate, an anti-obesity drug
  357. Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti‐obesity drugs
  358. Chromium Picolinate (CrP) a putative anti-obesity nutrient induces changes in body composition as a function of Taq1 dopamine D2 receptor polymorphisms in …
  359. Exmination of anti-obesity effect of regional special natural products of Anthrisci radix, Psoraleae semen, Siegesbeckiae herba and Corni fructus
  360. Fat chance: an analysis of anti-obesity efforts
  361. Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition
  362. Anti-obesity and Anti-diabetic Activities of a New β3 Adrenergic Receptor Agonist,(S)-(Z)-[4-[[1-[2-[(2-Hydroxy-3-phenoxypropyl)] amino] athyl]-1-propenyl] phenoxy] …
  363. Development of egg yolk antibody specific to the pancreatic lipase domain for anti-obesity
  364. Anti-obesity effect of dietary polyphenols from unripe apple in rats
  365. Characterization of tunicamycin as anti-obesity agent
  366. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models
  367. Anti-obesity effects of ginsenoside Rd via AMPK and PPAR gamma
  368. … of the GIP‐R antagonist (Pro3) GIP in streptozotocin‐induced diabetes suggests that insulin‐dependent mechanisms are critical to anti–obesity‐diabetes actions of …
  369. Anti-obesity potential of potash alum: pharmacological and biochemical approach
  370. Anti-obesity effects of black bean chungkugjang extract in 3T3-L1 adipocytes and obese mice induced by high fat diet
  371. Suspense builds on anti-obesity rollercoaster ride: despite high safety hurdles and a history of failure in the field, some drug firms remain cautiously optimistic for the …
  372. Building a MCHR1 homology model provides insight into the receptor–antagonist contacts that are important for the development of new anti-obesity agents
  373. Anti‐obesity effects of Emblica officinalis (Amla) are associated with inhibition of nuclear transcription factor, peroxisome proliferator‐activated receptor gamma …
  374. In-vitro anti-obesity assay of alcoholic and aqueous extracts of camellia sinensis leaves
  375. An International Perspective on Battling the Bulge: Japan’s Anti-Obesity Legislation and its Potential Impact on Waistlines Around the World
  376. Exploiting anti-obesity mechanism of Clerodendrum phlomidis against two different models of rodents.
  377. Centrally acting anti-obesity agents
  378. Targeting acetyl-CoA carboxylase for anti-obesity therapy
  379. Anti–diabetic and anti-obesity effects of plant extract from Cleome droserifolia (SAMWA)
  380. Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?
  381. Monoaminergic systems and anti-obesity drug discovery: chronic administration of sympathicomimetic amines, re-uptake inhibitors, or amine oxidase inhibitors
  382. Effect of orlistat, a novel anti-obesity agent, on the pharmacokinetics and pharmacodynamics of pravastatin in patients with mild hypercholesterolaemia
  383. Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: a possible mechanism for the anti-obesity effect of calcium …
  384. Natural ways are better: Adolescents and the ‘anti-obesity’gene
  385. The anti-obesity effects of Gambi-hwan extract on obese rats induced by high-fat diet through the expression of UCP-1 and PPAR-δ
  386. Anti-obesity effect of allene carotenoids, fucoxanthin and neoxanthin from seaweeds and vegetables
  387. Evaluation of ethanolic leaf extract of Ceiba pentandra for anti-obesity and hypolipidaemic activity in cafeteria diet (cd) treated wistar albino rats
  388. Inhibitors of absorption as anti-obesity drugs
  389. Cost-effectiveness of anti-obesity interventions
  390. Coke’s anti-obesity campaign: a FIZZ or not?
  391. Studies on fenfluramhe as an anti-obesity agent
  392. Anti obesity activity of Coccinia indica in female rats fed with cafeteria and atherogenic diets.
  393. Convenient total synthesis of taranabant (MK-0364), a novel cannabinoid-1 receptor inverse agonist as an anti-obesity agent
  394. Anti‐obesity and osteo‐protective effect of green tea polyphenols on long‐term high‐fat‐diet‐induced obesity in rats
  395. Quality standards of Safoof-E-Muhazzil, an anti-obesity unani formulation
  396. Anti-obesity effects of chitosan and psyllium husk with L-ascorbic acid in guinea pigs
  397. Effect of Enterococcus faecalis FK-23 on anti-obesity in diet-induced obesity mice.
  398. Mitochondria as pharmacological targets: The discovery of novel anti-obesity mitochondrial uncouplers from Africa’s Medicinal Plants
  399. Two anti-obesity hopefuls and their safety
  400. Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers
  401. An experimental research on the anti-obesity effect of konjac flour
  402. Balancing the risks of anti-obesity pills
  403. Anti-obesity drugs and bariatric surgery
  404. Effect of fermented soybean curd residue (FSCR; SCR-meju) by Aspergillus oryzae on the anti-obesity and lipids improvement
  405. Preparation of Fluorescent Nonpeptidic Neuropeptide Y Receptor Ligands: Analogues of the Quinazoline‐type Anti‐obesity Y5 Antagonist CGP 71683A
  406. One pill makes you smaller: the utilization of anti-obesity drugs
  407. Anti-obesity effect of Tridax procumbens in atherogenic diet-induced obese rats.
  408. Anti‐obesity and anti‐diabetic effects of carteolol in non‐insulin‐dependent diabetic mice
  409. Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?
  410. Computer-aided identification of ligands for GPCR anti-obesity targets
  411. Histological and Serological anti-Obesity Effect of Mori Folium in Obesity Induced SD Rat by High Fat Diet
  412. New anti-obesity drug comes to market.
  413. Anti-obesity drugs
  414. Anti-obesity effect of garlic-added kochujang in 3T3-L1 adipocytes
  415. Rodent models to evaluate anti-obesity drugs
  416. Anti-obesity effect of komulkosiraegi [Gracilaria vermiculophylla (Ohmi) Papenfuss] extract in 3T3-L1 cells
  417. Effect of combined plant extracts on anti-obesity in rats fed a high-fat diet
  418. Fractionation of active components from Piper cf. fragile essential oil as aromatherapy for anti-obesity
  419. … Cyclic Peptides for Human Melanocortin-4 Receptor (MC-4 R): Design, Synthesis, Bioactive Conformation, and Pharmacological Evaluation as an Anti-obesity Agent
  420. Biotechs pursue anti-obesity drugs, the holy grail of pharmaceuticals
  421. Anti‐obesity effects of resveratrol: from in vivo to in vitro study
  422. Anti‐obesity Effect of Bamboo Salt In Vivo
  423. Very low calorie diets and recently developed anti-obesity drugs for treating overweight in non-insulin dependent diabetics.
  424. Levels of N-acylethanolamines in O, O, S-trimethylphosphorothioate (OOS-TMP)-treated C57BL/6J mice and potential anti-obesity, anti-diabetic effects of OOS-TMP in …
  425. The anti-obesity effects of EGCG in relation to oxidative stress and air-pollution in China
  426. Anti-carcinoma, anti-obesity, antidiabetic and immune defence effects of Vernonia amygdalina leaf extract and leaf powder, in two human cancer patients
  427. The impact of biomics technology and DNA directed anti-obesity targeting of the brain reward circuitry
  428. Guidelines for Approval of Anti-obesity Drugs Affecting Atherosclerosis and/or Lipids
  429. Evaluation of anti-obesity activity of Lantana camara var Linn on butter induced Hyperlipidemia in Rats
  430. Vitamin C and the anti-obesity effect of fenfluramine.
  431. Anti-obesity effects of probiotics in fermented milk.
  432. Acute cardiac death associated with polypharmacy during use of anti‐obesity drug
  433. The physiological alterations induced by Sibutramine anti-obesity drug on the functions of the thyroid gland and the liver: an experimental study on Wistar rats
  434. Treatment of obesity simplex with kang ling anti-obesity mixture
  435. Insulin Sensitization and Anti‐obesity Effects of Astragalus Polysaccharide on High Fat Diet‐fed C57BL/6J Mice
  436. The anti-obesity effect of D-Lys3-GHRP-6 peptide, GHSR receptor antagonist in rats
  437. Anti-obesity Effects of alpha-lipoic Acid in OLETF Rats.
  438. Anti-obesity and anti-hyperlipidemic activity Of Terminalia catappa linn. in high-fat-diet induced obese rats
  439. Anti-obesity and anti-lipidemic effects of linalool in high-fat diet-induced obese mice
  440. Dose-linear pharmacokinetics, tissue distribution, and excretion of a recombinant fusion protein 125I-GST-TatdMt possessing potent anti-obesity activity
  441. Molecular cloning and characterization of the anti-obesity gene adipose in pig
  442. Anti-obesity effects of protopanaxatriol type ginsenosides isolated from American ginseng leaves in mice fed a high-fat diet
  443. A case of insulin autoimmune syndrome that developed after topiramate anti-obesity medication
  444. Evaluation of anti-obesity activity of Lantana camara var Linn on butter induced Hyperlipidemia in Rats
  445. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice
  446. Anti‐Obesity and Anti‐Inflammatory Effects of Cheonggukjang
  447. Disabilities Seen Complicating Anti-Obesity Efforts.
  448. Anti‐obesity effect of EGCG on lipid metabolism and adipokines gene expression
  449. Introducing GOAT: a target for obesity and anti-diabetic drugs?
  450. Study on effects of Codonopsis eupolyphaga anti-obesity powder in mice with nutritive obesity
  451. An assessment of the value of anti-obesity treatment in a chest clinic
  452. Pharmacokinetics of 125I-GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, after intravenous, nasal, oral, and subcutaneous …
  453. Preparation of the Chinese sweet leaf tea extract and its anti-obesity effect in rodents
  454. NPY and energy homeostasis: an opportunity for novel anti-obesity therapies
  455. Obesity and Presentations after Anti‐Obesity Surgery
  456. Role of branched chain amino acids and ACE inhibition in the anti‐obesity effect of milk
  457. Rosemary extract enriched in carnosic acid shows anti-obesity and anti-diabetic effects on in vitro and in vivo models
  458. Studies on kokum (Garcinia indica Choisy), an underutilized anti-obesity fruit tree of Western Ghats of South India
  459. Anti-obesity effect of sibutramine hydrochloride in alimentary obesity rats
  460. Update on anti-obesity medications
  461. Anti-Obesity Drug Discovery and Development
  462. Tackling the menace of obesity using botanicals having anti-obesity properties
  463. 18-Methoxycoronaridine, a potential anti-obesity agent, does not produce a conditioned taste aversion in rats
  464. Current status of medical therapy for obesity and the potential of novel anti-obesity drug development
  465. An experimental study by single blind method on the anti-obesity effect of Xiaopangmei.
  466. Crystallization and preliminary x-ray analysis of anti-obesity peptide hormone oxyntomodulin
  467. Ombudsman: European Medicines Agency should disclose clinical reports on anti-obesity drugs
  468. [Beta]^ sub 3^-Adrenergic Receptor Agonists and Other Potential Anti-obesity Agents
  469. Anti-Obesity Effect of Ethyl Acetate Extracts from Agrimonia pilosa Ledeb. in 3T3-L1 preadipocytes (62.3)
  470. Myostatin blockade with a form of the ActRIIB receptor has potent anti‐obesity and insulin sensitizing actions
  471. FOOD MARKETING PRACTICES AND ANTI-OBESITY POLICY: IMPACT ON SHAREHOLDER WEALTH.
  472. … training on the relationship with brain-derived neurotrophic factor expression and leptin mRNA expression in hypothalamus, serum leptin, and anti-obesity in high-fat …
  473. … that small-molecule targeting of methionine aminopeptidase 2 (MetAP2), an enzyme originally associated with tumor angiogenesis, will lead to a new anti-obesity …
  474. Brown Adipose Tissue In Humans: A New Target for Anti-Obesity Therapy
  475. Anti-obesity effect of bitter melon (Momordica charantia)
  476. Reinforce Anti-Obesity” Home Work” at School
  477. Anti-obesity effect of Forsythia leaf extract containing polyphenolic compounds and its mechanism
  478. Anti-Obesity Drugs: Guidance on appropriate prescribing and management
  479. Anti-inflammatory nutrition as a pharmacological approach to treat obesity
  480. Anti-obesity effect of Crataegus fructus extract from Chinese cultivation
  481. Anti-obesity activities of methyl alcohol extract of Enteromorpha linza in 3T3-L1 preadipocytes
  482. Anti-obesity effect of Sargassum muticum (Yendo) Fensholt in high fat diet-induced obese mice (P5092)
  483. First do no harm with anti-obesity and other drugs
  484. New prospects for the treatment of obesity-Leptin and the discovery of anti-obesity drugs
  485. Anti-obesity drug prescribing in children and adolescents: a population-based study in the UK
  486. Anti-obesity efficacy and mechanism of a Chinese herbal formulation
  487. New targets for obesity pharmacotherapy–developing anti-obesity drugs that do not necessarily produce weight loss
  488. Treatment of adolescents with morbid obesity with bariatric procedures and anti-obesity pharmacological agents
  489. Government invites food industry to fund anti-obesity campaign
  490. Anti-obesity drugs: use, mechanisms and clinical importance.
  491. Perceptions of Anti-obesity Medications among Spanish Personal Trainers
  492. The Korean traditional anti-obesity drug Gyeongshingangjeehwan stimulates AMPKα activation in skeletal muscle of OLETF rats
  493. A radioimmunoassay combined with solid-phase extraction for the determination of a novel anti-obesity agent, ARL 15849XX, in dog plasma
  494. Effect of MYC extracts on cholesterol-lowering and anti-obesity effects in Zucker rats fed a high-fat diet
  495. Anti-obesity fixed-dose combinations
  496. Anti-obesity ads go extreme
  497. Development of anti-obesity dietary supplement decreasing nutrient absorption by digestive enzyme inhibition in gut
  498. Association of anti-mullerian hormone levels with obesity in late reproductive-age women
  499. Metabolism of the anti-obesity agent, 4-amino-5-ethyl-3-thiophenecarboxylic acid methyl ester hydrochloride, in rats and dogs
  500. Determination technologies on appetite inhibitor of anti-obesity agent
  501. Proinflammatory, anti-inflammatory cytokines and adiponkines in students with central obesity
  502. Experimental study on decreasing serum lipid and anti-obesity effects of traditional medicine soft capsule.
  503. Newest anti-obesity drug fails to pass FDA muster
  504. Pharmacological and phytochemical studies of ayuvedic plants for anti-obesity and anti-diabetic activity
  505. Anti‐obesity effects of bamboo leaf extracts studied by microarray analysis
  506. Anti-Obesity Effect of Nepetae spica Extract in High-Fat Mice
  507. Mechanisms of the Anti-Obesity Effects of Oxytocin in Diet-Induced Obese
  508. Management of obesity in polycystic ovary syndrome, including anti-obesity drugs and bariatric surgery
  509. Expectations and disappointments of the human genome: the genomics health card and anti obesity pills
  510. Detection of phenolphthalein added illegally into anti-obesity and healthcare food by TLC-FTIR
  511. National institute for clinical excellence (NICE) guidance for anti‐obesity medication: is it being followed?
  512. Effect of anti-obesity drugs on lipase activity in vitro.
  513. Thermogenesis and related metabolic targets for anti-obesity drugs.
  514. Editorial Oncologic, Endocrine & Metabolic: Anti-obesity drugs: on target for huge market sales
  515. Obesity discrimination: the role of physical appearance, personal ideology, and anti-fat prejudice
  516. Anti-obesity effect of the mixture of herbal extracts containing a new material, Forsythia leaf extract
  517. Effect of anti-obesity media on body image and antifat attitudes
  518. Anti Obesity and Lipid-Lowering Effect of Lactobacillus Spp. as Probiotic on the Obese Rat.
  519. Leptin-an anti-obesity hormone obtained from fat cells
  520. Anti‐obesity effects of Cheonggukjang and Natto extract: from in vivo to in vitro study
  521. Isolation of anti‐obesity active compound orientin from Lythrum salicaria L.
  522. Anti-ghrelin vaccine for obesity: a feasible alternative to dieting?
  523. Identification of Anti-obesity Drugs Adulterated in Traditional Chinese Medicine Preparations by HPLC-MS
  524. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity
  525. Anti‐Obesity, Lipid‐lowering, and Anti‐Diabetic Effects of The Selective Thyroid Receptor Beta Agonist KB‐141
  526. Anti-obesity agents: An update
  527. Anti‐obesity Effect of Soy Protein Diet in High Fat Diet‐Induced Obese Rats
  528. Anti-obesity media content and its impact on people’s intention to eat healthy and exercise: A test of the protection motivation theory
  529. Anti-obesity effects of Isohumulones by modulating lipoid metabolism via Peroxisome Proliferator-activated receptors
  530. Anterograde continuous prolonged inhalation method produces anti-obesity and various respiratory control effects in 63 subjects (The 29th Symposium on Life …
  531. Anti-obesity Effects of a Dietary Isomerized Hop Extract Containing Isohumulones Generated via Peroxisome Proliferators-Activated Receptors
  532. Anti-obesity effects of Schisandra chinensis fruit water extract in rats fed a high-fat diet
  533. Lorcaserin Hydrochloride and A Combination of Phentermine and Topiramate: New FDA Approved Anti-Obesity Drugs after 15 Long Years
  534. Anti-obesity effects of resveratrol, black tea extract and caffeine in mice
  535. Anti-obesity effect of sea buckthorn (Hippohae rhamnoides L) on diet induced obese C57BL/6N mice
  536. Anti-obesity proteins
  537. Anti-obesity proteins
  538. In the search of leptin agonists as anti-obesity drugs: protein/protein docking, molecular dynamics, and virtual screening
  539. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
  540. Novel anti-obesity drugs
  541. Anti-inflammatory and antiobesity effects of mulberry leaf and fruit extract on high fat diet-induced obesity
  542. The use of intestinal microflora modification to maximize the anti-obesity and anti-diabetic effects of soy protein diets in female Zucker diabetic fatty rats
  543. Effect of NPK and Farm Yard Manure on the Accumulation of Forskolin, an Anti-Obesity Diterpenoid Molecule in Coleus forskohlii
  544. Anti-obesity drugs-are they underused in the United States?
  545. Potential Anti-obesity Effects of Costus (Saussurea costus) and Bitter Melon (Citrullus colocynthis (in Rats Fed on High Fat Diet
  546. Anti-obesity Drugs
  547. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity
  548. Anti-obesity effect of a non-salty soybean paste fermented with rice yeast on mice fed a high-fat diet.
  549. Very low calorie diets and recently developed anti-obesity drugs for treating overweight in non-insulin-dependent diabetics.
  550. New kids’ anti-obesity campaign
  551. Action mechanisms of anti-obesity drugs
  552. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
  553. Anti-visceral obesity and antioxidant effects of powdered sea buckthorn (Hippophae rhamnoides L.) leaf tea in diet-induced obese mice
  554. Anti-obesity drugs: status quo and recent advances
  555. Government’s new: anti-obesity campaign urges small steps
  556. Prospects for an anti-ghrelin vaccine to treat obesity
  557. Prescribing anti-obesity preparations
  558. Studies on the food compounds showing anti-obesity effect and
  559. Identification of candidate anti-obesity targets
  560. Anti-inflammatory diets for obesity and diabetes
  561. PSY55 NATIONAL TRENDS IN ANTI-OBESITY MEDICATION USE FROM 2002 TO 2007
  562. Novel molecular actions of the anti-obesity drug Orlistat (Xenical™) in cancer cells: Blockade of cell cycle progression, promotion of apoptotic cell death, PEA3 …
  563. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
  564. Verifying the Mechanism of Anti-Angiogenesis for Anti-Obesity
  565. ANALYSIS ON THE CONSUMPTION OF ANTI-OBESITY MEDICINES FROM PHARMACEUTICAL UNITS
  566. Development of Animal Anti-Obesity Model from Zebrafish
  567. Anti‐obesity Effect of TY‐1010, a Herbal Formulation, on obese patients
  568. Europeans approve anti-obesity charter
  569. Use of anti-obesity drugs among college students
  570. Surgical and hormonal avenues in anti-obesity therapy.
  571. Analysis on the consumption of anti-obesity medicines from pharmaceutical units.
  572. In‐vitro metabolism studies with BLX‐1026, a novel orexin‐2 agonist with anti‐obesity activity
  573. Promising new targets for the next generation of anti-obesity drugs.
  574. Anti-Obesity Surgery for Women Planning Pregnancy?
  575. Anti obesity effect of GTF extracts in high fat diet‐induced obesity mice
  576. Of Freedom and Fat: Why Anti-Obesity Laws Are Immoral
  577. Public health anti-obesity communication: An analysis of current campaigns for future guidance
  578. Iowa patients want new anti-obesity drug.
  579. Practical Tips for Prescribing Anti-obesity Drugs
  580. New targets may lead to novel classes of anti-obesity drugs
  581. New drugs signal rapid growth of anti-obesity drug market
  582. Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice
  583. 16 Cases of Anti-obesity Drug Intoxication Experienced in 4 Emergency Departments
  584. P129: Anti-obesity attitudes among healthcare providers and obese patients
  585. Anti-obesity drugs recalled from global market
  586. Ghrelin, Diabetes and Obesity-Prospects for an Anti-obesity Vaccine
  587. Anti-Angiogenic Capacity of Anthrisci Radix and Psoraleae Semen for Anti-Obesity Purpose
  588. Anti-obesity mechanism of conjugated linoleic acid
  589. ANTI-OBESITY ACTIVITY OF PU-ERH TEA IN MICE.
  590. The Study on Anti-obesity Activity of the Wild Plants of Jeju Island
  591. Anti-obesity Effect of Salicornia herbacea L. Extracts in vitro and in vivo
  592. [SP3-2] Research & Development of Anti-Obesity Functional Food APIC
  593. Anti‐obesity effect of the flavonoids isolated from Allium cepa L. var. agrogatum Don.
  594. Menstrual disturbance with the use of herbal anti-obesity preparation
  595. Anti-obesity Effects of Heloniopsis orientalis through Controlling Lipid Metabolism in High-fat induced Obesity Mouse
  596. Study on Anti-obesity Mechanism of rhCNTF in Neonatally Monosodium Glutamate. treated Obese Rats
  597. Anti-Obesity and Hypotriglyceridemic Properties of Coffee Bean Extract in SD Rats
  598. Anti-obesity Effects of Gambibang-2 on the Obese-Mice Induced by High-fat Diet
  599. Potential molecular targets for anti-obesity drugs–after the discovery of leptin
  600. Tea-Seed Saponin E1 as an Effective Ingredient for Anti-Cancer and Anti-Obesity Based on Anti-Angiogenesis
  601. Physiological Genomic Approach to Assess the Anti-Obesity Potential of Novel Weight Loss Supplements
  602. Screening of traditional medicinal plants and selected Asian spices for anti obesity-related bioactivities
  603. Dynamics in health care utilisation in patients prior to initiation of anti-obesity drug use
  604. CBR1 Blockade and New Anti-Obesity Drugs Development: Targeting the Adipose Tissue
  605. Anti-obesity drugorlistat enhances sensitivity toTRAIL by two different pathways inhormone-refractory prostate cancer cells
  606. Molecular Modelling on Leptin and the Ob Receptor as anti-obesity target
  607. Anti-Cell Adhesion Capacity of Siegesbeckiae Herba and Corni Fructus for Anti-Obesity Purpose
  608. Anti-obesity role of Aster glehni extract: in vivo and in vitro effects
  609. Development of a Human Growth Hormone Peptide Analogue AOD9604 into an Anti-Obesity Drug
  610. Weight Loss Mechanism of Siegesbeckiae herba for Anti-obesity Agent Based on Anti-angiogenesis.
  611. The effect of role sets and indirectness on the perceived face threat and perceived persuasiveness of anti-obesity messages
  612. Studies on Bitter Orange Peel Extract as an Anti-Obesity Agent.
  613. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes
  614. Neutraceutical Study on Marine Allenic Carotenoids with Anti-Obesity Effects on Mice
  615. PSY54 APPLICATION OF THE NON-LINEAR BLINDER-OAXACA DECOMPOSITION TO STUDY RACIAL/ETHNIC DISPARITIES IN ANTI-OBESITY MEDICATION USE
  616. The Anti-Obesity Effects in Obesity-Induced ICR Mouse by Oral Administration of Lactic AcidBacteria
  617. Effect of Microorganism-Fermented Houttuynia cordata against Anti-obesity
  618. Studies on Anti-obesity Effect of Undaria pinnatipida Extract using 3T3-L1
  619. Investigation of hydrogel nanoparticles delivery systems for anti-obesity drug
  620. Mitochondrial DNA C5178A Polymorphism Confers Anti-Obesity and Possible Anti-Atherogenic Property in the Non-Diabetic Subjects
  621. A new potent and specific 5‐HT2C receptor agonist with preclinical anti‐psychotic and anti‐obesity properties
  622. cure or material improvement is possible only after anti-obesity or weaning course of diel ing.
  623. Development of Monascus Pigment Derivatives Having Anti-obesity Effects on Mice
  624. Anti‐obesity and Anti‐inflammatory Effect of Acai Polyphenols in 3T3‐L1 Adipocytes
  625. Food intake-suppressing action of incretin and anti-obesity therapy
  626. PSY52 Is Anti-Obesity Medication (AOM) Use Medically or Socially Driven? An Analysis of Predictors of AOM Use Among Overweight and Obese Female Meps …
  627. Anti‐obesity and anti‐atherogenesis effect of Chungkookjang supplementation in overweight/obese Korean subjects: A randomized, double‐blind, placebo‐controlled …
  628. Characterization of the Anti-Obesity and Anti-Adipogenic Effects of the Limonoid Prieurianin
  629. HIGH BIOAVAILABILITY OF A STANDARDIZED GREEN TEA EXTRACT* A Clinical study on anti-obesity activity
  630. Anti-Obesity Effect of Oolong plus Tuo Tea, and Jasmine Tea on KK-Ay Mice
  631. Anti-obesity effect and ethanol production of Undaria pinnatifida
  632. A STUDY OF THE POTENTIAL PROTECTIVE THERAPEUTIC EFFECT OF THE ANTI OBESITY DRUG BRI 37344 IN AN EXPERIMENTAL MODEL OF …
  633. Anti‐obesity effects of garlic in uncoupling protein‐2 transgenic mice
  634. Heme oxygenase: a target gene for anti-diabetic and obesity
  635. Anti‐obesity effect of Actiponin supplementation in obese Korean subjects: A 12 week, randomized, double‐blind, placebo‐controlled clinical trial
  636. Anti-obesity effects of tea catechins are enhanced by the switch from high-fat to normal-fat diet in rats
  637. … ” A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model”(Biochem …
  638. Genomic Approach to Evaluate the Anti‐Obesity Potential of (−)‐Hydroxycitric Acid (HCA‐SX)
  639. Evaluation of weight reduction and anti–cholesterol activity of Punarnava root extract against high fat diets induced obesity in experimental rodent
  640. Feasibility study to test anti-obesity effects & safety of long-term consumption of momordica charantia (bitter melon)
  641. Anti‐obesity effect of methanol extract of gromwell in 3T3‐L1 cells and obese mice
  642. A Place At the Table for Weight-Based Public Health Media?: Effects of Anti-Obesity Media on Body Dissatisfaction, Drive for Thinness, and Mood
  643. Anti‐obesity effect of blumea balsamifera extract in 3T3‐L1 preadipocytes and adipocytes
  644. Antioxidative and Anti-obesity effects of Ligularia fischeri Turez. Extracts
  645. Beneficial Effects of Ginger as Hypoglyemic, Hypolipidemic, Anti-obesity, Anti-oxidant, and Anti-inflammatory Agent in Adult Female albino Rats
  646. Acute Toxicity Studies of a newly developed anti-obesity polyherbal formulation in Zebrafish
  647.  Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific! b₃-adrenoceptor agonist, in yellow KK mice: Erratum.
  648. Comparision of Anti-Obesity Effect of Korean and Chinese Unripe Rubus coreanus for Subsitution of Imported
  649. Anti-obesity surgery in men reduces morbidity and results in a mortality equivalent to that of a comparison cohort matched on BMI in young adulthood. A national study …
  650. Preclinical anti-obesity activity and safety assessment of a novel drug affecting CB1 receptor
  651. IS ANTI-OBESITY MEDICATION (AOM) USE MEDICALLY OR SOCIALLY DRIVEN? AN ANALYSIS OF PREDICTORS OF AOM USE AMONG OVERWEIGHT …
  652. Anti‐obesity and hypolipidemic effects of water and ethanolic extracts of Liu Wei Di Huang (LWDH) in rats fed a high‐fat diet
  653. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs
  654. Anti-Obesity Rhetoric as Disciplining Practice: A Foucauldian Analysis of Weight Management Communication in” The Biggest Loser”
  655. Applying for access to the clinical study reports and protocols for placebo-controlled trials of anti-obesity drugs submitted for marketing approval
  656. [S10-3] Anti-Diabetic and Anti-Obesity Effects of Edible Seaweed, Petalonia binghamiae
  657. Anti-obesity Effects of Oleoresin Capsicum (OC) Nanoparticles in Diet-induced Obese Rats
  658. Anti-diabetic and Anti-obesity Effects of Ethanol Extract of Boehmeria nivea (L.) Gaud
  659. Anti-obesity Effects of ethanol extract of Adenophora triphylla in vitro and in vivo
  660. Pharmacokinetics of GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, in Mice
  661. Lack of anti-obesity effect of Mimosa pudica seed mucilage on mice fed on a high-fat diet
  662. Anti-obesity effects of high hydrostatic pressure extract of ginseng in rats fed a high-fat diet
  663. Modulation of central noradrenergic function by the anti-obesity agent, sibutramine
  664. PEGylation of Conjugated Linoleic Acid for Anti-Obesity
  665. Proteomic Analysis for Anti-Obesity Effect of Capsaicin on White Adipose Tissue in Rats Fed with High Fat Diet
  666. Anti‐obesity and anti‐atherogenesis effects of Doenjang supplementation in overweight/obese Korean subjects: A randomized, double‐blind, placebo‐controlled …
  667. Appetite and Body Weight: Integrative Systems and the Development of Anti-Obesity Drugs: edited by Tim C Kirkham and Steven J Cooper, 2007, 384 pages …
  668. Anti‐obesity effect of green tea catechin in the uncoupling protein‐2 transgenic mouse
  669. Is Sitagliptin a Favorable Anti-Obesity Drug in New Onset Diabetes after Renal Transplantation?: 362
  670. Anti-Obesity Sodium Tungstate Treatment Triggers Axonal and Glial
  671. Novel semicarbazide-sensitive amine oxidase inhibitor screening from anti-obesity drugs using HPLC-MS based technique
  672. In vitro investigations into the effect of orlistat, an anti-obesity therapy, on the human fecal microbiota
  673. Anti-obesity effects of the fermented wheat extract with Bacillus subtilis (natto) strain DC15 (DC15-FE) on mice fed a high-fat diet
  674. Chemical Constituents and Anti-obesity Effects from the Leaves of Styrax obassia Siebold & Zucc in Jeju Island
  675. Anti-obesity Effect of Low-molecular Weight Hyaluronan in Mouse 3T3-L1 Adipocyte Differentiation
  676. Anti‐obesity and inflammatory effects of Lactobacillus sp. OPK‐3 isolated from kimchi in cell line and in animal model
  677. Antioxidative and Anti-obesity Activities of Ethanolic Aruncus dioicus var. kamtchaticus H. Hara Extract
  678. Anti-obesity and Anti-oxidant Effect of Acetone Ginger (Zingiber officinale) Extract in High Fat Diet Induced Obese C57BL/6 Mice
  679. Water‐soluble extract of Cauliflower mushroom shows anti‐obesity effects in high fat diet‐induced obese mice
  680. Differences in the anti-obesity effects of Delta-androstenedione and its precursor, dehydroepiandrosterone, in lean and obese Zucker rats.
  681. Anti-Obesity Effects of Germinated Secale cereale L. Extracts In Vitro Cell Based Assay System
  682. Research Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism
  683. Anti-obesity and Hypolipidemic Action of Leaves of Mulberry (Morus alba L.)
  684. … restriction and endurance exercise share potent anti-inflammatory function in adipose tissues in ameliorating diet-induced obesity and insulin resistance in …
  685. OA01. 38. Anti-obesity activity of Zizyphyus mauritiana lam: a potent pancreatic lipase inhibitor
  686. [S11-4] Anti-obesity Effect of Onion Containing Red Bean Paste
  687. Anti-obesity efficacy of a novel cannabinoid-1 receptor inverse agonist MK-0364 in rodents
  688. Anti‐obesity Effect of microalgal oil Supplementation in C57BL/6N Mice Fed a High Fat Diet
  689. Anti-atherosclerosis and Anti-obesity Effects of Zanthoxylum piperitum DC, Citrus junos Sieb ex Tanaka and Pinus koraiensis oil
  690. Cooked rice as dietary carbohydrate has anti‐obesity effect through down‐regulating lipogenic gene expression in high fat diet fed mice
  691. Anti-obesity effect of the ethyl acetate fraction from tulip tree leaf (Liriodendron tulipifera L.) on adipocyte differentiation in 3T3-L1 cells
  692. Fabrication Of Anti-Obesity Stilbene Analogues Using Engineered Microbial Platforms: Structure-Function Properties Towards Inhibition Of Digestive Enzymes
  693. Molecular Mechanisms and Target Identification of Indole-3-Carbinol as an Anti-Obesity Agent
  694. Calcium, Angiotensin Converting Enzyme Inhibitors, and Branched Chain Amino Acids Contribute to the Anti-Obesity Effects of Milk
  695. Pharmacological characterisation of selective Y4 and dual Y2/Y4 receptor agonists: novel targets for putative anti-obesity therapies
  696. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the …
  697. E016: Anti-obesity therapy with sibutramine has no clinically significant effect on cardiovascular variables, ventricular dimensions and heart valves in obese patients
  698. Anti-obesity effects of capsaicin via upregulation of UCP2 gene expression in high-fat diet induced obese rats
  699. Obesity impairs efficacy of anti-TNF therapy in patients with RA
  700. Anti-obesity activity of 3-hydroxymethyl N-methyl piperidine 4-chlorophenoxyacetate hydrochloride in mice treated with gold thioglucose
  701. Anti-Obesity Effect of a New Dietary Supplement Consisting of Hydroxycitrate, Carnitine and Red Pepper (3D-Relax Diet) in High-Fat Fed Rats
  702. Anti-obesity effect of ethanolic extract and butanol fraction from lotus leaves on SD rats fed with high energy diets and its DNA microarray analysis.
  703. Small Animal Imaging: The Use of Pet/ct Fusion to In Vivo and Longitudinally Assess Anti-Obesity Drug Effects on Fdg Uptake in Mice Target Tissues.
  704. Anti‐obesity Effect of Ethanol Extract from Korean traditional Kochujang Supplementation in C57BL/6N Mice Fed a High Fat Diet
  705. Anti-obesity Effect of Supercritical Fluid Extraction Oil Methanol Extracts from Cinnamomum verum on 3T3-L1 Pre-adipocytes
  706. [P8-262] Glycyrrhiza uralensis Fisch Shows Anti-obesity Effects in High-fat Induced Obesity Mouse Model
  707. Anti-obesity potential of the ethanolic extract and the isolated compound (Isoquercitrin) of aerial parts of Lagenaria Siceraria (Mol.) standley in …
  708. Biochemical Studies On Methanobrevibacter smithii RNase PA Model For Mesophilic Type A Archaeal RNase P And A Possible Anti-Obesity Target
  709. Gastric Cytokines, Gastric Microbial Overgrowth and Weight Loss After Anti-Obesity Gastroplasty
  710. Novel anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase
  711. The novel peptide prokineticin-2 potently inhibits food intake in rodents and is a potential novel anti-obesity therapy
  712. Abstract B61: Effects of anti-obesity dietary supplement DHEA on serum DHEA, DHEA-S, IGF-1 and IGFBP-3 in DMBA-induced breast cancer model.
  713. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs (1) The presence of canine β3-adrenergic receptor and in vivo lipomobilization by its …
  714. Anti-obesity effects of green tea EGCG, orange peel extract, black tea extract and caffeine in mice fed on a high-fat diet
  715. Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically-ill patients with extreme obesity
  716. Cooked Rice Exerts Anti-Obesity Effect via Down-Regulation of Adipogenic Gene Expression and Improves the Glucose Responses in High Fat Diet Fed Mice
  717. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin
  718. The anti-obesity effects of dietary trans-trans conjugated linoleic acid-rich soy oil in obese Zucker rats
  719. Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs (2) Recruitment of thermogenic brown adipocytes and reduction of adiposity after …
  720. [P8-346] Anti-obesity effect of Ecklonia Cava in Fed a High Fat Diet
  721. [P8-68] Anti-obesity Effect of Vegetable Sprouts in 3T3-L1 Adipocytes
  722. Role of uncoupling protein 1 in the anti-obesity effect of β3-adrenergic stimulation in the dog
  723. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver
  724. Understanding anti-fat bias in children: The role of media and appearance anxiety in third to sixth graders’ implicit and explicit attitudes toward obesity
  725. The WNT/β-catenin pathway mediates the anti-adipogenic mechanism of SH21B, a traditional herbal medicine for the treatment of obesity
  726. The anti-angiogenic herbal composition Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice
  727. Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy
  728. XOMA 052, an anti-IL-1β monoclonal antibody, improves glucose control and β-cell function in the diet-induced obesity mouse model
  729. Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
  730. Calorie restriction in overweight males ameliorates obesity-related metabolic alterations and cellular adaptations through anti-aging effects, possibly including AMPK …
  731. … cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity …
  732. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
  733. Energy expenditure regulation via macrophage migration inhibitory factor in obesity and in vitro anti-macrophage migration inhibitory factor effect of Alpinia officinarum …
  734. Diabetes, obesity and cancer: risk and anti-risk factors
  735. Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity
  736. Calorie restriction inhibits sympathetic nerve activity via anti-oxidant effect in the rostral ventrolateral medulla of obesity-induced hypertensive rats
  737. … orally active small molecules having anti‐adipogenic property, reduces weight gain, fat content and improves glucose tolerance in Diet Induced Obesity model in mice
  738. Anti-obesitic effect of mulberry root-bark (Mori radicis Cortex) in Zucker Rats with high lipid diet induced-obesity
  739. Early prevention of cardiovascular diseases in juvenile obesity: The anti-inflammatory effect of physical exercise
  740. In-Vivo Anti-oxidant activity of Methanolic extract of Sapindus emarginatus in mono sodium glutamate induced obesity rats.
  741. The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral obesity and dyslipidemia
  742. An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation
  743. The impact of an obesity awareness intervention on anti-fat attitudes and expectations of pre-service physical educators
  744. Patterns of obesity during anti-cancer chemotherapy in children with acute lymphoblastic leukemia
  745. Anti-inflammatory angle in obesity
  746. Social perceptions of obesity: the morality of obesity in the formation and maintenance of anti-fat attitudes
  747. Voluntary Handicaps-Should Drug Abuse, Alcoholism and Obesity Be Protected by Pennsylvania’s Anti-Discrimination Laws
  748. Role of adipose hypoxia in endocrine alterations: a possible new anti-inflammatory therapeutic target in obesity?
  749. Are anti-inflammatory drugs an appropriate option for treating obesity?
  750. Anti-VEGF therapy—a role in obesity-related breast cancer
  751. Can Anti-Smoking Campaigns Increase Obesity? Evidence from Belarus
  752. Is obesity the cause for the increasing incidence of CRC in patients under 50 years of age and can an anti-adenoma antibody identify those at risk
  753. Anti-Inflammatory Effects of Resveratrol May Help Obesity
  754. 23 Anti-Inflammatory Phytochemicals, Obesity, and Diabetes
  755. Anti-Angiogenic Actions of Vegf-a165B, a Novel Isoform of Vegf-a, in Human Obesity
  756. Role of costimulation in obesity-induced adipose inflammation and insulin resistance: pro-or anti-inflammatory?(P3105)
  757. Impaired platelet sensitivity to the anti-aggregating effects of adenosine in obesity and obese non-insulin-dependent diabetes mellitus
  758. Anti-miR33 Therapy Induces PGC1a Expression to Regulate Immunometabolic Pathways in Atherosclerosis and Obesity
  759. Atherogenic and anti-atherogenic risk markers in subjects with obesity and/or type 2 diabetes
  760. Anti-inflammatory and pro-resolution lipid mediators: lessons for obesity-related inflammation
  761. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARg by cdk5
  762. Mechanisms underlying the metabolic and anti-fibrotic effects of dietary tocotrienols in obesity related hypertension
  763. Natural anti-obesity agents
  764. Progress and challenges in anti-obesity pharmacotherapy
  765. 2014 EASO position statement on the use of anti-obesity drugs
  766. Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon
  767. Anti-obesity potential of natural methylxanthines
  768. Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids
  769. Natural products with anti-obesity effects and different mechanisms of action
  770. FDA-approved anti-obesity drugs in the United States
  771. The anti-obesity effects of green tea in human intervention and basic molecular studies
  772. Marine algae as a potential source for anti-obesity agents
  773. Natural dietary and herbal products in anti-obesity treatment
  774. Safety and tolerability of new-generation anti-obesity medications: a narrative review
  775. Anti-obesity therapy: from rainbow pills to polyagonists
  776. Resveratrol: anti-obesity mechanisms of action
  777. Anti-obesity and anti-diabetic effect of neoagarooligosaccharides on high-fat diet-induced obesity in mice
  778. Recent progress in anti-obesity and anti-diabetes effect of berries
  779. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
  780. Capsaicin as an anti-obesity drug
  781. Molecular mechanisms of the anti-obesity potential effect of Moringa oleifera in the experimental model
  782. Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications
  783. Anti-obesity activity of the marine carotenoid fucoxanthin
  784. Anti-inflammatory and anti-obesity properties of food bioactive components: effects on adipose tissue
  785. Anti-diabetes and anti-obesity medicinal plants and phytochemicals
  786. Physiological characteristics and anti-obesity effect of Lactobacillus plantarum K10
  787. Food ingredients as anti-obesity agents
  788. Brown adipose tissue as an anti‐obesity tissue in humans
  789. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee
  790. Anti-obesity effects of Taif and Egyptian pomegranates: Molecular study
  791. Recent advances in understanding the anti-obesity activity of anthocyanins and their biosynthesis in microorganisms
  792. Anti-obesity effects of medicinal and edible mushrooms
  793. Anti-obesity effects of gut microbiota are associated with lactic acid bacteria
  794. Anti-obesity and anti-diabetic effects of nitrate and nitrite
  795. Metabolic regulation and the anti-obesity perspectives of human brown fat
  796. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
  797. Marine-derived bioactive compounds with anti-obesity effect: A review
  798. Molecular mechanism on functional food bioactives for anti-obesity
  799. The failure of anti-obesity programmes in schools
  800. Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: a review
  801. Overview on the antihypertensive and anti-obesity effects of secondary metabolites from seaweeds
  802. Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation
  803. Gut microbiota mediates the anti-obesity effect of calorie restriction in mice
  804. Anti-obesity and antioxidant activities of selected medicinal plants and phytochemical profiling of bioactive compounds
  805. Mechanisms of anti-obesity effects of catechins: a review
  806. Anti‐obesity and metabolic efficacy of the β3‐adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22° C
  807. Purification and identification of anti-obesity peptides derived from Spirulina platensis
  808. A hamster model of diet-induced obesity for preclinical evaluation of anti-obesity, anti-diabetic and lipid modulating agents
  809. Alternative treatments for weight loss: Safety/risks and effectiveness of anti-obesity medicinal plants
  810. Human brown adipose tissue: regulation and anti-obesity potential
  811. The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet
  812. Persistence of newer anti-obesity medications in a real-world setting
  813. A systematic review of the anti‐obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action
  814. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
  815. Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans
  816. Anti-obesity molecular mechanism of soy isoflavones: Weaving the way to new therapeutic routes
  817. The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice
  818. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced …
  819. Does fish oil have an anti-obesity effect in overweight/obese adults? A meta-analysis of randomized controlled trials
  820. Anti-obesity activities of the yoshinone A and the related marine γ-pyrone compounds
  821. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans
  822. Recent advances in anti-obesity agents
  823. Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial
  824. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of …
  825. A review of potential marine-derived hypotensive and anti-obesity peptides
  826. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats
  827. A mindful eating intervention: A theory-guided randomized anti-obesity feasibility study with adolescent Latino females
  828. Anti-obesity and Hypolipidemic effects of garlic oil and onion oil in rats fed a high-fat diet
  829. Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice
  830. Chemical profiles, antioxidant and anti-obesity effects of extract of Bambusa textilis McClure leaves
  831. Flavanols are potential anti-obesity agents, a systematic review and meta-analysis of controlled clinical trials
  832. Anti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptying
  833. MicroRNA functions in brite/brown fat—novel perspectives towards anti-obesity strategies
  834. Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet-induced obese rats
  835. Tolerability and safety of the new anti-obesity medications
  836. Anti-obesity Effect of Capsaicin in Mice Fed with High-Fat Diet Is Associated with an Increase in Population of the Gut Bacterium Akkermansia muciniphila
  837. Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial
  838. Characterization and identification of novel antidiabetic and anti-obesity peptides from camel milk protein hydrolysates
  839. Assessment of essential oil as a potential anti-obesity agent: a narrative review
  840. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice
  841. Nesfatin-1: role as possible new anti-obesity treatment
  842. Niclosamide as an anti-obesity drug: an experimental study
  843. The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women
  844. Robust anti‐obesity and metabolic effects of a dual GLP‐1/glucagon receptor peptide agonist in rodents and non‐human primates
  845. In vitro anti-diabetic, anti-obesity and antioxidant proprieties of Juniperus phoenicea L. leaves from Tunisia
  846. Stilbenes: chemistry and molecular mechanisms of anti-obesity
  847. Anti-obesity and anti-inflammatory effects of macrophage-targeted interleukin-10-conjugated liposomes in obese mice
  848. Oat products modulate the gut microbiota and produce anti-obesity effects in obese rats
  849. Anti‐obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high‐fat diet
  850. New insights into the anti-obesity activity of xanthones from Garcinia mangostana
  851. Anti-Obesity Effects of Collagen Peptide Derived from Skate (Raja kenojei) Skin Through Regulation of Lipid Metabolism
  852. Anti-obesity effects of resveratrol: Comparison between animal models and humans
  853. Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice
  854. Anti-obesity effects of seaweeds of Jeju Island on the differentiation of 3T3-L1 preadipocytes and obese mice fed a high-fat diet
  855. Cardiovascular effects of current and future anti-obesity drugs
  856. Anti-obesity effect of ethanolic extract from Cosmos caudatus Kunth leaf in lean rats fed a high fat diet
  857. Adolescent experiences of anti‐obesity drugs
  858. Anti-obesity potential of corn silks: Relationships of phytochemicals and antioxidation, anti-pre-adipocyte proliferation, anti-adipogenesis, and lipolysis induction
  859. Anti-obesity and anti-inflammatory effects of synthetic acetic acid vinegar and Nipa vinegar on high-fat-diet-induced obese mice
  860. Anti-obesity effects of artificial planting blueberry (Vaccinium ashei) anthocyanin in high-fat diet-treated mice
  861. With all due caution: Global anti-obesity campaigns and the individualization of responsibility
  862. Natural products in anti-obesity therapy
  863. Active components of essential oils as anti-obesity potential drugs investigated by in silico techniques
  864. Transdermal delivery of anti‐obesity compounds to subcutaneous adipose tissue with polymeric microneedle patches
  865. Anti-obesity property of the brown seaweed, Sargassum polycystum using an in vivo animal model
  866. Anti-obesity and anti-diabetic effects of flavonoid derivative (Fla-CN) via microRNA in high fat diet induced obesity mice
  867. Why are anti-obesity drugs stigmatized?
  868. Education as a tool to modify anti-obesity bias among Pediatric residents
  869. Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota
  870. The anti-obesity drug orlistat reveals anti-viral activity
  871. Effects of anti-obesity messages on women’s body image and eating behaviour
  872. Anti-Obesity Effects of Hispidin and Alpinia zerumbet Bioactives in 3T3-L1 Adipocytes
  873. Anti-obesity and fatty liver-preventing activities of Lonicera caerulea in high-fat diet-fed mice
  874. Lactic acid bacteria-fermented product of green tea and Houttuynia cordata leaves exerts anti-adipogenic and anti-obesity effects
  875. Anti-obesity effects of tea from Mangifera indica L. leaves of the Ubá variety in high-fat diet-induced obese rats
  876. Anti-Obesity Effects of Spiramycin In Vitro and In Vivo
  877. Ethanol extract of lotus (Nelumbo nucifera) root exhibits an anti-adipogenic effect in human pre-adipocytes and anti-obesity and anti-oxidant effects in rats fed a high …
  878. Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells
  879. Anti-obesity effects of Lentinus edodes on obese mice induced by high fat diet
  880. Enhanced anti-obesity effects of complex of resistant starch and chitosan in high fat diet fed rats
  881. Anti-obesity and anti-diabetic effects of a standardized potato extract in ob/ob mice
  882. Effectiveness, tolerability and practical application of the newer generation anti-obesity medications
  883. Structural analysis and anti-obesity effect of a pectic polysaccharide isolated from Korean mulberry fruit Oddi (Morus alba L.)
  884. Ethnobotanical study of medicinal plants used as anti-obesity remedies in the nomad and hunter communities of Burkina Faso
  885. Regulation of food intake and the development of anti-obesity drugs
  886. Evaluation of anti-obesity activities of ethanolic extract of Terminalia paniculata bark on high fat diet-induced obese rats
  887. Adenylate cyclase 3: a new target for anti‐obesity drug development
  888. Anti-obesity effects of zeaxanthin on 3T3-L1 preadipocyte and high fat induced obese mice
  889. Anti-obesity effect of extract from fermented Curcuma longa L. through regulation of adipogenesis and lipolysis pathway in high-fat diet-induced obese rats
  890. Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
  891. In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti‐obesity agents with α‐amylase and pancreatic lipase inhibitory …
  892. Transcriptome analysis revealed anti-obesity effects of the Sodium Alginate in high-fat diet-induced obese mice
  893. Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration
  894. Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice
  895. Anti‐Obesity Activity of Saringosterol Isolated from Sargassum muticum (Yendo) Fensholt Extract in 3T3‐L1 Cells
  896. The anti-obesity effect of fermented barley extracts with Lactobacillus plantarum dy-1 and Saccharomyces cerevisiae in diet-induced obese rats
  897. Anti-obesity effect of chitosan oligosaccharide capsules (COSCs) in obese rats by ameliorating leptin resistance and adipogenesis
  898. Purple corn silk: A potential anti-obesity agent with inhibition on adipogenesis and induction on lipolysis and apoptosis in adipocytes
  899. Anti-obesity and anorectic effects of saffron and its constituent crocin in obese Wistar rat
  900. Anti‐obesity and hypolipidaemic effects of Nelumbo nucifera seed ethanol extract in human pre‐adipocytes and rats fed a high‐fat diet
  901. In vivo and in vitro anti-obesity activities of dihydropyranocoumarins derivatives from Peucedanum japonicum Thunb
  902. Anti-obesity effects of enzymatically-digested alginate oligomer in mice model fed a high-fat-diet
  903. Myricetin exerts anti-obesity effects through upregulation of SIRT3 in adipose tissue
  904. Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice
  905. Physiological and molecular study on the anti-obesity effects of pineapple (Ananas comosus) juice in male Wistar rat
  906. Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: an approach for acceptable level of evidence of an effective novel herbal weight loss …
  907. Anti-obesity effect of arq zeera and its main components thymol and cuminaldehyde in high fat diet induced obese rats
  908. Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway
  909. Novel Anti-Obesity Properties of Palmaria mollis in Zebrafish and Mouse Models
  910. The anti‐obesity effects of the dietary combination of fermented red ginseng with levan in high fat diet mouse model
  911. Screening of six Ayurvedic medicinal plants for anti-obesity potential: An investigation on bioactive constituents from Oroxylum indicum (L.) Kurz bark
  912. Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists
  913. Anti-obesity effects of starter fermented kimchi on 3T3-L1 adipocytes
  914. Anti-obesity effect of yogurt fermented by Lactobacillus plantarum Q180 in diet-induced obese rats
  915. Anti-Obesity Effect of 6,8-Diprenylgenistein, an Isoflavonoid of Cudrania tricuspidata Fruits in High-Fat Diet-Induced Obese Mice
  916. Anti-obesity effects of gochujang products prepared using rice koji and soybean meju in rats
  917. Identification of Mest/Peg1 gene expression as a predictive biomarker of adipose tissue expansion sensitive to dietary anti-obesity interventions
  918. Nutritional composition and anti-obesity effects of cereal bar containing Allium fistulosum (welsh onion) extract
  919. BMP-9 as a potent brown adipogenic inducer with anti-obesity capacity
  920. Akebia quinata extract exerts anti-obesity and hypolipidemic effects in high-fat diet-fed mice and 3T3-L1 adipocytes
  921. Anti-obesity activity of Yamabushitake (Hericium erinaceus) powder in ovariectomized mice, and its potentially active compounds
  922. Theasaponin E1 as an effective ingredient for anti-angiogenesis and anti-obesity effects
  923. The evaluation and utilization of marine-derived bioactive compounds with anti-obesity effect
  924. Panax ginseng Leaf Extracts Exert Anti-Obesity Effects in High-Fat Diet-Induced Obese Rats
  925. The anti diabetic and anti obesity effect of Memecylon umbellatum extract in high fat diet induced obese mice
  926. Alterations to metabolically active bacteria in the mucosa of the small intestine predict anti-obesity and anti-diabetic activities of grape seed extract in mice
  927. Anti-obesity effects of Spirulina maxima in high fat diet induced obese rats via the activation of AMPK pathway and SIRT1
  928. Evaluation of anti-obesity and lipid-lowering properties of Vaccinium myrtillus leaves powder extract in a hamster model
  929. Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats
  930. Anti-Obesity Activities of Chikusetsusaponin IVa and Dolichos lablab L. Seeds
  931. Preparation of a nano emodin transfersome and study on its anti-obesity mechanism in adipose tissue of diet-induced obese rats
  932. Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning
  933. Evaluation of the effects and mechanism of L-citrulline on anti-obesity by appetite suppression in obese/diabetic KK-Ay mice and high-fat diet fed SD rats
  934. Urine and serum metabolite profiling of rats fed a high-fat diet and the anti-obesity effects of caffeine consumption
  935. Anti-obesity effect and protection of liver-kidney functions by Codium fragile sulphated polysaccharide on high fat diet induced obese rats
  936. Beyond lifestyle interventions: exploring the potential of anti‐obesity medications in the UK
  937. Appraisal of adaptive neuro-fuzzy computing technique for estimating anti-obesity properties of a medicinal plant
  938. Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice
  939. New ethanol extraction improves the anti-obesity effects of black tea
  940. Anti‐obesity effect of feeding probiotic dahi containing Lactobacillus casei NCDC 19 in high fat diet‐induced obese mice
  941. Anti-obesity effect of Triticum aestivum sprout extract in high-fat-diet-induced obese mice
  942. A New Ergosterol Analog, a New Bis-Anthraquinone and Anti-Obesity Activity of Anthraquinones from the Marine Sponge-Associated Fungus Talaromyces stipitatus …
  943. Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents
  944. Galectin-12 is involved in corn silk-induced anti-adipogenesis and anti-obesity effects
  945. Parent and child interactions with two contrasting anti-obesity advertising campaigns: a qualitative analysis
  946. PGC-1α may associated with the anti-obesity effect of taurine on rats induced by arcuate nucleus lesion
  947. Anti-obesity effect of milk fermented by Lactobacillus plantarum NCDC 625 alone and in combination with herbs on high fat diet fed C57BL/6J mice
  948. Emblica officinalis – Anti-obesity activity
  949. Anti‐obesity effect of Allomyrina dichotoma (Arthropoda: Insecta) larvae ethanol extract on 3T3‐L1 adipocyte differentiation
  950. Soyasaponins Aa and Ab exert an anti‐obesity effect in 3T3‐L1 adipocytes through downregulation of PPARγ
  951. Anti-obesity effect of Dioscorea oppositifolia extract in high-fat diet-induced obese mice and its chemical characterization
  952. Targeted hyaluronate–hollow gold nanosphere conjugate for anti-obesity photothermal lipolysis
  953. Anti-obesity activity, acute toxicity, and chemical constituents of aqueous and ethanol Viola mandshurica extracts
  954. In vitro evidence of anti-inflammatory and anti-obesity effects of medium-chain fatty acid-diacylglycerols
  955. Development and validation of UPLC and LC-MS/MS methods for the simultaneous determination of anti-obesity drugs in foods and dietary supplements
  956. Partially purified Peucedanum japonicum Thunb extracts exert anti-obesity effects in vitro
  957. Anti-obesity effect of fermented whey beverage using lactic acid bacteria in diet-induced obese rats
  958. The anti-obesity effect of Taheebo (Tabebuia avellanedae Lorentz ex Griseb) extract in ovariectomized mice and the identification of a potential anti-obesity compound
  959. Enhanced anti-obesity effects of bacterial cellulose combined with konjac glucomannan in high-fat diet-fed C57BL/6J mice
  960. Pre-meal tomato (Lycopersicon esculentum) intake can have anti-obesity effects in young women?
  961. Anti-obesity efficacy of nanoemulsion oleoresin capsicum in obese rats fed a high-fat diet
  962. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis
  963. Deep brain stimulation of the nucleus accumbens shell induces anti-obesity effects in obese rats with alteration of dopamine neurotransmission
  964. Chemical Composition of Essential Oil, Antioxidant, Antidiabetic, Anti-obesity, and Neuroprotective Properties of Prangos gaubae
  965. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line
  966. Anti-obesity effects of yellow catfish protein hydrolysate on mice fed a 45% kcal high-fat diet
  967. Desalted Salicornia europaea powder and its active constituent, trans-ferulic acid, exert anti-obesity effects by suppressing adipogenic-related factors
  968. Physiological characteristics and anti-obesity effect of Lactobacillus plantarum Q180 isolated from feces
  969. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind …
  970. Antidiabetic and anti-obesity activity of Ficus carica: In vitro experimental studies
  971. Anti-obesity effect of Solidago virgaurea var. gigantea extract through regulation of adipogenesis and lipogenesis pathways in high-fat diet-induced obese mice …
  972. Anti-obesity and anti-inflammatory effects of high hydrostatic pressure extracts of ginseng in high-fat diet induced obese rats
  973. Anti-obesity effects of extracts from young Akebia quinata D. leaves
  974. Anti-obesity activity of the water extract of Lactobacillus paracasei subsp. paracasei NTU 101 fermented soy milk products
  975. Anti-Obesity Effects of the Mixture of Eriobotrya japonica and Nelumbo nucifera in Adipocytes and High-Fat Diet-Induced Obese Mice
  976. In vivo anti-obesity efficacy of curcumin loaded nanofibers transdermal patches in high-fat diet induced obese rats
  977. Phytochemical profile, antioxidant, antibacterial, antidiabetic and anti-obesity activities of fruits and pits from date palm (Phoenix dactylifera L.) grown in south of …
  978. The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the …
  979. Anti-Obesity Effects of Soy Leaf via Regulation of Adipogenic Transcription Factors and Fat Oxidation in Diet-Induced Obese Mice and 3T3-L1 Adipocytes
  980. Study on health hazards through medicines purchased on the Internet: a cross-sectional investigation of the quality of anti-obesity medicines containing crude …
  981. Anti-obesity effect of total phenylpropanoid glycosides from Ligustrum robustum Blume in fatty diet-fed mice via up-regulating leptin
  982. CST, an herbal formula, exerts anti-obesity effects through brain-gut-adipose tissue axis modulation in high-fat diet fed mice
  983. Immobilized tannase treatment alters polyphenolic composition in teas and their potential anti-obesity and hypoglycemic activities in vitro
  984. Enhanced gastric tolerability and improved anti-obesity effect of capsaicinoids-loaded PCL microparticles
  985. Lipid peroxidation and anti-obesity activity of Nigella sativa seeds
  986. Phytochemical evaluation, anti-obesity and antihyperlipidemic effects of combined administration of green coffee, cinnamon and ginger
  987. Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
  988. Dried pomegranate potentiates anti-osteoporotic and anti-obesity activities of red clover dry extracts in ovariectomized rats
  989. Civilising recalcitrant boys’ bodies: pursuing social fitness through the anti-obesity offensive
  990. Anti-obesity effects of water and ethanol extracts of black ginseng
  991. Evaluation of the anti-obesity effect of the microalga Phaeodactylum tricornutum
  992. In vivo metabolomic interpretation of the anti‐obesity effects of hyacinth bean (Dolichos lablab L.) administration in high‐fat diet mice
  993. Clinical trial success rates of anti‐obesity agents: the importance of combination therapies
  994. Anti-obesity effects of Laminaria japonica fermentation on 3T3-L1 adipocytes are mediated by the inhibition of C/EBP-α/β and PPAR-γ
  995. Anti-obesity potential of enzymatic fragments of hyaluronan on high-fat diet-induced obesity in C57BL/6 mice
  996. Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats
  997. The Anti-Obesity Effects of Green Tea: A Controlled, Randomized, Clinical Trial.
  998. Anti-obesity and lipid lowering effects of Cymodocea nodosa sulphated polysaccharide on high cholesterol-fed-rats
  999. … based on 3D-QSAR CoMFA/CoMSIA and design of aryloxypropanol-amine agonists with selectivity for the human β3-adrenergic receptor and anti-obesity and anti …
  1000. The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross sectional study
  1001. Small lipidated anti-obesity compounds derived from neuromedin U
  1002. Anti-Obesity Effects of Jeju Hallabong Tangor (Citrus kiyomi? onkan) Peel Extracts in 3T3-L1 Adipocytes
  1003. Anti‐obesity and pro‐diabetic effects of hemochromatosis
  1004. Anti-obesity mechanism of Curcuma longa L. – An over view
  1005. Differential protein expression in white adipose tissue from obesity-prone and obesity-resistant mice in response to high fat diet and anti-obesity herbal …
  1006. Anti-Obesity and Hypoglycemic Effects of Poncirus trifoliata L. Extracts in High-Fat Diet C57BL/6 Mice
  1007. Anti-obesity therapy by food component: unique activity of marine carotenoid, fucoxanthin
  1008. Hepatoprotective and anti-obesity effects of Korean blue honeysuckle extracts in high fat diet-fed mice
  1009. Advancing insights on the anti-obesity biochemical mechanism of (−)-epigallocatechin gallate (EGCG) by inhibiting α-amylase activity
  1010. Anti-Obesity Effect of Bombus ignitus Queen Glycosaminoglycans in Rats on a High-Fat Diet
  1011. Anti-obesity effect of a traditional Chinese dietary habit—blending lard with vegetable oil while cooking
  1012. Saturated fatty acid attenuates anti-obesity effect of green tea
  1013. Anti-obesity effects of Asian dayflower, Commelina communis, in mice with high-fat diet-induced obesity and in 3T3-L1 cells
  1014. Anti-obesity effects of Clausena excavata in high-fat diet-induced obese mice
  1015. The anti-obesity effect of Smilax china extract
  1016. Comparative evaluation of anti-obesity effect of Aloe vera and Gymnema sylvestre supplementation in high-fat diet fed C57BL/6J mice
  1017. Anti-obesity and anti-hepatosteatosis effects of dietary scopoletin in high-fat diet fed mice
  1018. Ethanol extract of Pinus koraiensis leaves containing lambertianic acid exerts anti-obesity and hypolipidemic effects by activating adenosine monophosphate …
  1019. Anti-obesity effect of Polygala tenuifolia
  1020. Ginsenoside Rg5: Rk1 exerts an anti-obesity effect on 3T3-L1 cell line by the downregulation of PPARγ and CEBPα
  1021. Evidence of anti-obesity and mixed hypolipidemic effects of extracts from pink shrimp (Penaeus brasiliensis and Penaeus paulensis) processing residue
  1022. Anti-obesity effect of Crinum asiaticum var. japonicum Baker extract in high-fat diet-induced and monogenic obese mice
  1023. Mutagenic potential of Cordia ecalyculata alone and in association with Spirulina maxima for their evaluation as candidate anti-obesity drugs
  1024. The anti-obesity properties of the proanthocyanidin extract from the leaves of Chinese bayberry (Myrica rubra Sieb. et Zucc.)
  1025. Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET
  1026. Anti-obesity effect of ethanolic extract of jasmine flowers (jasminumsambac (l) Ait) in high-fat diet-induced mice: potent inhibitor of pancreatic lipase enzyme
  1027. A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects
  1028. Microalgal oil supplementation has an anti-obesity effect in C57BL/6J mice fed a high fat diet
  1029. Anti-oxidative and anti-obesity effects of Amomum Cardamomum L. extract
  1030. Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designing
  1031. Potency of turmeric (Curcuma longa L.) extract and curcumin as anti-obesity by inhibiting the cholesterol and triglycerides synthesis in HepG2 cells
  1032. Safety of anti-obesity drugs approved for long-term use
  1033. The nutritional composition and anti-obesity effects of an herbal mixed extract containing Allium fistulosum and Viola mandshurica in high-fat-diet-induced …
  1034. Anti-Obesity Effects of Melastoma malabathricum var Alba Linn in Rats Fed with a High-Fat Diet
  1035. Anti-oxidative and anti-obesity effect of combined extract and individual extract of samjunghwan
  1036. Anti-obesity action of INDUS810, a natural compound from Trigonella foenum-graecum: AMPK-dependent lipolysis effect in adipocytes
  1037. The anti-obesity effect of starch in a whole grain-like structural form
  1038. A combination of glucosyl hesperidin and caffeine exhibits an anti‐obesity effect by inhibition of hepatic lipogenesis in mice
  1039. Anti-obesity effects of a mixture of fermented ginseng, Bifidobacterium longum BORI, and Lactobacillus paracasei CH88 in high-fat diet-fed mice
  1040. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice
  1041. The enhanced anti-obesity effect and reduced gastric mucosa irritation of capsaicin-loaded nanoemulsions
  1042. Evaluation of survival, free radical scavenging and human enterocyte adherence potential of lactobacilli with anti‐obesity and anti‐inflammatory CLA isomer …
  1043. … and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT 2C …
  1044. Farnesol has an anti-obesity effect in high-fat diet-induced obese mice and induces the development of beige adipocytes in human adipose tissue derived …
  1045. Dubious anti-obesity agent hca from Garcinia: A systematic review
  1046. Self-treatment with anti-obesity medications in overweight and obese women in Tehran-Iran
  1047. Anti-obesity effect of intranasal administration of galanin-like peptide (GALP) in obese mice
  1048. Anti-obesity effect of (8-E)-niizhenide, a secoiridoid from Ligustrum lucidum, in high-fat diet-induced obese mice.
  1049. Deletion of nuclear factor-κB p50 upregulates fatty acid utilization and contributes to an anti-obesity and high-endurance phenotype in mice
  1050. Anti-obesity and anti-hepatosteatosis effects of dietary Zingiber officinale extract in male obese rats
  1051. Anti-obesity effect of halophyte crop, Limonium tetragonum in high-fat diet-induced obese mice and 3T3-L1 adipocytes
  1052. Anti-obesity effect of Korean Hamcho (Salicornia herbacea L.) powder on high-fat diet-induced obese rats
  1053. Anti-Obesity Effect of Allium hookeri Leaf Extract in High-Fat Diet-Fed Mice
  1054. 2, 4, 6-Trihydroxybenzaldehyde, a potential anti-obesity treatment, suppressed adipocyte differentiation in 3T3-L1 cells and fat accumulation induced by high-fat diet in …
  1055. Antihyperlipidemic and anti-obesity effects of the methanolic extract of parijoto (Medinilla speciosa)
  1056. Anti-diabetes and anti-obesity: A meta-analysis of different compounds
  1057. Orlistat-an anti-obesity drug-An overview
  1058. Fish protein hydrolysate exhibits anti-obesity activity and reduces hypothalamic neuropeptide Y and agouti-related protein mRNA expressions in rats
  1059. The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function
  1060. Anti-obesity effects of granulocyte-colony stimulating factor in Otsuka-Long-Evans-Tokushima fatty rats
  1061. Peanut sprouts extract (Arachis hypogaea L.) has anti-obesity effects by controlling the protein expressions of PPARγ and adiponectin of adipose tissue in …
  1062. Evaluation of Anti-Obesity Activity of Convolvulus pluricaulis Extract
  1063. Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
  1064. Comparison of the anti‐obesity and hypocholesterolaemic effects of single Lactobacillus casei strain Shirota and probiotic cocktail
  1065. Aqueous and methanol extracts of Vernonia amygdalina leaves exert their anti-obesity effects through the modulation of appetite-regulatory hormones
  1066. Anti-obesity properties of the dietary green alga, codium cylindricum, in high-fat diet-induced obese mice
  1067. Novel anti-obesity drugs and plasma lipids
  1068. A high fat diet enriched with sea cucumber gut powder provides cardio-protective and anti-obesity effects in C57BL/6 mice
  1069. Cooking methods affect phytochemical composition and anti-obesity potential of soybean (Glycine max) seeds in Wistar rats
  1070. Anti-obesity and haematological effects of Malaysia Hibiscus sabdariffa L. aqueous extract on obese Sprague Dawley rats
  1071. Chemical constituents from Ainsliaea acerifolia as potential anti-obesity agents
  1072. Anti-obesity pharmacotherapy and the potential for preventing progression from prediabetes to type 2 diabetes
  1073. Anti-obesity effects on unripe Rubus coreanus Miquel extract in high fat diet-induced obese mice
  1074. Anti-obesity drugs: A necessary part of treatment
  1075. Anti-obesity effects of pectinase and cellulase enzyme‑treated Ecklonia cava extract in high‑fat diet‑fed C57BL/6N mice
  1076. Herbal-derived anti-obesity compounds and their action mechanisms
  1077. An evidence-based review: Anti-obesity effects of Coleus forskohlii
  1078. In-vitro antioxidant and anti-obesity properties of Bauhinia Variegata
  1079. Evaluation of anti-obesity activity, acute toxicity, and subacute toxicity of probiotic dark tea
  1080. New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents
  1081. Ursolic acid in experimental models and human subjects: Potential as an anti-obesity/overweight treatment
  1082. Anti-obesity effects of Sparassis crispa on high-fat diet-induced obese mice
  1083. Anti-obesity effects of Arctii Fructus (Arctium lappa) in white/brown adipocytes and high-fat diet-induced obese mice
  1084. Anti-obesity activity of Taraxacum officinale in high fat diet induced obese rats.
  1085. Review of current anti-obesity drugs in obese adults
  1086. Isolation compound anti-obesity from the Bark Ara (Ficus racemosa) of Aceh
  1087. Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target
  1088. Docking evaluation of catechin and its derivatives on fat mass and obesity-associated (FTO) protein for anti-obesity agent
  1089. Irisin peptide is myokine, anti-obesity and anti-lipidemic factor
  1090. Anti-obesity effect of ethyl acetate fraction from 50% ethanol extract of fermented Curcuma longa L. in 3T3-L1 cells
  1091. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet
  1092. Anti-obesity medicinal plants
  1093. Application of response surface methodology (RSM) for optimization of anti-obesity effect in fermented milk by lactobacillus plantarum Q180
  1094. How does perceived effectiveness affect adults’ ethical acceptance of anti-obesity threat appeals to children? When the going gets tough, the audience gets …
  1095. Synthesis of prenylated quinolinecarboxylic acid derivatives and their anti-obesity activities
  1096. Standardization of extract mixture of Chaenomeles sinensis and Phyllostachys bambusoides for anti-obesity by HPLC–UV
  1097. Anti-Obesity Effect of the Above-Ground Part of Valeriana dageletiana Nakai ex F. Maek Extract in High-Fat Diet-Induced Obese C57BL/6N Mice
  1098. The Study on anti-obesity of Myrrh ethanol extract
  1099. The anti-obesity effects of Younggyechulgam-tang-ga Hwanggi on obesity in mice induced by high fat diet
  1100. In vitro anti-obesity effects of kimchi prepared with solar salts without bittern on 3T3-L1 adipocytes
  1101. Cardiometabolic effects of anti-obesity pharmacotherapy
  1102. Anti-obesity phenotypic screening looking to increase OBR cell surface expression
  1103. Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in-vivo anti-obesity efficacy
  1104. Anti-obesity potentials of aqueous and methanol extracts of Vernonia amygdalina Del. Leaves in high-fat diet fed rats
  1105. … and the OB-receptor as anti-obesity target: recent in silico advances in the comprehension of the protein-protein interaction and rational drug design of anti-obesity …
  1106. Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model
  1107. An eudesman derivative from Verbesina persicifolia DC as a natural mild uncoupler in liver mitochondria. A new potential anti-obesity agent?
  1108. Anti-obesity effects of the water extract from Orostachys japonicus in high-fat diet-fed mice
  1109. CTSK inhibitor exert its anti-obesity effects through regulating adipocyte differentiation in high-fat diet induced obese mice
  1110. Anti-obesity effect of radix Angelica sinensis and candidate causative genes in transcriptome analyses of adipose tissues in high-fat diet-induced mice
  1111. Anti-obesity effect of EGCG and glucosamine-6-phosphate through decreased expression of genes related to adipogenesis and cell cycle arrest in 3T3-L1 …
  1112. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice
  1113. Anti-obesity drug orlistat (xenical) is a novel antitumor medication
  1114. Anti-obesity effect of red radish coral sprout extract by inhibited triglyceride accumulation in a microbial evaluation system and in high-fat diet-induced obese …
  1115. The MCH1 receptor, an anti‐obesity target, is allosterically inhibited by 8‐methylquinoline derivatives possessing subnanomolar binding and long residence times
  1116. A feminist analysis of anti-obesity campaigns: manipulation, oppression, and autonomy
  1117. In vitro anti-obesity effect of macrolichens Heterodermia leucomelos and Ramalina celastri by pancreatic lipase inhibitory assay
  1118. Neuropeptide Y1 and Y5 receptor antagonists as potential anti-obesity drugs: Current status
  1119. PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration
  1120. Anti-obesity activity of peanut sprout extract
  1121. Anti-obesity drug discovery and development
  1122. Anti-obesity effects of fermented soybean oils in 3T3-L1 pre-adipocytes and high fat diet-fed C57BL/6J mice
  1123. Comparison of anti-obesity effect between two types of syrup containing rare sugars in Wistar rats
  1124. Anti-obesity effects of African mango (Irvingia gabonesis, IGOB 131TM) extract in leptin-deficient obese mice
  1125. Characterization of anti-obesity compounds from soybean paste
  1126. Physiological characteristics and anti-obesity effect of Lactobacillus plantarum K6 isolated from Kimchi
  1127. Anti-obesity effect of Panax Ginseng in animal models: study protocol for a systematic review and meta-analysis
  1128. The anti-obesity effect of Seungyangjeseup-tang for high fat diet induced obese mice
  1129. … (rosemary): a novel therapeutic agent for antioxidant, antimicrobial, anticancer, antidiabetic, antidepressant, neuroprotective, anti-inflammatory and anti-obesity …
  1130. Combinatorial gene construct and non-viral delivery for anti-obesity in diet-induced obese mice
  1131. Commonly prescribed oral anti-obesity medication and alternative anorectics
  1132. Anti-obesity and antioxidant activity of Cucurbita maxima Duchesne (L) albino wistar rats.
  1133. Evaluation of anti-obesity effect of fattolin, a polyherbal formulation in progesterone induced obesity in mice
  1134. In vivo anti-obesity efficacy of fucoxanthin-loaded emulsions stabilized with phospholipid
  1135. Dose dependent anti-obesity effect of three different Lactobacillus sakei strains using a diet induced obese murine model
  1136. Anti-obesity effects of Galgeun-tang in high fat diet induced obese mice model
  1137. Comparison of anti-obesity effects of sprit vinegar and natural fermented vinegar products on the differentiation of 3T3-L1 cells and obese rats fed a high-fat diet
  1138. Anti-obesity effect of fermented detoxified Rhus verniciflua vinegar supplementation in diet-induced obese rats
  1139. Antioxidant, enzyme inhibitory and anti-obesity potential of sorrel calyx extracts in 3T3-L1 adipocytes
  1140. Anti-obesity effects of Lipid Extract from Sea-reared of Rainbow Trout (Oncorhynchus mykiss) Fed with Sea Squirt (Halocynthia roretzi) Tunic’s Carotenoids and …
  1141. Anti-obesity effects of traditional and standardized meju in high-fat diet-induced obese C57BL/6J mice
  1142. Anti-obesity effect of Eriobotrya japonica leaves extract on obese mice induced by high-fat diet
  1143. Experiential documentation of Trimad for its anti-obesity potential: A survey of Ayurvedic physicians from Pune city
  1144. Anti-obesity effects of flavonoids and saponins from adzuki bean
  1145. In-vitro anti-obesity efficacy of selected plants in 3T3-l1 cell line
  1146. Anti-obesity effect of proanthocyanidins from the coat of scarlet runner beans on high-fat diet-fed mice
  1147. The anti-obesity and anti-inflammatory effects of “LICONINE TM”, an extract of Glycyrrhiza uralensis, on diet-induced obese mice and 3T3-L1 mouse adipocytes
  1148. Evaluating the anti-obesity potential of Lactobacillus fermentum 4B1, a probiotic strain isolated from balao-balao, a traditional Philippine fermented food
  1149. Development of an anti-obesity polyherbal formulation containing Terminalia arjuna, Lagenaria siceraria and Piper nigrum
  1150. … and Nelumbo nucifera Gaertn. root extracts for functional food: metabolic profiling by MS, FTIR and fluorescence and evaluation of cytotoxicity and anti-obesity properties on 3T3 …
  1151. Anti-obesity and anti-fatty liver effects of Cynara scolymus L. leaf extract in mice under diet-induced obesity
  1152. Anti-obesity and LDL-cholesterol lowering effects of silkworm hemolymph inC57BL/6N mice fed high fat diet
  1153. Anti-obesity and anti-hyperlipidemic activities of fermented coffee with Monascus ruber mycelium by solid-state culture of green coffee beans
  1154. Anti-obesity Effects of black soybean Doenjang in C57BL/6 mice
  1155. Anti-obesity effect of Solidago virgaaurea extract in high-fat diet-fed SD rat
  1156. Anti-obesity activity of Vateria indica linn. stem bark in rats
  1157. Hypoglycemic and Anti-obesity Polyherbal Mixtures
  1158. Assessment of nutritional value, chemical composition and anti-obesity effect of dried jojoba leaves in North Sinai
  1159. Multifaceted Effects of Guggulsterone as Anti‐obesity Agent
  1160. Synthesis and lipid-lowering evaluation of 3-methyl-1H-purine-2, 6-dione derivatives as potent and orally available anti-obesity agents
  1161. Anti-obesity effects of the stem bark of Japanese horse chestnut (Aesculus turbinate) in 3T3-L1 preadipocytes
  1162. Shaping the family; Anti-obesity discourses and family life
  1163. A case study: Advancing public health through Gardens for Healthy Communities (GHC) in New York City: The role of anti-obesity objectives in urban agriculture …
  1164. Ursolic acid, a promising dietary bioactive compound of anti‐obesity (1045.40)
  1165. Anti-obesity effect of Trimad, a polyherbal formulation: a review
  1166. Anti‑obesity effect of robusta fermented with Leuconostoc mesenteroides in high‑fat diet‑induced obese mice
  1167. Current status of medical therapy and new targets for anti obesity drug development
  1168. Anti-obesity efficacy of roots of Stereospermum suaveolens in high fat-induced obese rats
  1169. Efficient and reliable screening of anti‐obesity agents on a micro‐cell pattern chip
  1170. Anti-obesity effect and antioxidant activity in high-fat diet mice fed fermented buckwheat products (Miso)
  1171. Anti-obesity property of lichen Thamnolia vermicularis extract in 3T3-L1 cells and diet-induced obese mice
  1172. Anti-obesity effect of black vinegar fermented with herbal extracts
  1173. Mining Molecular Pharmacological Effects from Biomedical Text: a Case Study for Eliciting Anti‐Obesity/Diabetes Effects of Chemical Compounds
  1174. Evaluation of anti-obesity potentials of Sphenostylis stenocarpa ethanolic seed extract
  1175. Lingonberry (vacciniumvitis-idaea L) mobilizes L6 muscle GLUT4 transporters and exerts anti-obesity and antidiabetic effects in vivo
  1176. A comparative study of efficacy of Argyreia speciosa and orlistat for their anti-obesity action in high fat diet induced obese rats
  1177. Anti-obesity and anti-inflammation effects of Cheonggukjang in C57Bl/6 mice with high fat diet induced obesity
  1178. Anti-Obesity and Anti-Hypertensive Action of Calanus Oil
  1179. In Vitro Anti-obesity and anti-cancer activities of different extracts of Annona squamosa L. and Ficus racemosa L. leaves
  1180. Anti-obesity effect of Fructus pyri Pyrifoliae extract fermented by lactic-acid bacteria on rats
  1181. An investigation into the Anti-obesity properties of Cyclopia
  1182. Okra (Abelmoschus esculentus L Moench) as anti-cholesterolemia, anti-diabetic and anti-obesity in white male rats
  1183. The Anti-Obesity effect of instant Pu-Erh ripe tea in mice with hydrogenated oil Diet-Induced obesity
  1184. In vivo anti-obesity activity of methanolic extract of Helianthus annuus seeds
  1185. Identification and determination of phenolphthalein added into the anti-obesity product and healthcare food by TLCS
  1186. Anti-obesity drugs currently used and new compounds in clinical development
  1187. Effect of Platycodon grandiflorum Fermentation with Salt on Fermentation Characteristics, Microbial Change and Anti-obesity Activity
  1188. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
  1189. Lipase inhibitory and anti-obesity effect of the hydro alcoholic extract of Pinus sylvestris bark.
  1190. Anti-obesity Effects of the Administration of Tournefortia paniculata Cham Extract on Wistar Rats Subjected to a Hypercaloric Diet
  1191. Reevaluation of anti-obesity action of mazindol and elucidation of its effect on the reward system
  1192. Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida
  1193. Hypolipidemic and anti-obesity effect of nobiletin and its role in prevention of fatty liver in high fat diet-fed rats.
  1194. In vitro anti-diabetic and anti-obesity activities of compounds from the Cuban medicinal plant, Allophylus cominia (L.) Sw
  1195. EVALUATION OF HYPOLIPIDEMIC AND ANTI-OBESITY ACTIVITIES OF BIOPHYTUMSENSITIVUM LINN EXTRACTS ON HIGH FAT DIET INDUCED …
  1196. Anti-obesity drugs: present and future
  1197. Anthocyanins from Cornus kousa ethanolic extract attenuate obesity in association with anti-angiogenic activities in 3T3-L1 cells by down-regulating …
  1198. Recent Advances for Anti-Obesity Agents
  1199. Anti-obesity effect of phenylcoumarins from two Calophyllum spp in 3T3-L1 adipocytes
  1200. Development and validation of HPTLC methodfor estimation of imperatorin in anti-obesity polyherbalformulation, Safoof-e-Muhazzil and some of its ingredients
  1201. The anti‐obesity effect of FGF19 occurs independent of the thermogenic protein UCP1
  1202. The synergistic anti‐obesity effect of Gelidium elegans extract and orlistat in vivo and in vitro
  1203. Anti-adipogenic effect of Artemisia annua in diet-induced-obesity mice model
  1204. Taxation as Nudge: The Failure of Anti-Obesity Paternalism
  1205. Synthesis Design of an Anti-Obesity Agent ‘Sibutramine’: A Reatrosynthetic Approach
  1206. Preformulation characterization and in vivo absorption in beagle dogs of JFD, a novel anti-obesity drug for oral delivery
  1207. [Corrigendum] The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells
  1208. Anti-obesity potential of the ethanolic extract of Alstonia boonei stem bark on high carbohydrate diet induced obesity in male Wistar rats
  1209. Can anti-obesity drugs be repurposed to treat cocaine addiction?
  1210. Leishmanicidal, anti-inflammatory and anti-obesity properties of natural products from common medicinal and edible plants.
  1211. Evaluation of Anti-Obesity Properties of Few South Indian Medicinal Plants by Using Pancreatic Lipase Assay
  1212. Novel anti-obesity quercetin-derived Q2 prevents metabolic disorders in rats fed with high-fat diet
  1213. Anti-obesity effects of alcohol extract from Abelmoschus esculentus Linn. and its correlation with gene SREBP-1 and FAS
  1214. Anti-obesity effect of lactoferrin; subgroup analysis excluding subjects with obese and/or hyper-LDL cholesterolemia
  1215. Hepatic proteome and its network response to supplementation of an anti-obesity herbal mixture in diet-induced obese mice
  1216. Biologically active ingredients from food with anti-obesity properties
  1217. Simultaneous Determination of 20 Anti-Obesity Drugs Illegally Added in Weight-loss Functional Foods by Matrix Solid Phase Dispersion-High Performance Liquid …
  1218. Australian native plants: anti-obesity and anti-inflammatory properties
  1219. Anti-Obesity Effect of Auricularia spp.
  1220. Role of anti-inflammatory adipokines in obesity-related diseases
  1221. Anti‐obesity effect of bamboo salt on diet‐induced obesity in C57BL/6 mice (811.12)
  1222. Anti-obesity and anti-diabetic effects of fucoxanthin
  1223. Anti-obesity public service announcements: an exploratory study on perceived realism and identification with advertisement characters
  1224. Anti-obesity and lipid-decreasing effects of Pu-er tea.
  1225. Anti‐obesity effect of Chungkugjang in 3T3‐L1 Adipocytes
  1226. Oleaginous yeast Rhodosporidium toruloides as a tool for rapid evaluation of anti-obesity candidates: inhibitory effect of persimmon leaf fermentate on lipid …
  1227. Anti-obesity potential of Indian traditional medicinal plants and their phytochemicals
  1228. Anti-obesity effect of resveratrol in rats on high fat diet through regulation of gene expression of visceral white adipose tissue
  1229. Anti-obesity and anti-diabetic properties of two natural extracts rich in flavonoids (helichrysum and grapefruit): physiological and molecular mechanisms
  1230. Development and Characterization of Calcium Silicate Based Formulations for Anti-Obesity Therapy: Orlistat
  1231. Anti-obesity and Hypolipidemic Effects of N-(β-d-Xylopyranosyl) Taurine Sodium Salt Supplementation in Rats Fed a High-Fat Diet and β-Alanine
  1232. … to” Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents”[Eur. J. Med …
  1233. Resveratrol exerts anti-obesity effect involving modulation of UCP-1 and HO-1.
  1234. Novel Anti-Obesity Effects of Human Milk Oligosaccharide LNnT
  1235. Are there irrationalities in the consumption of anti-obesity drugsin Brazil? a pharmaco-econometric analysis of panel datasets
  1236. Anti-obesity effect of Rhizophora mucronata-a true mangrove
  1237. Study of lipoprotein lipase inhibitory activity of anti-obesity herb extracts
  1238. Radical Scavenging and Anti-Obesity Effects of 50% Ethanol Extract from Fermented Curcuma longa L.
  1239. Antioxidant and anti-obesity activity of ethanol extracts from fermented Arctium lappa L
  1240. Anti-obesity Activity of Broussonetia luzonicus (Moraceae) leaves
  1241. N-(d-Ribopyranosyl)Taurine Sodium Salt Has Anti-obesity Effect in Diet-Induced Obesity and Taurine Deficiency Rat Model
  1242. Anti-obesity effect of the jasminum sambac (l.) W. ait. Ethanol extract in high fat diet induced mice
  1243. Anti-Obesity Effects of 6
  1244. Anti-Obesity Pharmacotherapy
  1245. Anti-obesity Effects of Curcuma longa L. Extracts through Inhibiting Adipogenic Transcription Factors
  1246. Anti-Obesity Effect of 10 Kinds of Herbal Medicines Mixture with Sauce Base in High Fat Diet-Induced Obese C57BL/6 Mice
  1247. Evaluation of anti-obesity effect of roasted Inonotus obliquus in 3T3-L1 cells
  1248. β2GPI exerts an anti-obesity effect in female mice by inhibiting lipogenesis and promoting lipolysis
  1249. Advancing public health through Gardens for Healthy Communities (GHC) in New York City: The role of anti-obesity objectives in urban agriculture policy
  1250. Anti-obesity Effect of Gooseberry (Physalis peruviana) Fruits in-Induced Obese Rats
  1251. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents
  1252. Herbal Formulation development for Hypolipidemic and Anti-Obesity activity on Heartwood of Caesalpinia sappan Linn
  1253. Comparison of Anti‐obesity Effects of Onion Peels by Different Extraction Methods Using 3T3‐L1 and Primary Brown Adipocytes In Vitro
  1254. Back yard malabar tamarind (Garcinia Gummi- gutta): A miracle anti-obesity agent
  1255. Natural anti-obesity agents
  1256. Anti‐obesity Activity of Black Rice with Giant Embryo in ob/ob Mice
  1257. Piceatannol exerts anti-obesity effect through modulating adipogenic proteins and gut microbiota in C57BL/6 mice
  1258. Anti-oxidant and Anti-inflammatory activity of Safoof Mohazzil: A traditional, Poly-herbal Unani formulation for Obesity
  1259. Anti-obesity effect of steamed soybean and fermented steamed soybean in high-fat diet-induced obese ICR mice
  1260. Identification by docking simulation and in vivo effect of essential oil from Cinnamommum burmannii as anti-obesity with leptin receptor in the olfactory system of mice …
  1261. Yeast hydrolysate as a functional anti-obesity ingredient: appetite suppressive effects of yeast hydrolysate in food-deprived mice
  1262. Characterization of In Vivo Metabolites of a Potential Anti-obesity Compound, the 3-Methyl-1H-Purine-2,6-Dione Derivative C-11, Employing Ultra-High Performance …
  1263. The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes
  1264. Anti-inflammatory effects of melatonin in obesity and hypertension
  1265. Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity
  1266. Anti-Obesity Effect of Calcium
  1267. Natural Compounds–Anti-Obesity Properties
  1268. Obesity status and anti-obesity regimen: The case among adolescents in Iloilo City, Philippines
  1269. The efficacy and safety of novel anti-obesity therapies.
  1270. Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta …
  1271. The road to increased access to anti-obesity drugs in the USA
  1272. Anti-obesity medication
  1273. Drug therapy for obesity with anti-aging genes modification
  1274. Determinants of State Policy on Childhood Obesity: An Analysis of Anti-Obesity Legislation Passed From 2003 to 2013
  1275. Fat-shaming: Change4Life’s anti-obesity ‘nudge’campaign glosses over social inequalities
  1276. Measuring anti–factor Xa activity to monitor low-molecular-weight heparin in obesity: a critical review
  1277. Anti-Obesity Properties of Bentonite in Diet-Induced Obesity Mice
  1278. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression
  1279. Studies on the food compounds showing anti-obesity effect and their mechanism to suppress obesity
  1280. LEAFY HERBS AS A TOOL FOR ANTI-OBESITY
  1281. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
  1282. Anti-Obesity Molecules from Plants and their Mode of Action
  1283. SAFETY AND EFFICACY USING ANTI-OBESITY MEDICATIONS IN ELDERLY PATIENTS
  1284. Anti-Obesity Activity of Euptelea Pleiosperma Ethanol Extract
  1285. Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood
  1286. Relationship between obesity and anti‐Müllerian hormone in reproductive‐aged African American women
  1287. Evidence of bias against adoption of anti-obesity pharmacotherapies
  1288. Anti-obesity Pharmacotherapy: Past and Present
  1289. Anti-obesity effects of green tea catechins.
  1290. SCREENING OF CITRUS PLANTS FOR ANTI-OBESITY PROPERTIES
  1291. Investigation of the role of pharmacokinetics and the development of novel anti-obesity agents
  1292. Review of current anti-obesity drugs in obese adults
  1293. Anti-obesity effect of traditional Chinese medicine and natural products
  1294. Development of Anti-obesity Agents on a Micro Cell Pattern Chip
  1295. SCREENING OF SELECTED NATIVE PLANTS IN MALAYSIA FOR ANTI-OBESITY ACTIVITY
  1296. Anti-Obesity Drugs of the Twenty-First Century: Hope or Hype?
  1297. Pro-and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity
  1298. Anti-Obesity Activity of Medicinal Plants: A Review
  1299. Anti-obesity Activity for 14 Wild Plants from Palestine
  1300. Institutionalization of anti-obesity messages in Chilean schools
  1301. Daily Exercise for Anti-Obesity Anti-Diabetes Lifestyle
  1302. Receptomics to identify the targets for plant-based anti-obesity compounds
  1303. MECHANISTIC STUDIES OF POTENTIAL ANTI-OBESITY NUTRACEUTICAL PROPERTIES IN SELECTED MALAYSIAN PLANTS
  1304. Efficacy and Safety of HSG4112, a Novel Anti-Obesity Oral Agent in Diet-Induced Obesity (DIO) Mice
  1305. Drug Utilisation Study of Anti-Obesity Products Dispensed by Pharmacies in South Africa
  1306. Anti-obesity effect of Aster spathulifolius Maxim extract
  1307. In-silico study of native plants in Malaysia for anti-obesity activity
  1308. Withdrawal of anti-obesity medicines reviewed
  1309. Anti-Obesity Agents and the US Food and Drug Administration
  1310. Smith, F.,… Viner, RM (2015). Adolescent experiences of anti-obesity drugs. Clinical Obesity, 5 (3), 116-26. DOI: 10.1111/cob. 12101
  1311. Anti-inflammatory effects of physical exercise on obesity
  1312. Monitoring of anti-impotence drug, anti-obesity drugs and their analogues in foods
  1313. Pomegranate: potential prevention and treatment in obesity using the anti-obesity and anti-inflammatory agents in PPARs pathways
  1314. Studies on the molecular mechanisms underlying the anti-obesity effect of green algal siphonaxanthin
  1315. Anti-obesity effect of abelmoschus manihot extract
  1316. ANTI-OBESITY EFFECTS OF OLEOYLETHANOLAMIDE IN A RODENT MODEL OF DIET INDUCED OBESITY
  1317. Anti-obesity properties of selected phytochemicals in cell culture and animal models
  1318. Anti-Obesity Vaccines Could Reverse the Epidemic
  1319. Anti-Obesity Vaccines Could Reverse the Epidemic
  1320. ELECTROCHEMICAL CHARACTERIZATION OF TWO OLEAMIDE ANALOGUES ANTI-OBESITY AGENTS.
  1321. Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women
  1322. Anti-obesity effects of green tea extracts on humans
  1323. Investigation of anti obesity activity of alcoholic extract of roots of Carica papaya on obesity induced animal model.
  1324. Mini review: NESFATIN–1: ROLE AS POSSIBLE NEW ANTI-OBESITY TREATMENT
  1325. Screening and Evaluation of Edible Plant Extracts for Anti-Obesity effect
  1326. Anti‐obesity Effect of Solar Salt Produced in Korea on C57BL/6 Mice
  1327. Enhanced external counterpulsation for glycemic control and anti-obesity effect
  1328. In Vitro Anti-Obesity Effect of Ethanolic Fermant of Cudrania tricuspidata
  1329. Cross-state comparison of medicaid Anti-Obesity medication coverage: 1999-2013
  1330. Anti-obesity potential of Medohar Ark: A traditional Ayurvedic preparation in high fat diet-induced rat model
  1331. Resveratrol: Anti-Obesity Mechanisms of Action
  1332. LC/MS analysis and anti-obesity effect of the chungtaejun tea water extract
  1333. Anti-obesity and hypolipidemic activity of siddha drugs: A review
  1334. Approaches for Development of Anti-Obesity Agents Using Natural Compounds and Microbiota Modification
  1335. Discovery of anti-obesity agents from biosynthetic engineering by radiation fusion technology
  1336. Demographics Are Not Enough: Targeting and Segmentation of Anti-Obesity Campaigns in Mexico
  1337. Early Biomarkers Predicting Successful Weight Loss after Anti-obesity Intervention
  1338. The role of hen yolk egg as an alternative anti-obesity treatment on high fat diet-induced obesity
  1339. Curcumin mimics the neurocognitive and anti-inflammatory effects of caloric restriction in a mouse model of midlife obesity
  1340. Effects of dietary control, exercise and anti-obesity prescriptions on weight loss: An interview-based study
  1341. In vitro and in vivo anti-obesity effects of carob and wakame combination
  1342. Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology
  1343. Evaluation of anti‐obesity activity of different extracts from Grifola frondosa in vitro
  1344. Screening of polyphenolic plant extracts for anti-obesity properties in Wistar rats
  1345. Anti-obesity drugs MetS or NAFLD
  1346. Effect of Mixed Extract from Korean Cheongkukjang on high fat diet induced anti-obesity in mice
  1347. In vitro studies on anti-obesity activity of Korean Memilmuk through AMPK activation
  1348. Nutrigenomic Approach of Anti-Obesity Phytochemicals
  1349. Favorable changes in body weight and BMI as a result of a complex non-medicated anti-obesity therapy in patients with overweight and obesity.
  1350. Antioxidant and Anti-Obesity Effects of Albedo Flour Citrus Sinensis
  1351. Anti-obesity drug that shrinks fat without suppressing appetite
  1352. Anti-obesity study of Indonesian medicinal plants: an in vitro study in adipocytes
  1353. Basic Studies on Modulation of Physiological Signals Generated by Fatty Acid Metabolisms for Anti-obesity and Anti-diabetes
  1354. Herbal Black Vinegar and the Anti-obesity Complications in vivo
  1355. Free Radical Scavenging and Anti-obesity Activities of Bansi (Diospyroskaki), Chenogdo flat persimmon
  1356. Efficacy, Safety and Epidemiology of Anti-Obesity Drug Prescribing in Children and Adolescents
  1357. Fat-O: A natural, halal, cost effective and holistic novel anti-obesity drink
  1358. IMPACT OF PRECEDING ANTI-OBESITY PSAS ON PROCESSING OF FOOD COMMERCIALS AND DESIRE FOR HIGH-CALORIE FOODS
  1359. Anti-obesity effect in mice and monkeys of partial inhibition of PI3K [alpha]
  1360. ANTI-OBESITY PROPERTIES OF DEEP SEA WATER ON ADIPOCYTES CELL
  1361. Validation of RNA interferences as technique to study CNS anti-obesity drug targets
  1362. Quality of evidence of anti-obesity pharmacotherapy: an overview of systematic reviews
  1363. Anti-obesity Effect of Snowbell Tree Fruit in 3T3-L1 Adipocytes
  1364. Human Milk Oligosaccharide LNnT as a Novel Anti-Obesity Agent
  1365. Proteomic analysis of the anti-obesity effect of Taeumjowui-Tang in high fat diet-induced obese mice
  1366. Anti-obesity effects of Phyllostachys pubescens and Scutellaria baicalensis complex
  1367. Efficacy of a Traditional Herbal Mixture as an Anti-Obesity Supplement in Obese Individuals: A Randomized Controlled Trial
  1368. Sirtuins and Bile Acids: Potential Anti-obesity Strategies Targeting Mitochondria
  1369. Studies on Extraction of Fucoxanthin and Its Potential Anti‐obesity Effect
  1370. Anti-obesity effect of Chitosan-glycyrrhizin conjugate
  1371. Anti-obesity effects of IGOB 131™ complex in leptin receptor-deficeint obese mice
  1372. Chicken protein hydrolysates have anti-inflammatory effects on high-fat diet induced obesity in mice
  1373. Targeting GUCY2C for anti‐obesity pharmacotherapy (1142.12)
  1374. … OF A MARKETED POLY HERBAL FORMULATION FOR ANTI-OBESITY ACTIVITY ON MONOSODIUM GLUTAMATE WITH HIGH FAT DIET INDUCED OBESITY
  1375. Studies on the structural analysis of Sanguisorba officinalis L. EtOAc fractions having anti-obesity effect
  1376. Malaysian obesity DNA bank; Towards developing anti obese nation wide strategy
  1377. The Anti-Obesity Effect of Pinus densiflora Sieb. et Zucc. in Mice
  1378. Anti‐Obesity Effects of Solar Salt Prepared from Concentrated New Sea Water on 3T3‐L1 Adipocytes
  1379. Investigation of the pancreatic safety of proglucagon-derived peptides and the development of novel anti-obesity agents
  1380. Anti-obesity and anti-inflammatory effects of ginger extracts in rats fed a high-fat diet
  1381. … & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
  1382. Studies on the isolation of Sanguisorba officinalis L. extract having anti-obesity effect
  1383. Anti-obesity effect of probiotic strain, Lactobacillus gasseri SBT2055
  1384. A META-ANALYSIS OF CARDIOVASCULAR SAFETY OF FDA APPROVED ANTI OBESITY DRUGS
  1385. Ending Fat Stigma: Precious, Visual Culture, and Anti-Obesity in the “Fat Moment”
  1386. Diabetic Progression in Obese Subjects after Drinking Anti-Obesity Herbal Tea
  1387. Anti-obesity and Anorectic Effects of Saffron and its Constituent Crocin in Obese Wistar Rat
  1388. Molecular mechanisms for anti-obesity and anti-photoaging effects of natural product-derived substances
  1389. Anti-obesity Effects of Purple Kohlrabi on Pig Preadipocytes and 3T3-L1 Cells
  1390. Low-Cost Production of Anti-Diabetic and Anti-Obesity Sweetener from Stevia Leaves by Diafiltration Membrane Process
  1391. Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins
  1392. Anti Obesity preparations of plant origin-are they effective? Weight reduction with Zerofat-A, in obese diabetics and non diabetics, a cross-sectional, observational pilot …
  1393. Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats
  1394. Effects of glycosylation of natural flavonoids on anti-Cancer, anti-Obesity and Immune modulating activities
  1395. Evaluation of Anti-obesity Potentials of Phenolic-Rich Fraction of Solanum aethiopicum L. and Solanum macrocarpon L on Diet-induced Obesity in Wistar Rats
  1396. A novel redox-activation pathway controls the anti-obesity function of brown adipose tissue
  1397. Anti-obesity effect of polymeric microparticles containing capsaicinoids
  1398. Investigation of the anti-obesity effect of Pueraria montana var. lobata
  1399. Extracts from New Zealand spinach (Tetragonia tetragonioides) conferring anti-obesity effects
  1400. Outcomes after laparoscopic anti-reflux surgery related to obesity: A systematic review and meta-analysis
  1401. Anti-obesity effect of green alga sulphated polysaccharide on high fat diet
  1402. Anti-obesity effects of rutin in high-fat diet induced obese rats
  1403. Anti-obesity effect of butterbur (Petasites japonicus) root in C57BL/6N mice
  1404. Anti-obesity effects of Saururs chinesis Baill in C57BL/6N obese mice
  1405. Apelin and novel stable peptide analogues: assessing their anti-diabetic and anti-obesity potential
  1406. The study of the anti‐obesity effect of dairy administration green tea extract in high fat diet induced obese rats
  1407. Anti-Diabetic and Anti-Obesity Activities of Cocoa (Theobroma cacao) via Physiological Enzyme Inhibition
  1408. Anti‐obesity and anti‐inflammatory effects of peroxisome proliferator activated receptor‐γ induced by bofutsushosan powder versus extract
  1409. Molecular mechanisms underlying the antioxidant, anti-inflammatory, and anti-obesity effects of Chinese medicine triterpene celastrol
  1410. Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice
  1411. Browning and activation of brown adipose tissue as an anti-obesity treatment
  1412. Mechanisms of the pro-lipolytic and anti-obesity effects of the VGF-derived peptide TLQP-21
  1413. Hydrolysis and Anti-Obesity Effect of the Sea-Tangle Extract by A Single and Mixture Enzymes
  1414. New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes: Implication for exercise in obesity
  1415. Anti-obesity function of ellagic acid on high-fat diet-induced rats.
  1416. ANTI-OBESITY EFFECT OF THE POMEGRANATE LEAVES ETHANOL EXTRACT (PUNICAGRANATUML.) IN HIGH-FAT DIET INDUCED MICE
  1417. Anti-Obesity Effects of Solar Salt Prepared from Concentrated New Sea Water on High Fat Diet Induced Obese Mice
  1418. The Anti-Obesity Effect of Instant Pu-Erh Black Tea in Mice with Hydrogenated Oil Diet-Induced Obesity
  1419. POTENTIAL OF NATIVE SAGO STARCH AS PREBIOTIC WITH AN ANTI-OBESITY FUNCTIONALITY
  1420. Analysis method development of anti-obesity drugs in health functional foods by LC/PDA and LC/MS
  1421. Evaluation of Anti-obesity Effects of Aqueous and Ethanolic Extracts of Pomegranate Fruit Peel Using Anthropometrical Indices in Male Wistar Rats
  1422. Anti-obesity and Antioxidant Effects of Bibimmyeon Sauce and Jajang Containing Functional Ingredient in 3T3-L1 Adipocytes
  1423. In vitro Anti-obesity Effect of 4-hydroxybenzyl Alcohol from Cudrania tricuspidata
  1424. Anti-Obesity Effects and Metabolism in DIO Mice of a Novel Hybrid Lipid with Lauric and Lipoic Acid
  1425. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen
  1426. Evaluation of anti-obesity effects of aqueous and ethanolic extracts of pomegranate fruit peel using anthropometrical indices in male wistar rats
  1427. Anti-obesity Effect of (8-E)-Nüzhenide, a Secoiridoid from Ligustrum lucidum, in High-fat Diet-induced Obese Mice
  1428. Cistanches herba enhances mitochondrial functions: antioxidant and anti-obesity effects
  1429. Evaluation of anti-obesity effects based on dynamics of transcription factor network in adipocyte differentiation using D-psicose
  1430. Consumer Food Preferences: Three Essays On Labeling, Anti-Obesity Policies And Social Presence
  1431. Anti-Obesity Mechanisms of Ethanolic Extract and Two Meroterpenoids from Sargassum serratifolium Using In Vitro and In Vivo Model
  1432. SYNTHETIC STUDY OF ANTI-OBESITY IRIDOID ISOLATED FROM TABEBUIA AVELLANEDAE
  1433. Role of pro-and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
  1434. Anti-obesity activity of OBEX is regulated by activation of thermogenesis and decreasing adiposity gain
  1435. UNDERSTANDING THE ANTI-OBESITY EFFECTS OF RESVERATROL: PHASE-II CONJUGATES VS GUT MICROBIOTA METABOLITES
  1436. Lingonberries have Anti‐obesity Effects and Modulate the Gut Microbiota in High‐fat Fed C57BL/6J Mice
  1437. Evaluation of Anti-obesity Effect of Rice Using aP2-Luciferase Assay
  1438. Phytochemical investigations of jiaogulan (Gynostemma pentaphyllum), a traditional Asian medicinal plant with anti-obesity activity
  1439. Anti-obesity effects of Cornus walteri wanger on the diet-induced obese adult Zebrafish (Danio rerio)
  1440. Proteomic Identification of Target Proteins of Thiodigalactoside (an anti-obesity drug candidate) in Rat Adipose Tissues
  1441. Study In vitro and in vivo of anti-diabetic and anti-obesity active principles of Curcubita ficifolia Bouche and Vaccinium angustifolium Ait
  1442. Formulation and Evaluation of Liquisolid Tablets Containing an Anti-Obesity Drug
  1443. Differential Tissue-specific and Pathway-specific Anti-obesity Effects of Green Tea and Taeumjowitang, a Traditional Korean Medicine, in Mice
  1444. Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice
  1445. Anti-obesity effect of gardeniae fructus on fatty liver mice induced by HFLCA
  1446. More than an anti-diabetic bariatric surgery, metabolic surgery alleviates systemic and local inflammation in obesity
  1447. Anti-Obesity Effects of Androgens, Dehydroepiandrosterone (DHEA) and Testosterone
  1448. Study on anti-obesity activity of Aspergillus fermented Platycodon grandiflorum and Curcuma longa L.
  1449. Selective tropical fruit waste component exhibiting adipocyte differentiation inhibition, a future anti-obesity therapeutic strategy
  1450. Neuromedin peptides-Potential for anti-obesity drug candidates?
  1451. Anti-obesity Effect of Burdock Tea in Healthy Japanese: A Randomized, Double-blind, Placebo-controlled Study
  1452. Anti-obesity and hypocholesterolemic effects of ginger extract in high-fat diet induced obese rats
  1453. Anti-obesity and antidiabetic properties of lactoferrin are independent of calorie intake
  1454. Anti-obesity Effects of Spergularia marina Griseb Powder in Rats Fed a High Fat Diet
  1455. ANTI-OBESITY AND ANTI-OXIDATIVE EFFECTS OF METHANOLIC Albizia myriophylla (L. BENTH) BARK EXTRACT IN OBESE MICE
  1456. Anti-diabetic and anti-obesity effects of the allosteric PTP1B inhibitor KY-226 via insulin and leptin signal enhancement
  1457. In vivo photoacoustic monitoring of anti-obesity photothermal lipolysis
  1458. 2P-7: Antioxidant and anti-obesity effects of purple sweet potato extract
  1459. Anti-obesity and anti-inflammatory effects of high hydrostatic pressure extract of mulberry leaves in high-fat diet-induced obese rats
  1460. Leptin deficiency shifts mast cells toward anti-inflammatory actions and protects mice from obesity and diabetes by polarizing M2 macrophages
  1461. The Anti-obesity Effects of Xanthohumol are Mediated Partly by the Adenosine Monophosphate-Protein Kinase Signaling Pathway
  1462. The Anti-Obesity Effects of Xanthohumol Are Partly Mediated by the Adenosine Monophosphate-activated Protein Kinase Signaling Pathway
  1463. The Hypolipidemic and Anti-Obesity Effects of the Cheonggukjang Extract Prepared Using Bacillus subtilis T77 Strain
  1464. Targeting GUCY2C for anti-obesity pharmacotherapy Uroguanylin Replacement Opposes Obesity by Restoring Anorexigenic GUCY2C Signaling Silenced by …
  1465. Anti-obesity effects of pine ramulus powder and ethanol extract in C57BL/6N mice
  1466. Studies on the Anti-obesity Effects of Major Isoflavones in the Hot Water Extract of Pueraria Flowers
  1467. Anti-obesity activity, acute toxicity, and chemical constituents of aqueous and ethanol Viola mandshurica extracts
  1468. Synthesis and biological evaluation of novel thiosemicarbazone-triazole hybrid compounds as anti-malarial and anti-obesity agents
  1469. Anti-obesity Effect of Ethanol Extract from Codium fragile in High-fat Diet Induced Obese Mice
  1470. Anti-Obesity Effect of Organic Solvent Fractions obtained from Korean Unripe Rubus coreanus Miquel
  1471. STUDY OF ANTI-OBESITY EFFECT OF SIX MEDICINAL PLANTS (CARUM COPTICUM, ORIGANUM MAJORANA, RUTA…)
  1472. The Addition Of Anti-Obesity Medications To Transoral Outlet Reduction For The Treatment Of Weight Regain After Bypass Surgery
  1473. Anti-obesity effect of boiled tuna extract on C57BL/6N mice fed a high fat diet
  1474. Marine Drug Discovery: Anti-obesity Mechanism of Palmaria Mollis in Zebrafish and Mice
  1475. Gene Expression in Differentiated in 3T3-L1 Cells and Anti-Obesity Properties of Salacia Chinensis Extract (SCE)
  1476. Isolation of new polyacetylene from atractylodes lancea rhizome and evaluation of lipase inhibition and anti-obesity effect
  1477. Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications
  1478. Anti-Obesity Effects of Anthocyanin Rich and Flavonoid Rich Fractions from Mulberry in C57BL/6 Mice Model
  1479. ANTI-OBESITY EFFECT OF CROCIN AND ETHANOLIC EXTRACT OF SAFFRON (Crocus sativus L.) IN RATS FED WITH HIGH-FAT DIET
  1480. Anti-obesity Effects of the Mixture of Bamboo Leaves Extract and Chaenomeles sinensis Extract (KJM024) in the C57BL/6J Mice
  1481. Acute anti‐obesity effects of intracerebroventricular 11β‐HSD 1 inhibitor administration in diet‐induced obese mice
  1482. Evaluation of anti-obesity activity of biscuits fortified with dried red rose buds and petals on albino rats
  1483. Anti-obesity effects of angiotensin converting enzyme inhibitor are mediated by brown adipose tissue activation
  1484. Anti-Obesity Property of Gentiopicroside by Suppressing Adipogenic and Inflammatory Cytokine Gene Expression in 3T3-L1 Cells
  1485. FOXTAIL MILLET (SETARIA ITALICA) EXTRACT AS PANCREATIC LIPASE INHIBITOR AND POTENTIAL NATURAL ANTI-OBESITY DRUG
  1486. First evidence for the anti-inflammatory activity of fucoxanthin in high-fat-diet-induced obesity in mice and the antioxidant functions in PC12 cells
  1487. Anti-obesity Effect of Polygonum multiflorum Thunb. Water Extract via Down-regulation of Adipogenic Transcription Factors in 3T3-L1 Adipocytes
  1488. In vitro Anti-Obesity Effect and Ginsenoside Composition of Heated Ginseng with Different Soaking Conditions
  1489. Anti-Obesity Effects of Collagen Peptides Extracted from Skate Skin in db/db Mice via Regulation of Lipid Metabolism
  1490. Anti-obesity Effects of Fermented Soy-powder Milk with Lactobacillus Plantarum P1201 in High-fat Diet-induced Obese Mice
  1491. Pharmacognostical, Phytochemical, Formulation and Evaluation of Hypolipidemic and Anti-Obesity Activity on Heartwood of Caesalpinia Sappan Linn
  1492. Anti-obesity Effects and Mechanisms of American Ginseng and Its Ginsenosides in Pre-adipocytes and Obese Mice
  1493. Enhancement of Anti-Obesity Effect of Roasted Inonotus obliquus and Coffee Extract in 3T3-L1 Adipocyte
  1494. Comparison of Anti-obesity Effects between Gochujang Prepared Using Different Kinds of Koji Products and Tabasco Hot Sauce in High-fat Diet-induced Rats
  1495. Akebia quinata extract exerts anti-obesity and hypolipidemic effects in high-fat diet-fed mice and 3T3-L1 adipocytes
  1496. Strategies for isolation of DNA prone to biotin deficiency recombination, mitochondria-protein interaction detection and an anti-obesity screening targeting acetyl-CoA …
  1497. The non-flavonoid polyphenol resveratrol induces anti-obesity effects via SIRT1 dependent improved mitochondrial functioning
  1498. A synergistic anti-obesity effect by combination of Gelidium elegans extract and orlistat in high fat diet induced obese mice
  1499. Anti-obesity mechanisms of conjugated linoleic acid (CLA): Role of inflammatory signaling and browning in white adipose tissue
  1500. ENZYMATIC SYNTHESIS, ENCAPSULATION AND ANTI-OBESITY EFFECT OF PALM-BASED MEDIUM-AND LONG-CHAIN TRIACYLGLYCEROL …
  1501. Anti-obesity effects of Astragalus fermented with lactic acid bacteria in high-fat diet induced obese mouse
  1502. … Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human 3-Adrenergic Receptor and Anti-Obesity and Anti …
  1503. Anti-obesity effects of Mulberry Leaves and Robusta Fermented with Leuconostoc mesenteroides in Highfat Diet Induced Obese Mice
  1504. The nutritional composition and anti-obesity effects of an herbal mixed extract containing Allium fistulosum and Viola mandshurica in high-fat-diet-induced obese mice
  1505. Increased Monoamine Transporter mRNA Expression in the Hypothalamus Following Chronic Anti-obesity Drug Treatment Coincides with Diminishing Appetite …
  1506. Diets along with interval training regimes improves inflammatory & anti-inflammatory condition in obesity with type 2 diabetes subjects
  1507. Quercetin‐rich onion peel extract of anti‐obesity in C57BL/6J mice fed a high fat diet (642.11)
  1508. Investigating the mechanisms involved in the anti-obesity effect of conjugated linoleic acid (CLA) isomers in 3T3-L1 adipocytes, and in obese db/db and lean C57BL/6 …
  1509. Anti-obesity effect of novel extracts from mulberry (Morus alba) leaves fermented with Cordyceps militaris in high-fat-diet-induced obese C57BL/6 mice
  1510. Anti-Obesity Effect of Caffeic Acid Phenethyl Ester through Control of Reactive Oxygen Species Related with Regulation of NADPH Oxidase 4 Complex in 3T3-L1 Cell …
  1511. An Ursolic Acid-Enriched Cynomorii Herba Extract Induces Mitochondrial Uncoupling: Antioxidant and Anti-obesity Effects
  1512. Anti-Obesity Effects of Tunisian Halophyte Nitraria retusa (Forsk.) Asch. Through Modulation of Lipid Metabolism
  1513. … for isolation of DNA prone to biotin deficiency recombination, mitochondria-protein interaction detection and an anti-obesity screening targeting acetyl-CoA …
  1514. Morusin exerts anti-obesity effect through the stimulation of lipolysis and inhibition of the lipogenesis the 3T3L-1 adipocyte and the primary adipocytes of SD (Sprague …
  1515. Ethanol extract of Pinus koraiensis leaves containing lambertianic acid exerts anti-obesity and hypolipidemic effects by activating adenosine monophosphate …
  1516. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
  1517. Obesity depresses the anti‐inflammatory HSP 70 pathway, contributing to NAFLD progression
  1518. Glucagon-like peptide 1: a potential anti-inflammatory pathway in obesity-related asthma
  1519. Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries
  1520. Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy
  1521. The effect of obesity on anti-Xa concentrations in bariatric patients
  1522. Total salivary anti-oxidant levels, dental development and oral health status in childhood obesity
  1523. Lunasin attenuates obesity-associated metastasis of 4T1 breast cancer cell through anti-inflammatory property
  1524. Partial reversal of obesity-induced insulin resistance owing to anti-inflammatory immunomodulatory potential of flaxseed oil
  1525. The impact of an obesity awareness intervention on anti-fat attitudes and expectations of preservice physical educators
  1526. Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model
  1527. Anti-inflammatory effects of rosiglitazone in obesity-impaired wound healing depend on adipocyte differentiation
  1528. Anti-inflammatory and autonomic effects of electroacupuncture in a rat model of diet-induced obesity
  1529. Obesity, diabetes and gastrointestinal malignancy: The role of metformin and other anti-diabetic therapy
  1530. Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids
  1531. Anti-sRAGE autoimmunity in obesity: downturn after bariatric surgery is independent of previous diabetic status
  1532. EVALUATION OF ANTI DIABETIC DRUG ALOGLIPTIN FOR THE TREATMENT OF OBESITY IN RATS
  1533. … adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity model
  1534. Slit2 E xerts Anti‐Inflammatory Actions in Human Placenta and is Decreased with Maternal Obesity
  1535. In case of obesity, longevity-related mechanisms lead to anti-inflammation
  1536. Anti-ghrelin Therapeutic Vaccine: A Novel Approach for Obesity Treatment
  1537. Short-term exercise training reduces anti-inflammatory action of interleukin-10 in adults with obesity
  1538. Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies—Issues, Dosing Implications …
  1539. Anti-fat discrimination in marriage more clearly explains the poverty–obesity paradox
  1540. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome
  1541. … by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift
  1542. Adipogenesis 관련 유전자발현감소와 Cell Cycle Arrest 를 통한 EGCG 와 Glucosamine-6-Phosphate 의 Anti-Obesity 효과
  1543. Does acupuncture modulate anti-inflammation via haemorphin in obesity?
  1544. … among Danish general practitioners and whether this bias and general practitioners’ lifestyle can affect treatment of tension headache in patients with obesity
  1545. Is obesity a disability? The definition of disability by the Court of Justice of the European Union and its consequences for the application of EU anti-discrimination law
  1546. Obesity and anti-bacterial agents
  1547. Obesity associated with resistance to anti-angiogenic therapy
  1548. Therapeutic effect of leafy herbs (Camellia sinensis, Malva parviflora, Rosmarinus officinalis and Salvia officinalis) as a tool for anti-over-obesity
  1549. Effects of deep transcranial magnetic stimulation (dTMS) on anti-inflammatory gut bacterial species in obesity
  1550. … anti-dyslipidemic effects of milled root bark Ethanolic extract of Capparis Erythrocarpus in Sprague-Dawley Rats: implications for obesity and cardiovascular diseases
  1551. In vivo second‐harmonic generation and ex vivo coherent anti‐stokes raman scattering microscopy to study the effect of obesity to fibroblast cell function using an Yb …
  1552. Obesity hampers effects of anti-TNF agents
  1553. Abstract LB-203: Obesity promotes resistance to anti-VEGF therapy in breast cancer via pro-inflammatory and angiogenic pathways
  1554. Consumption of Green Tea As Anti-Dyslipidemia Agent and Obesity Prevention: A Systematic Review
  1555. Anti-müllerian hormone and obesity
  1556. Effect of Obesity on Anti Oxidant Enzymes and Type 2 Diabetes
  1557. Anti-Fat Prejudice: Is there discrimination towards obesity?
  1558. An Unfortunate Interaction Between Anti-Psychotic Medication and Obesity
  1559. The role of anti-mullerian hormone as an indicator of reproductive health in women with obesity and concomitant polycystic ovary syndrome
  1560. The anti‐inflammatory effects of manniflavanone extracted from Garcinia buchananii bark in obesity‐induced mice model (259.3)
  1561. Comparative Study of Anti Psychotic Drugs regarding Safety Profile in patients with Diabetes and Obesity
  1562. In vitro anti-obesity and ani-inflammatory effects of Ceratonia Siliqua L. extracts
  1563. PRO-INFLAMMATORY AND ANTI-INFLAMMATORY MAST CELLS IN OBESITY AND DIABETES
  1564. Is anti-Mullerian hormone an indicator of potential polycystic ovary syndrome in prepubertal girls with simple obesity?
  1565. THE EFFECTIVENESS OF ANTI-STRESS MASSAGE AND THE IMPACT OF ACCEPTING YOUR OWN BODY IN TREATING OBESITY.
  1566. F-111 Effect of anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model
  1567. Bardoxolone methyl: a potential therapeutic for the prevention of anti-psychotic drug-induced obesity?
  1568. 7D. 05: MATERNAL OBESITY ATTENUATES THE ANTI-CONTRACTILE EFFECT OF PERIVASCULAR ADIPOSE TISSUE IN OFFSPRING
  1569. Attenuation of obesity and related metabolic disorders by the individual or combination treatment with IL-2/anti-IL-2 complex and hyperbaric oxygen
  1570. Obesity depresses anti-inflammatory HSP70 pathway contributing to the progression of NAFLD
  1571. Anti-diabetic actions of esculentin-2CHa (1–30) and its stable analogues in a diet-induced model of obesity-diabetes
  1572. EXERCISE REDUCES HEALTHCARE COSTS IN OLDER ADULTS WITH OBESITY BY REDUCING ANTI-HYPERTENSIVE AND ANTI-HYPERGLYCEMIC …
  1573. Soy tri-peptide FLV and obesity-related adipose anti-inflammation.
  1574. Anti-inflammatory Diets to Reduce Gestational Problems Caused by Obesity, Metabolic Syndrome, and Diabetes
  1575. Anti-Inflammatory Activities of Oligosaccharides in High-Fat Diet Induced Obesity Mouse Model
  1576. DEVELOPMENT OF AN ANTI-AP2 MONOCLONAL ANTIBODY TO TREAT OBESITY RELATED DIABETES AND FATTY LIVER DISEASE
  1577. Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta …
  1578. Pain as a barrier to physical activity in severe obesity and the alter-g anti-gravity treadmill as a potential therapeutic tool
  1579. To Study the Relationship between Obesity and Anti-Mullerian Hormone: As a Serum Marker of Ovarian Reserve In premenopausal Women
  1580. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity
  1581. The impact of anti-inflammatory drug sulindac on obesity-associated colon tumor growth
  1582. Visfatin level in hypertensive patients with abdominal obesity against the combination of anti-hypertensive therapy and atorvastatin
  1583. Nicotinic anti-inflammatory pathway: a new target to control low-grade inflammation and glucose homeostasis in obesity
  1584. Effects of Obesity on Functional Fitness and Anti-aging Hormones in Normal Weight and Overweight Elderly Women
  1585. The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity
  1586. To study the anti-hypertensive and lipid-lowering effects of garlic as add-on therapy to amlodipine in patients of hypertension with obesity
  1587. Obesity adversely affects interaction between anti-mullerian hormone (AMH) and age among African American (AA) but not caucasian (C) women
  1588. Simvastatin has anti-tumorigenic effects in endometrial cancer via reversal of obesity-driven upregulation of lipid biosynthesis
  1589. Effect anti inflammatory and anti obesity of the polyphenolic extracts of carob leaves” Ceratonia siliqua” and cladode” Opuntia ficus-indica”
  1590. miR-34a aggravates obesity-induced adipose inflammation and metabolic dysfunction via blocking polarization of anti-inflammatory M2 macrophage
  1591. AB1323 Does obesity represent a risk factor for a poor remission rate in japanese patients with rheumatoid arthritis treated with anti-tumour necrosis factor …
  1592. Interactive effects of exercise on bicycle ergometer and anti-inflammatory extract of nettle on some obesity-related inflammatory markers in overweight and obese …
  1593. Relationship between serum anti-heat shock protein 27 antibody levels and obesity
  1594. … dan antidiabetes tipe 2= Constructing a marine database and its screening to PTP1B (protein tyrosine phosphatase 1B) as anti-obesity and anti-type 2 diabetes
  1595. Anti-proliferative effects of Celastrol, a quinine methide triterpene extracted from the Perennial vine Tripterygium wilfordii, on obesity-related cancers
  1596. … Q180, на предотвращение развития ожирения; опыты на крысах.(Южная Корея)]. Park Sun-Young, Seong Ki-Seung, Lim Sang-Dong Anti-obesity Effect of Yogurt …
  1597. … Q180, на предотвращение развития ожирения; опыты на крысах.(Южная Корея)]. Park Sun-Young, Seong Ki-Seung, Lim Sang-Dong Anti-obesity Effect of Yogurt …
  1598. PS 0108; Cardiology: Using Anti-Infl ammatory Index in Predicting Vascular Abnormality in Indonesia Docar (Diabetes-Obesity-Cardiovascular Disease) Prevention …
  1599. Anti-inflammatory role of GLP-1 and the effect of gastric bypass on diabetes-and obesity-associated inflammation
  1600. Relationship between serum anti-heat shock protein 27 antibody levels and obesity
  1601. Anti-inflammatory role of cannabinoid receptor type 1 antagonist AM251 in high fat diet-induced obesity—a focus on microRNAs.
  1602. … ANTI-ATHEROSCLEROTIC EFFECT OF MILD BILIRUBIN ELEVATION IS MASKED BY THE CONFOUNDING FACTOR OF FATTY LIVER AND ABDOMINAL OBESITY …
  1603. Long-term efficacy and safety of anti-obesity treatment: where do we stand?
  1604. Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective
  1605. Comprehensive review of current and upcoming anti-obesity drugs
  1606. Anti-obesity effects of polyphenol intake: Current status and future possibilities
  1607. Anti-obesity drugs: long-term efficacy and safety: an updated review
  1608. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs
  1609. Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants
  1610. Nondigestible oligosaccharides with anti-obesity effects
  1611. Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
  1612. Adipogenesis as a potential anti-obesity target: A review of pharmacological treatment and natural products
  1613. Anti-obesity effects of microalgae
  1614. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis
  1615. Anti-obesity effects of dietary calcium: the evidence and possible mechanisms
  1616. Anti-obesity effects of capsaicin and the underlying mechanisms: a review
  1617. Phenolic compounds as natural and multifunctional anti-obesity agents: A review
  1618. The anti-obesity effect of traditional Chinese medicine on lipid metabolism
  1619. Palmitoleoylethanolamide is an efficient anti-obesity endogenous compound: comparison with oleylethanolamide in diet-induced obesity
  1620. The beneficial effects of essential oils in anti-obesity treatment
  1621. Brown and brite: the fat soldiers in the anti-obesity fight
  1622. 6‐Paradol Acts as a Potential Anti‐obesity Vanilloid from Grains of Paradise
  1623. Lead anti-obesity compounds from nature
  1624. The anti-obesity and health-promoting effects of tea and coffee
  1625. Stilbenes in grape berries and wine and their potential role as anti-obesity agents: A review
  1626. Predictors and effects of anti-obesity message fatigue: A thought-listing analysis
  1627. In-vitro screening of selected traditional medicinal plants for their anti-obesity and anti-oxidant activities
  1628. Anti-obesity effects of macroalgae
  1629. Gender‐related issues in the pharmacology of new anti‐obesity drugs
  1630. A critical review on anti-diabetic and anti-obesity effects of dietary resistant starch
  1631. The role of anti-obesity medication in prevention of diabetes and its complications
  1632. Review of advances in anti-obesity pharmacotherapy: implications for a multimodal treatment approach with metabolic surgery
  1633. Anti‐obesity potentiality of Tapra fish (Opisthopterus tardoore) oil
  1634. Novel insights on anti-obesity potential of the miracle tree, Moringa oleifera: A systematic review
  1635. A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota
  1636. Gut microbiome modulation based on probiotic application for anti-obesity: A review on efficacy and validation
  1637. Therapeutic promises of chlorogenic acid with special emphasis on its anti-obesity property
  1638. Anti-obesity effects of instant fermented teas in vitro and in mice with high-fat-diet-induced obesity
  1639. Interactions of tea polyphenols with intestinal microbiota and their implication for anti‐obesity
  1640. Behavior of non‐digestible polysaccharides in gastrointestinal tract: A mechanistic review of its anti‐obesity effect
  1641. 18KHT01, a potent anti-obesity polyherbal formulation
  1642. Anti-obesity effect of carotenoids: direct impact on adipose tissue and adipose tissue-driven indirect effects
  1643. Polyphenols and their anti-obesity role mediated by the gut microbiota: a comprehensive review
  1644. Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions
  1645. Anti-obesity natural products
  1646. The use of stigmatizing messaging in anti-obesity communications campaigns: quantification of obesity stigmatization
  1647. Anti-Obesity and Anti-Diabetic Effects of Ishige okamurae
  1648. The potential of artemisinins as anti-obesity agents via modulating the immune system
  1649. An overview of microbiome based strategies on anti‐obesity
  1650. Natural dietary and medicinal plants with anti-obesity therapeutics activities for treatment and prevention of obesity during lock down and in post-COVID-19 era
  1651. Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice
  1652. New hope for anti-obesity drugs
  1653. Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota
  1654. … Enterococcus faecium dfa1 on Anti-Obesity in High Fat-Induced Obesity Mice Possibly through the Differences in Gut Dysbiosis Attenuation, despite the Similar Anti …
  1655. Treatment outcomes and trajectories of change in patients attributing their eating disorder onset to anti-obesity messaging
  1656. Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude
  1657. Oxytocin as an Anti-obesity Treatment
  1658. Anti-obesity effects of Diospyros lotus leaf extract in mice with high-fat diet-induced obesity
  1659. Anti‑obesity effect of Carica papaya in high‑fat diet fed rats
  1660. Capsaicin has an anti-obesity effect through alterations in gut microbiota populations and short-chain fatty acid concentrations
  1661. RNA-seq based transcriptome analysis of the anti-obesity effect of green tea extract using zebrafish obesity models
  1662. Development of novel functional snacks containing nano-encapsulated resveratrol with anti-diabetic, anti-obesity and antioxidant properties
  1663. Efficiently anti-obesity effects of unsaturated alginate oligosaccharides (UAOS) in high-fat diet (HFD)-fed mice
  1664. Network pharmacology-based strategy for the investigation of the anti-obesity effects of an ethanolic extract of Zanthoxylum bungeanum Maxim
  1665. Anti-obesity potential of Moringa olifera seed extract and lycopene on high fat diet induced obesity in male Sprauge Dawely rats
  1666. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe (?) practice
  1667. Anti-obesity public health messages and risk factors for disordered eating: a systematic review
  1668. Anti-Obesity Effect of Standardized Extract of Microalga Phaeodactylum tricornutum Containing Fucoxanthin
  1669. Anti-obesity effect of trans-cinnamic acid on HepG2 cells and HFD-fed mice
  1670. Anti‐obesity and hypolipidemic effect of water extract from Pleurotus citrinopileatus in C57BL/6J mice
  1671. Anti-obesity Potential of Lactobacillus spp. Isolated from Infant Feces
  1672. Anti-obesity effects of red seaweed, Plocamium telfairiae, in C57BL/6 mice fed a high-fat diet
  1673. The anti-obesity effect of lotus leaves on high-fat-diet-induced obesity by modulating lipid metabolism in C57BL/6J mice
  1674. Anti-obesity effects of medicinal plants from Asian countries and related molecular mechanisms: a review
  1675. Anti-obesity, antioxidant and in silico evaluation of Justicia carnea bioactive compounds as potential inhibitors of an enzyme linked with obesity: Insights from kinetics …
  1676. Resveratrol anti-obesity effects: Rapid inhibition of adipocyte glucose utilization
  1677. Anti‐obesity effect of plant diterpenes and their derivatives: a review
  1678. Anti-obesity effects of kaempferol by inhibiting adipogenesis and increasing lipolysis in 3T3-L1 cells
  1679. Anti-obesity effect of argel (Solenostemma argel) on obese rats fed a high fat diet
  1680. Diallyl disulfide potentiates anti-obesity effect of green tea in high-fat/high-sucrose diet-induced obesity
  1681. Anti-Obesity Effect of Dictyophora indusiata Mushroom Polysaccharide (DIP) in High Fat Diet-Induced Obesity via Regulating Inflammatory Cascades and …
  1682. Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss
  1683. Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response …
  1684. Taurine-mediated browning of white adipose tissue is involved in its anti-obesity effect in mice
  1685. Simulating the fiscal impact of anti-obesity medications as an obesity reduction strategy
  1686. Anti‐obesity effect of Liupao tea extract by modulating lipid metabolism and oxidative stress in high‐fat‐diet‐induced obese mice
  1687. A clinical and computational study on anti-obesity effects of hydroxycitric acid
  1688. ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue
  1689. Gold nanoparticles synthesized with Smilax glabra rhizome modulates the anti-obesity parameters in high-fat diet and streptozotocin induced obese diabetes …
  1690. The anti-obesity effects of Tongbi-san in a high-fat diet-induced obese mouse model
  1691. Upregulation of MC4R and PPAR-α expression mediates the anti-obesity activity of Moringa oleifera Lam. in high-fat diet-induced obesity in rats
  1692. Anti-Obesity Attributes; UHPLC-QTOF-MS/MS-Based Metabolite Profiling and Molecular Docking Insights of Taraxacum officinale
  1693. Lactobacillus sakei ADM14 Induces Anti-Obesity Effects and Changes in Gut Microbiome in High-Fat Diet-Induced Obese Mice
  1694. Anti-Obesity Effects of the Flower of Prunus persica in High-Fat Diet-Induced Obese Mice
  1695. Anti-obesity effects of chondroitin sulfate oligosaccharides from the skate Raja pulchra
  1696. The anti-obesity effects of lemon fermented products in 3T3-L1 preadipocytes and in a rat model with high-calorie diet-induced obesity
  1697. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation
  1698. Immuno-enhancing and anti-obesity effect of Abelmoschus manihot root extracts
  1699. Anti-obesity effects of Grifola frondosa through the modulation of lipid metabolism via ceramide in mice fed a high-fat diet
  1700. Anti-obesity effects of soybean embryo extract and enzymatically-modified isoquercitrin
  1701. Anti-obesity and lipid lowering effects of Varanadi kashayam (decoction) on high fat diet induced obese rats
  1702. Computational data of phytoconstituents from Hibiscus rosa-sinensis on various anti-obesity targets
  1703. Anti-obesity and anti-adipogenic effects of chitosan oligosaccharide (GO2KA1) in SD rats and in 3T3-L1 preadipocytes models
  1704. Adipose tissue as a possible therapeutic target for polyphenols: A case for Cyclopia extracts as anti-obesity nutraceuticals
  1705. Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid …
  1706. Deciphering the anti-obesity benefits of resveratrol: the “gut microbiota-adipose tissue” axis
  1707. Enzymatic preparation of chitooligosaccharides and their anti-obesity application
  1708. Integrating pathway elucidation with yeast engineering to produce polpunonic acid the precursor of the anti-obesity agent celastrol
  1709. Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice
  1710. The anti-obesity effects exerted by different fractions of Artemisia sphaerocephala Krasch polysaccharide in diet-induced obese mice
  1711. Mulberry leaf phenolics and fiber exert anti‐obesity through the gut microbiota‐host metabolism pathway
  1712. The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis
  1713. Microneedle Patch Delivery of Capsaicin‐Containing α‐Lactalbumin Nanomicelles to Adipocytes Achieves Potent Anti‐Obesity Effects
  1714. … of the bioactive potential of Roselle (Hibiscus sabdariffa L.) calyx and its by-product: Phenolic characterization by UPLC-QTOF MSE and their anti-obesity effect in vivo
  1715. Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
  1716. Anti-Obesity Effect of DKB-117 through the Inhibition of Pancreatic Lipase and α-Amylase Activity
  1717. Cocoa (Theobroma cacao L.) Seed Proteins’ Anti-Obesity Potential through Lipase Inhibition Using In Silico, In Vitro and In Vivo Models
  1718. A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors
  1719. Mucuna pruriens treatment shows anti-obesity and intestinal health effects in obese rats
  1720. A new flavone glucoside together with known ellagitannins and flavones with anti-diabetic and anti-obesity activities from the flowers of pomegranate (Punica …
  1721. Antioxidant and anti-obesity properties of local chilies varieties in Malaysia
  1722. Anti‐obesity activity of anthocyanin and carotenoid extracts from color‐fleshed sweet potatoes
  1723. Anti-Obesity Effects of Grateloupia elliptica, a Red Seaweed, in Mice with High-Fat Diet-Induced Obesity via Suppression of Adipogenic Factors in White Adipose …
  1724. Addressing weight stigma and anti-obesity rhetoric in policy changes to prevent eating disorders
  1725. … for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity …
  1726. Crystal structure of pathogenic Staphylococcus aureus lipase complex with the anti-obesity drug orlistat
  1727. Understanding the mechanism of action and clinical implications of anti-obesity drugs recently approved in Korea
  1728. Gadd45b is required in part for the anti-obesity effect of constitutive androstane receptor (CAR)
  1729. Role of neuro-immune cross-talk in the anti-obesity effect of electro-acupuncture
  1730. Anti-obesity potential of rare sugar d-psicose by regulating lipid metabolism in rats
  1731. Anti‐obesity effect of Lactobacillus plantarum CQPC01 by modulating lipid metabolism in high‐fat diet‐induced C57BL/6 mice
  1732. Moringa peregrina leaf extracts produce anti-obesity, hypoglycemic, anti-hyperlipidemic, and hepatoprotective effects on high-fat diet fed rats
  1733. Anti-Obesity Effects of Lactobacillus fermentum CQPC05 Isolated from Sichuan Pickle in High-Fat Diet-Induced Obese Mice through PPAR-α Signaling Pathway
  1734. Repurposing disulfiram as an anti-obesity drug: treating and preventing obesity in high-fat-fed rats
  1735. … oils of hedgenettles (Stachys inflata, S. lavandulifolia, and S. byzantina) have antioxidant, anti-Alzheimer, antidiabetic, and anti-obesity potential: A comparative study
  1736. Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice
  1737. Anti-Obesity Effect of Diphlorethohydroxycarmalol Isolated from Brown Alga Ishige okamurae in High-Fat Diet-Induced Obese Mice
  1738. Anti-obesity effect of taurine through inhibition of adipogenesis in white fat tissue but not in brown fat tissue in a high-fat diet-induced obese mouse model
  1739. Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes
  1740. … the phyto-constituents of Punica granatum fruits peel extract and accessing its in-vitro antioxidant, anti-diabetic, anti-obesity, and angiotensin-converting …
  1741. Anti-obesity effects of α-amylase inhibitor enriched-extract from white common beans (Phaseolus vulgaris L.) associated with the modulation of gut microbiota …
  1742. Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects
  1743. Inorganic nitrate, a natural anti-obesity agent: A systematic review and meta-analysis of animal studies
  1744. Anti‐Obesity Effect of T. Chebula Fruit Extract on High Fat Diet Induced Obese Mice: A Possible Alternative Therapy
  1745. Anti-Obesity Effect of Lactobacillus plantarum LB818 Is Associated with Regulation of Gut Microbiota in High-Fat Diet-Fed Obese Mice
  1746. Anti-Obesity Medication Use in Children and Adolescents with Prader–Willi Syndrome: Case Review and Literature Search
  1747. A Pilot Study on Anti-Obesity Mechanisms of Kappaphycus Alvarezii: The Role of Native κ-Carrageenan and the Leftover Sans-Carrageenan Fraction
  1748. Structural analysis and anti‐obesity effect of Polygonatum cyrtonema polysaccharide against obesity induced by high‐fat diet in mice
  1749. Chemical structure elucidation of an inulin-type fructan isolated from Lobelia chinensis lour with anti-obesity activity on diet-induced mice
  1750. Molecular networking aided metabolomic profiling of beet leaves using three extraction solvents and in relation to its anti-obesity effects
  1751. Hepatoprotective and anti-obesity properties of sardine by-product oil in rats fed a high-fat diet
  1752. Anti-adipogenic and anti-obesity activities of purpurin in 3T3-L1 preadipocyte cells and in mice fed a high-fat diet
  1753. White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of …
  1754. Anti-obesity drug orlistat alleviates Western-Diet-Driven colitis-associated colon cancer via inhibition of STAT3 and NF-κB-Mediated signaling
  1755. Anti‐obesity effects of enzyme‐treated celery extract in mice fed with high‐fat diet
  1756. The benefit of short-term weight loss with anti-obesity medications in real-world clinical practice
  1757. Past, present and future anti-obesity effects of flavin-containing and/or copper-containing amine oxidase inhibitors
  1758. Salvia Species as Nutraceuticals: Focus on Antioxidant, Antidiabetic and Anti-Obesity Properties
  1759. Assessment the of anti-obesity effects and safety of Lactobacillus paracasei AO356
  1760. In vivo evaluation of the anti-obesity effects of combinations of Monascus pigment derivatives
  1761. Comparative Analysis of Metabolite Profiling of Momordica charantia Leaf and the Anti-Obesity Effect through Regulating Lipid Metabolism
  1762. Anti-Obesity Effect of α-Cubebenol Isolated from Schisandra chinensis in 3T3-L1 Adipocytes
  1763. New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists.
  1764. Anti-obesity effect of hot water extract of barley sprout through the inhibition of adipocyte differentiation and growth
  1765. In Vitro Antidiabetic, Anti-Obesity and Antioxidant Analysis of Ocimum basilicum Aerial Biomass and in Silico Molecular Docking Simulations with Alpha-Amylase and …
  1766. Gold nanoparticles synthesized with Poria cocos modulates the anti-obesity parameters in high-fat diet and streptozotocin induced obese diabetes rat model
  1767. Trends in prescribing anti‐obesity pharmacotherapy for paediatric weight management: Data from the POWER Work Group
  1768. Antioxidant and anti-obesity activities of Polygonum cuspidatum extract through alleviation of lipid accumulation on 3T3-L1 adipocytes
  1769. Anti-obesity effect of garlic oil on obese rats via Shenque point administration
  1770. Possible anti‐obesity effects of phytosterols and phytostanols supplementation in humans: A systematic review and dose–response meta‐analysis of randomized …
  1771. Anti-obesity effects of ginsenosides in high-fat diet-fed rats
  1772. Probiotic BSH activity and anti-obesity potential of Lactobacillus plantarum strain TCI378 isolated from Korean Kimchi
  1773. The anti-obesity effect of fermented tremella/blueberry and its potential mechanisms in metabolically healthy obese rats
  1774. Neuroprotective and anti-obesity effects of tocotrienols
  1775. Comparison of main chemical composition of Plantago asiatica L. and P. depressa Willd. seed extracts and their anti-obesity effects in high-fat diet-induced obese …
  1776. Anti-Obesity Effects of Matoa (Pometia pinnata) Fruit Peel Powder in High-Fat Diet-Fed Rats
  1777. Anti-Obesity Effect of Polygalin C Isolated from Polygala japonica Houtt. via Suppression of the Adipogenic and Lipogenic Factors in 3T3-L1 Adipocytes
  1778. Anti-Obesity and Gut Microbiota Modulation Effect of Secoiridoid-Enriched Extract from Fraxinus mandshurica Seeds on High-Fat Diet-Fed Mice
  1779. Anti-Obesity Effects of Sargassum thunbergii via Downregulation of Adipogenesis Gene and Upregulation of Thermogenic Genes in High-Fat Diet-Induced Obese …
  1780. Profiles of gut microbiota in children with obesity from Harbin, China and screening of strains with anti‐obesity ability in vitro and in vivo
  1781. Stronger anti-obesity effect of white ginseng over red ginseng and the potential mechanisms involving chemically structural/compositional specificity to gut microbiota
  1782. Polysaccharides from TCM herbs exhibit potent anti-obesity effect by mediating the community structure of gut microbiota
  1783. Anti-Obesity Effect of Erigeron annuus (L.) Pers. Extract Containing Phenolic Acids
  1784. Anti-obesity effect of an ethanol extract of cheongchunchal in vitro and in vivo
  1785. Molecular Mechanisms of the Anti-obesity Properties of Agardhiella subulata in Mice Fed a High-Fat Diet
  1786. Anti‑obesity effect in high‑fat‑diet‑induced obese C57BL/6 mice: Study of a novel extract from mulberry (Morus alba) leaves fermented with Cordyceps militaris
  1787. Creation of an anti-inflammatory, leptin-dependent anti-obesity celastrol mimic with better druggability
  1788. Analysis of anti-obesity and anti-diabetic effects of acacia bark-derived proanthocyanidins in type 2 diabetes model KKAy mice
  1789. Eruca sativa Mill. seed extract promotes anti‐obesity and hypoglycemic effects in mice fed with a high‐fat diet
  1790. Anti-Obesity and antidiabetic effects of nelumbinis semen powder in high-fat diet-induced obese C57BL/6 Mice
  1791. Anti-obesity effects of dichloromethane leaf extract of Gnidia glauca in high fat diet-induced obese rats
  1792. Withaferin A exerts an anti-obesity effect by increasing energy expenditure through thermogenic gene expression in high-fat diet-fed obese mice
  1793. Cardiovascular safety and superiority of anti-obesity medications
  1794. Simultaneous Intake of Euglena gracilis and Vegetables Exerts Synergistic Anti-Obesity and Anti-Inflammatory Effects by Modulating the Gut Microbiota in Diet …
  1795. The anti-obesity effects of rhein on improving insulin resistance (IR) and blood lipid levels are involved in endoplasmic reticulum stress (ERs), inflammation, and …
  1796. Hypothesizing nutrigenomic-based precision anti-obesity treatment and prophylaxis: Should we be targeting sarcopenia induced brain dysfunction?
  1797. Bound phenolics from fresh lotus seeds exert anti-obesity effects in 3T3-L1 adipocytes and high-fat diet-fed mice by activation of AMPK
  1798. Resveratrol as anti-obesity and anticancer agent
  1799. Phytochemical analysis, in-vitro anti-proliferative, anti-oxidant, anti-diabetic, and anti-obesity activities of Rumex rothschildianus Aarons. extracts
  1800. Association between shared medical appointments and weight loss outcomes and anti‐obesity medication use in patients with obesity
  1801. Salvianolic acid B plays an anti-obesity role in high fat diet-induced obese mice by regulating the expression of mRNA, circRNA, and lncRNA
  1802. Trifluoromethylated Flavonoid-Based Isoxazoles as Antidiabetic and Anti-Obesity Agents: Synthesis, In Vitro α-Amylase Inhibitory Activity, Molecular Docking and …
  1803. Anti-Obesity Effects of a Prunus persica and Nelumbo nucifera Mixture in Mice Fed a High-Fat Diet
  1804. Epigallocatechin Exerts Anti‐Obesity Effect in Brown Adipose Tissue
  1805. Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model
  1806. Anti-obesity effect of pine needle extract on high-fat diet-induced obese mice
  1807. Orobol, an enzyme-convertible product of genistein, exerts anti-obesity effects by targeting casein kinase 1 epsilon
  1808. Anti-microbiological, anti-hyperglycemic and anti-obesity potency of natural antioxidants in fruit fractions of Saskatoon berry
  1809. MCH-R1 antagonist GPS18169, a pseudopeptide, is a peripheral anti-obesity agent in mice
  1810. Anti-obesity activity of gold nanoparticles synthesized from Salacia chinensis modulates the biochemical alterations in high-fat diet-induced obese rat model …
  1811. Anti-obesity effect of Echigoshirayukidake (Basidiomycetes-X) in rats
  1812. Addition of probiotics to anti-obesity therapy by percutaneous electrical stimulation of dermatome T6. A pilot study
  1813. Cytotoxicity, Anti-Obesity and Anti-Diabetic Activities of Heteromorpha arborescens (Spreng.) Cham Leaves
  1814. Anti-obesity effects of Lactobacillus rhamnosus 4B15, and its synergy with hydrolysed lactose skim milk powder
  1815. Detection and quantification of the anti-obesity drug celastrol in murine liver and brain
  1816. Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years
  1817. An anti-obesity immunotherapy?
  1818. Anti‑obesity effects of a mixed extract containing Platycodon grandiflorum, Apium graveolens and green tea in high‑fat‑diet‑induced obese mice
  1819. Novel anti-obesity peptide (RLLPH) derived from hazelnut (Corylus heterophylla Fisch) protein hydrolysates inhibits adipogenesis in 3T3-L1 adipocytes by regulating …
  1820. Anti-Obesity Effect of Extract from Nelumbo Nucifera L., Morus Alba L., and Raphanus Sativus Mixture in 3T3-L1 Adipocytes and C57BL/6J Obese Mice
  1821. Exploring the antidiabetic and anti‐obesity properties of Samanea saman through in vitro and in vivo approaches
  1822. Anti-Obesity Effects of Tanshinone I from Salvia miltiorrhiza Bunge in Mice Fed a High-Fat Diet through Inhibition of Early Adipogenesis
  1823. Involvement of fat mass and obesity gene (FTO) in the anti-obesity action of Annona muricata Annonaceae: in silico and in vivo studies
  1824. Anti-obesity natural products tested in juvenile zebrafish obesogenic tests and mouse 3T3-L1 adipogenesis assays
  1825. The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters
  1826. Investigating anti-obesity effects by oral administration of Aloe vera gel extract (AVGE): Possible involvement in activation of brown adipose tissue (BAT)
  1827. Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
  1828. Anti‐obesity activity of Heracleum moellendorffii root extracts in 3T3‐L1 adipocytes
  1829. Anti-Obesity and Anti-Diabetic Effects of a Polyherbal Extract Consisting of Coptidis Rhizoma, Salviae Miltiorrhizae Radix, and Cinnamomi Cortex in High Fat …
  1830. Evaluation of anti-obesity activity of an herbal formulation (F2) in DIO mice model and validation of UPLC-DAD method for quality control
  1831. Anti-obesity and hypocholesterolemic actions of protamine-derived peptide RPR (Arg-Pro-Arg) and protamine in high-fat diet-induced C57BL/6J mice
  1832. Dose-dependent and strain-dependent anti-obesity effects of Lactobacillus sakei in a diet induced obese murine model
  1833. Plasma Lipidomics Reveals Insights into Anti-Obesity Effect of Chrysanthemum morifolium Ramat Leaves and Its Constituent Luteolin in High-Fat Diet-Induced …
  1834. Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent
  1835. The in vitro anti-diabetic and anti-obesity effect of monascus-fermented grain vinegar
  1836. Potential Anti-Obesity, Anti-Steatosis, and Anti-Inflammatory Properties of Extracts from the Microalgae Chlorella vulgaris and Chlorococcum amblystomatis …
  1837. Recent trends in anti-obesity and anti-inflammatory studies in modern health care
  1838. In vitro antioxidant and anti-obesity activities of freeze-dried Canarium sp., Averrhoa bilimbi L. and Malus domestica
  1839. The anti-obesity potential of Ilex paraguariensis: results from a meta-analysis
  1840. Recent development on anti-obesity compounds and their mechanisms of action: a review
  1841. Anti-obesity effect and mechanism of mesenchymal stem cells influence on obese mice
  1842. Anti-obesity effect of ginkgo vinegar, a fermented product of ginkgo seed coat, in mice fed a high-fat diet and 3T3-L1 preadipocyte cells
  1843. Anti-obesity effects of tocotrienols and bran in high-fat diet-treated mice
  1844. Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models
  1845. Fuse your mitochondria, lose appetite: an anorexic, anti‐obesity sphingolipid
  1846. Anti-obesity synergistic effect of pomegranate seed oil (PSO) and Arabic Gum (AG) in albino rats.
  1847. Investigating the Mechanistic Differences of Obesity-Inducing Lactobacillus kefiranofaciens M1 and Anti-obesity Lactobacillus mali APS1 by Microbolomics …
  1848. Anti-obesity and lipid lowering activity of bauhiniastatin-1 is mediated through PPAR-γ/AMPK expressions in diet-induced obese rat model
  1849. Metabolite analysis and anti-obesity effects of celery seed in 3T3-L1 adipocytes
  1850. Microencapsulated duck oil diacylglycerol: Preparation and application as anti-obesity agent
  1851. Aquaporin 7 involved in GINSENOSIDE-RB1-mediated anti-obesity via peroxisome proliferator-activated receptor gamma pathway
  1852. Anti-obesity efficacy of the selected high altitude Himalayan herbs: In vitro studies
  1853. Hydrolyzed collagen from defatted sea bass skin and its conjugate with epigallocatechin gallate: In vitro antioxidant, anti-inflammatory, wound-healing and anti-obesity …
  1854. Efficacy of Gynostemma pentaphyllum extract in anti-obesity therapy
  1855. Anti-obesity effects of individual or combination treatment with Spirulina platensis and green coffee bean aqueous extracts in high-fat diet-induced obese rats
  1856. Identification of key candidate genes and molecular pathways in white fat browning: An anti-obesity drug discovery based on computational biology
  1857. Studies on antioxidant and anti-obesity activity of Salvia hispanica (Chia) seeds extracts
  1858. Anti-Obesity Effects of Petasites japonicus (Meowi) Ethanol Extract on RAW 264.7 Macrophages and 3T3-L1 Adipocytes and Its Characterization of Polyphenolic …
  1859. Anti-Obesity Properties of Calocybe Indica in Zebra fishes with Short-Term High-Fat Diet Induction
  1860. Development of a novel anti-obesity compound with inhibiting properties on the lipid accumulation in 3T3-L1 adipocytes
  1861. Polyphenols in peanut shells and their antioxidant activity: Optimal extraction conditions and the evaluation of anti-obesity effects
  1862. In vitro anti diabetic and anti obesity effect of J. communis extract on 3T3L1 mouse adipocytes: A possible role of MAPK/ERK activation
  1863. Anti-obesity and gut microbiota modulation effect of Astragalus Polysaccharides combined with berberine on high-fat diet-fed obese mice
  1864. Anti-Obesity Effects of Morus alba L. and Aronia melanocarpa in a High-Fat Diet-Induced Obese C57BL/6J Mouse Model
  1865. Metabolic regulation and the anti-obesity perspectives of Brown Adipose Tissue (BAT); a Systematic Review
  1866. Synergistic action of Erigeron annuus L. Pers and Borago officinalis L. enhances anti-obesity activity in a mouse model of diet-induced obesity
  1867. Polymethoxyselenoflavones exert anti-obesity effects through activation of lipolysis and brown adipocyte metabolism
  1868. Anti-obesity effect of gold nanoparticles from Dendropanax morbifera Léveille by suppression of triglyceride synthesis and downregulation of PPARγ and CEBPα …
  1869. Anti-Obesity Effect of Fermented Panax notoginseng Is Mediated Via Modulation of Appetite and Gut Microbial Population
  1870. Polypyrrole-coated hollow gold nanoshell exerts anti-obesity effects via photothermal lipolysis
  1871. Adiponectin homolog osmotin, a potential anti-obesity compound, suppresses abdominal fat accumulation in C57BL/6 mice on high-fat diet and in 3T3-L1 adipocytes
  1872. Lactiplantibacillusplantarum ATG-K2 Exerts an Anti-Obesity Effect in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiome
  1873. Anti‐obesity effect of Melandrium firmum Rohrbach extract in 3T3‐L1 cells and high‐fat diet‐induced obese C57BL/6N mice
  1874. Trial data of the anti-obesity potential of a high resistant starch diet for canines using Dodamssal rice and the identification of discriminating markers in feces for …
  1875. Immunostimulatory activity and anti-obesity activity of Hibiscus manihot leaves in mouse macrophages, RAW264. 7 cells and mouse adipocytes, 3T3-L1 cells
  1876. Antioxidant, antidiabetic, and anti-obesity potential of Ipomoea reptans Poir leaves
  1877. Rapid model to evaluate the anti-obesity potential of a combination of Syzygium aromaticum (clove) and Cuminun cyminum (cumin) on C57BL6/j mice fed high-fat diet
  1878. Anti-obesity effect with reduced adverse effect of the co-administration of mini-tablets containing orlistat and mini-tablets containing xanthan gum: In vitro and in vivo …
  1879. Linifanib exerts dual anti-obesity effect by regulating adipocyte browning and formation
  1880. Anti-hyperglycemic, lipid-lowering, and anti-obesity effects of the triterpenes α and β-amyrenones in vivo
  1881. Hibiscus sabdariffa extract as anti-aging supplement through its antioxidant and anti-obesity activities
  1882. Characterization of ethyl acetate and methanol extracts of Commiphora myrrha and evaluating in vitro anti-diabetic and anti-obesity activities
  1883. Evaluation of an online cognitive behavioural therapy weight loss programme as an adjunct to anti-obesity medications and lifestyle interventions
  1884. A Combination of Korean Red Ginseng Extract and Glycyrrhiza glabra L. Extract Enhances Their Individual Anti-Obesity Properties in 3T3-L1 Adipocytes and C57BL …
  1885. Berberine is as effective as the anti-obesity drug Orlistat in ameliorating betel-nut induced dyslipidemia and oxidative stress in mice
  1886. … and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects
  1887. Determination of macro, micro, trace essential, and toxic elements in Garcinia cambogia fruit and its anti‐obesity commercial products
  1888. Antioxidant, Anti-Obesity, and Anti-Aging Activities of Jeju Citrus Blended Vinegar
  1889. 48Biochemical mechanisms of the anti-obesity effect of a triterpenoid-enriched extract of Cynomorium songaricum in mice with high-fat-diet-induced obesity
  1890. Anti-obesity effect of cocoa proteins (Theobroma cacao L.) variety “Criollo” and the expression of genes related to the dysfunction of white adipose tissue in high-fat …
  1891. Anti-obesity effects of galla rhois via genetic regulation of adipogenesis
  1892. Impact of green tea epigallocatechin-3-gallate on HIF1-α and mTORC2 expression in obese women: anti-cancer and anti-obesity effects?
  1893. Mechanisms of action and clinical applications of anti-obesity drugs currently available in Korea
  1894. Chenodeoxycholic acid has non-thermogenic, mitodynamic anti-obesity effects in an in vitro CRISPR/Cas9 model of bile acid receptor TGR5 knockdown
  1895. Anti-obesity effect of fresh and browned Magnolia denudata flowers in a high fat diet murine model
  1896. Anti-obesity effect of fermented persimmon extracts via activation of AMP-activated protein kinase
  1897. A new scope for orlistat: Effect of approved anti-obesity drug against experimental microsporidiosis
  1898. Transcriptomic and metabonomic profiling reveal the anti-obesity effects of Chikusetsusaponin V, a compound extracted from Panax japonicus
  1899. Changes in the profiling of bioactive components with the roasting process in Lycium chinense leaves and the anti‐obesity effect of its bioaccessible fractions
  1900. Anti-obesity and anti-inflammatory effects of ginseng vinegar in high-fat diet fed mice
  1901. The use of anti-obesity medications in people with mental illness as an adjunct to lifestyle interventions—Effectiveness, tolerability and impact on eating behaviours: A …
  1902. Effects of extraction solvents on phytochemical screening, cytotoxicity and anti-obesity activities of selected Sri Lankan medicinal plants
  1903. Evaluation of Anti-obesity of Pithecellobium dulce against high fat diet Induced Obesity in Experimental Animals
  1904. In vivo anti-obesity effects of Monascus pigment threonine derivative with enhanced hydrophilicity
  1905. Contrasting anti-obesity effects of smectite clays and mesoporous silica in Sprague-Dawley rats
  1906. RNA-seq analysis of diet-driven obesity and anti-obesity effects of quercetin glucoside or epigallocatechin gallate in Drosophila adults.
  1907. Shifting the blame frame: Agency and the parent–child relationship in an anti-obesity campaign
  1908. Antioxidant and Anti-Obesity Potentials of Korean-Native Wild Vegetables (Allium species)
  1909. Anti-obesity action of fermented barley extracts with Lactobacillus plantarum dy-1 and associated MicroRNA expression in high-fat diet-induced obese rats
  1910. Anti-obesity and anti-lipidemic properties of ascorbic acid in fructose induced obese Wistar rats
  1911. Oxidative stress and anti-obesity approach in behavior of COVID-19: A review
  1912. In Vivo Evaluation of Dendropanax morbifera Leaf Extract for Anti-Obesity and Cholesterol-Lowering Activity in Mice
  1913. Antioxidant activity of sprouts extracts is correlated with their anti-obesity and anti-inflammatory effects in high-fat diet-fed mice
  1914. Impact of anti‐obesity medication initiation and duration on weight loss in a comprehensive weight loss programme
  1915. Metabolite profiling and biological properties of aerial parts from Leopoldia comosa (L.) Parl.: Antioxidant and anti-obesity potential
  1916. A systematic review on obesity and herbal anti-obesity medicines
  1917. Phenotypic Discovery of SB1501, an Anti‐obesity Agent, through Modulating Mitochondrial Activity
  1918. Anti-hyperlipidemia and anti-obesity properties of Garcinia atroviridis and Camellia sinensis extracts in high-fat diet mice
  1919. Spirulina as Anti-Obesity and Hepato-Renal Protective Agent in MSG-Exposed Female Rats
  1920. Is there a simple, quick, and inexpensive method available for in vitro testing of potential herbal products: Anti-obesity and antidiabetic activity of Coleus schinzii?
  1921. Using of licensed and unlicensed anti-obesity medications among the university students
  1922. An in vitro study reveals the anti-obesity effects of 7-methoxy-3-methyl-5-((E)-prop-1-enyl)-2-(3, 4, 5-trimethoxyphenyl)-2, 3-dihydrobenzofuran from Myristica fragrans
  1923. Alcoholic Extract of Poly Herbal Powder Mixture for Anti-Obesity effect on Wistar Rats
  1924. Bioassay-guided isolation and identification of anti-obesity phytochemicals from fruits of Amomum tsao-ko
  1925. Evaluation of anti-obesity potential of aqueous extract of Achyranthes aspera Linn. in high fat diet induced obese rats
  1926. Fermentation of Chestnut (Catanea crenata Sieb) Inner Shell Enhances Anti-Obesity Effects in 3T3-L1 and C3H10T1/2 Adipocytes
  1927. Identification of Dacinostat as a potential anti-obesity compound through transcriptional activation of adipose thermogenesis in mice
  1928. “I enjoy the treadmill very much”: Moving beyond traditional understandings of self-efficacy in anti-obesity interventions
  1929. Identification of short-chain pyroglutamyl peptides in Japanese salted fermented soy paste (miso) and their anti-obesity effect
  1930. Discovery of a novel GLP-1/GIP dual receptor agonist CY-5 as long-acting hypoglycemic, anti-obesity agent
  1931. Anti-obesity and lipid metabolism effects of Ulmus davidiana var. japonica in mice fed a high-fat diet
  1932. Anti-obesity and hepatoprotective effects in obese rats fed diets supplemented with fruit purees
  1933. Potential Anti-obesity effects of some medicinal herb: In vitro α-amylase, α-glucosidase and lipase Inhibitory Activity
  1934. The effects of anti-obesity pharmacotherapy interventions on psychosocial factors among adolescents with obesity: a scoping review
  1935. Anti-Obesity Effects of Combined Cornus officinalis and Ribes fasciculatum Extract in High-Fat Diet-Induced Obese Male Mice
  1936. Brown-like adipocyte progenitors derived from human ips cells: a new tool for anti-obesity drug discovery and cell-based therapy?
  1937. Dihydropyranocoumarins exerted anti-obesity activity in vivo and its activity was enhanced by nanoparticulation with polylactic-co-glycolic acid
  1938. Pre-clinical evidence for the anti-obesity potential of quercetin and curcumin loaded chitosan/PEG blended PLGA nanoparticles
  1939. Ethnobotanical Study of Medicinal Plants used as Anti-Obesity Remedies in Foumban and Dschang Cities (West-Cameroon)
  1940. Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent
  1941. Anti-obesity of dried mulberry fruit powder in mice fed with high-fat diet
  1942. The potency of Carica papaya L. seeds powder as anti-obesity ‘coffee’drinks
  1943. Anti-obesity medications in cancer therapy: A comprehensive insight
  1944. 2D-QSAR study of the anti-obesity activity for the compounds based on 2-anilino, 4-aryl pyrimidines and 2, 4-diaryl 7-azaindoles using statistical methods
  1945. Citrus reticulata peel extract: an anti-obesity therapy for adolescents
  1946. Anti-Obesity Efficacy of Lipoidal Matter of Vitis Vinifera Leaves in Rats
  1947. Sustained anti-obesity effects of life-style change and anti-inflammatory interventions after conditional inactivation of the activin receptor ALK7
  1948. Anti-obesity medical devices
  1949. Scientific evaluation of anti-obesity potential of aqueous seed kernel extract of Mangifera indica Linn. in high fat diet induced obese rats
  1950. Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo …
  1951. EGCG as Anti-Obesity and Anticancer Agent
  1952. Anti-obesity effects of Tenebrio molitor larvae powder in high-fat diet-induced obese mice
  1953. Anti-obesity and anti-diabetic effects of the fermented ethanol extracts from white jelly fungus (Tremella fuciformis Berk) with Lactobacillus rhamnosus BHN-LAB 76
  1954. Metabolic analysis of the illegal analogues of anti-obesity drugs using LC-Q-TOF-MS/MS
  1955. Anti-obesity effects of Korean red ginseng extract in healthy beagles
  1956. Synthesis, drug likeness and in-vitro screening of some novel quinazolinone derivatives for anti-obesity activity
  1957. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds
  1958. Anti-obesity effect of Ramulus mori extracts and stilbenes in high fat dietfed C57BL/6J mouse
  1959. Ethnopharmacological approach of anti-obesity medicinal plants: A review
  1960. Anti-Obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1
  1961. Structure–activity relationship study of the anti‐obesity natural product yoshinone A
  1962. A Mechanistic Review of Anti-Obesity Drugs
  1963. Anti-Obesity Effect of Licorice Acetone Extract in a Mouse Model of Obesity Induced by a High-Fat Diet
  1964. Anti-obesity effects of α-cyclodextrin-stabilized 4-methylthio-3-butenyl isothiocyanate from daikon (Raphanus sativus var. longipinnatus) in mice
  1965. Anti-obesity effect of mulberry anthocyanins in C57BL/6J mice
  1966. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities
  1967. Anti-obesity potential of almond (Prunus dulcis) in experimental animals under cafeteria and atherogenic diets
  1968. Anti-obesity Effects of Fucoxanthin, a Major Marine Carotenoid Isolated from Edible Brown Seaweeds-A Narrative Review
  1969. Anti-Obesity and Antihyperlipidemic Effects of Musa cavendishii
  1970. Anti-obesity effects of combined extracts of Terminalia chebula and Phyllanthus emblica (FBF-TC) in matured 3T3-L1 adipocytes and high fat diet-induced obese mice
  1971. Anti-obesity, anti-atherosclerotic and anti-oxidant effects of Pu-Erh tea on a high fat diet-induced obese rat model
  1972. Perspectives of Anti-Obesity Medication Use among Persons with Obesity and Health Care Providers
  1973. The behavioral responses of consumers to the intensity and type of fear appeals used in anti-obesity advertisements: An experimental study on college students in …
  1974. Anti-obesity activity of ethanol extract from bitter melon in mice Fed high-fat diet
  1975. Anti-obesity effects of Garcinia indica high pressure ethanolic extract in vitro
  1976. Anti-Obesity Properties of Black Pepper (Piper nigrum L.): Completing Puzzle using Computational Analysis
  1977. The synthesis and characterization of gold nanoparticles with polyunsaturated oils contribute to hypolipidemic and anti-obesity activities in vivo.
  1978. Downregulation of adipogenic genes in 3T3-L1 Pre adipocytes-a possible mechanism of anti-obesity activity of herbal decoction Varanadi Kashayam
  1979. Anti-obesity effects of Banggihwnggi-tang-hap-yeonggyechulgam-tang in high fat diet induced obese mice model
  1980. Evaluation of anti-obesity activity of Gymnema sylvestre leaves extract
  1981. Anti-obesity effect of Crataegus pinnatifida through gut microbiota modulation in high-fat-diet induced obese mice
  1982. Natural Phenolic Compounds as Anti-obesity and Anti-cardiovascular Disease Agent
  1983. Production of Functional Peptide with Anti-obesity Effect from Defatted Tenebrio molitor Larvae Using Proteolytic Enzyme
  1984. Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and …
  1985. Antioxidant and anti-inflammatory potential of polyphenols contained in Mediterranean diet in obesity: Molecular mechanisms
  1986. Pregnancy outcomes after inadvertent exposure of anti-obesity drugs during pregnancy
  1987. Identification of a new chemotype of anti-obesity compounds by ensemble screening
  1988. Plant extracts and reactive oxygen species as two counteracting agents with anti-and pro-obesity properties
  1989. Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
  1990. Scientific evaluation of anti-obesity potential of methanolic leaves extract of Ocimum sanctum (Linn.) in monosodium glutamate-high fat diet induced obese mice
  1991. The active ingredients in the anti‐obesity drug bofutsushosan in high‐fat‐diet‐fed obese mice
  1992. Statistical Design of Sustained-Release Tablet Garcinia cambogia Extract and Bioconverted Mulberry Leaf Extract for Anti-Obesity
  1993. Antibacterial and anti-obesity effects of Abeliophyllum distichum Nakai: an in vitro study
  1994. Screening of Weight-Loss Herbal Products for Synthetic Anti-Obesity Adulterants: A Target-Oriented Analysis by Liquid Chromatography–Tandem Mass Spectrometry
  1995. Collateral Damage of the ‘War on Obesity’: The Australian Anti-Obesity Campaign: From Fat Stigma to Eating Disorders
  1996. Hypocholesterolemic and anti-obesity effects of radish sprouts (Raphanus sativus) in adult females
  1997. Active Fraction as Anti-obesity by in Vitro toward Pancreatic Lipase Activity
  1998. Old and New Anti-obesity Devices for Medical, Surgical, and Endoscopical Use
  1999. Anti-Obesity Effects of Aloe Vera Whole Leaf and Sitagliptin in Diabetic Rats
  2000. Anti-Obesity Drug Prescribing Pattern to the Young People in Primary Care: An Indian Scenario
  2001. Physiological characteristics and anti-obesity effect of milk fermented by Lactobacillus plantarum KI134
  2002. The vicious cycle of stressors, food advertising and overeating: how stigmatizing anti-obesity PSAs, which precede food commercials, influence subsequent implicit …
  2003. Anti-obesity effects of Celastrus orbiculatus extract containing celastrol on canine adipocytes
  2004. Correction: A clinical and computational study on anti-obesity effects of hydroxycitric acid
  2005. A study of an anti-obesity, anti-obesity campaign
  2006. Assessing the effects of orlistat as an anti-obesity drug in high fat diet induced obesity in male rats
  2007. A matter of weight? Anti-obesity strategies in Spain
  2008. Studies on the anti-obesity activity of ethanolic extract of Centella asiatica in Triton-X, High fat diet and Progesterone induced obesity
  2009. Anti-obesity attitudes, food symptomatology and meanings associated with obesity in students linked to the health area
  2010. In Vitro Anti-Obesity Effects of Raw Garlic and Pickled Garlic
  2011. Involvement of YAP/TAZ Signaling Pathway in Anti-obesity Activity of Moringa oleifera Leaf Extract
  2012. Anti-adipogenic effects of viscothionin in 3T3-L1 adipocytes and high fat diet induced obesity mice
  2013. Anti-Obesity Effect of Yoghurt Synbiotic in High Fat Diet Induced Wistar Rats
  2014. Anti-Obesity Medication Prescriptions by Race/Ethnicity and Use of an Interpreter in a Pediatric Weight Management Clinic
  2015. Influence of Organic and Conventional Agricultural Practices on Chemical Profile, In Vitro Antioxidant and Anti-Obesity Properties of Zingiber officinale Roscoe
  2016. Caffeic Acid Phenethyl Ester and Its Fluorinated Derivative as Natural Anti-obesity Agents (P06-089-19)
  2017. Mechanistic Study of Anti-Obesity Effect of Polymethoxyflavones Through Their Bioavailability, Biotransformation and Interaction with Gut Microbiota in Vivo
  2018. Looking for crumbs in the obesity forest: anti-obesity interventions in the Mexican population. History, and systematic review with Meta-Analysis
  2019. … combination of anti-obesity medications and bariatric surgery can be effective in resetting the cerebral adipostat in individuals with autism suffering from severe obesity
  2020. Carotenoids as Anti-obesity Supplements
  2021. Update on the Evaluation of the Anti-Obesity Effect of Green Tea (Camellia sinensis)
  2022. Anti-obesity effects of the novel long-acting amylin analogue ZP4982 in high-fat diet fed rats
  2023. Anti-Sarcopenic Obesity Effects of Lonicera caerulea Extract in High-Fat Diet-Fed Mice
  2024. Effects of Combination Therapy with Anti-Obesity Herbal Medicine Including Ephedra Herba and Lorcaserin in Obese Patients: Two Case Reports
  2025. Anti-obesity and hypolipidemic effects of Morus alba-A review
  2026. Anti-obesity effect of 3, 5-dicaffeoylquinic acid on high-fat diet mouse
  2027. Use of pectin fibers from water hyacinth and banana peels as an anti-obesity food supplement
  2028. Antidiabetic and Anti-obesity Properties of Moringa Species
  2029. Anti-Obesity and Anti-Inflammatory Effects of the Desalted Salicornia europaea L. Fermented by Bacillus velezensis K26
  2030. An overview of Pu-erh tea and its health-promoting effects of lipid-lowering and anti-obesity.
  2031. Identification of potential anti-obesity drug scaffolds using molecular modelling
  2032. A Study on Patients Drop-Out in Unani Pharmacopeial Validation of An Anti-obesity Drug
  2033. Ephedra alata extracts exhibits anti-obesity, anti-hyperlipidaemic, anti-hyperglycemia, anti-antipyretic and analgesic effects through the inhibition of lipase, α-amylase …
  2034. Acclaimed anti-obesity drug fails to impress scouts for clinically important research
  2035. Inhibitory effects of tannins from leaves of Hippophae rhamnoids and their anti-inflammatory and anti-obesity effects
  2036. FDA approval and surveillance process for anti-obesity drugs and devices
  2037. Anti-obesity activity of extract under various fractions of jambu air samarang (syzygium samarangense) leaves on wistar female rats
  2038. The anti-obesity effect of licorice extract and licorice banana mixture
  2039. Anti-obesity Effect of Whole Body Vibration Exercise: A Clinical Pilot Trial
  2040. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity
  2041. Okra (Abelmoschus esculentus L. Moench) as Anti-cholesterol, Anti-diabetic and Anti-obesity in White Male Rats
  2042. Pharmacophore-based Virtual Screening From Phytocannabinoids for Anti-obesity Activity
  2043. Lactobacillus plantarum Outperforms Enterococcus faecium on Anti-obesity Possibly through the Differences in Gut Dysbiosis Attenuation, Despite the Similar Anti …
  2044. Anti-Obesity Effects of Red Beet Extract
  2045. The Anti-Obesity Effect of Kaempferia Parviflora (KP) Is Attributed to Leptin in Adipose Tissue
  2046. Evaluation Anti-Obesity Activity of Psyllium Seeds Powder on Rats Fed a High Fat Diet
  2047. Kisspeptin-52 partially rescues the activity of the hypothalamus-pituitary-gonadal axis in underweight male rats dosed with an anti-obesity compound
  2048. Standardization of marketed anti‐obesity nutraceuticals containing amla and ginseng
  2049. Anti-diabetic and anti-obesity potentials of naringin and naringenin
  2050. Evaluation of Anti-Obesity Potential of Cappris Spinosa
  2051. Wood cultivated ginseng exerts immunostimulatory activity in mouse macrophages, RAW264. 7 cells and anti-obesity activity in mouse adipocytes, 3T3-l1 cells
  2052. Potential Prebiotic and Anti-Obesity Effects of Polysaccharides from Codium fragile
  2053. Disparagement humor and anti-obesity attitudes
  2054. Anti obesity prospective of Dalbergia latifolia (Roxb.) hydroalcoholic bark extract in high fat diet induced obese rats
  2055. The Anti-obesity Effects of Bangpungtongseong-san and Daesiho-tang: A Study Protocol of Randomized, Double-blinded Clinical Trial
  2056. Anti-obesity potential of glutinous black rice bran extract: Anti-adipogenesis and lipolysis induction in 3T3-L1 adipocyte model.
  2057. Some Spices with Anti-Obesity Activity
  2058. Novel insights into the mechanisms underlying the anti-obesity effects of whey protein
  2059. Novel Cell-Derived Delivery Systems for Anti-Obesity Treatment
  2060. Anti-Diabetic Obesity Effects of Wasabia Japonica Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice
  2061. Anti-atherogenic effects of orlistat on obesity-induced vascular oxidative stress rat model
  2062. Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice
  2063. The Anti-obesity Effect of Aureobasidium pullulans SM-2001 Extract (Polycan®) on 3T3-L1 Preadipocytes and Adipocytes
  2064. Anti-Obesity Effects of Sticky Japanese Diet (SJD) Assessed by Regulations of Leptin and Adiponectin
  2065. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity
  2066. Revealing the lactogenic, anti-obesity and antidiabetic activity of Cyperus rotundus.
  2067. The effects of obesity on anti-cancer immunity and cancer immunotherapy
  2068. Anti-Obesity Medications: An Update for Canadian Physicians
  2069. A Review on Anti Obesity Drugs
  2070. The Anti-Obesity Effect of Polysaccharide-Rich Red Algae (Gelidium amansii) Hot-Water Extracts in High-Fat Diet-Induced Obese Hamsters
  2071. Differential Anti‐Adipogenic Effects of Eicosapentaenoic and Docosahexaenoic Acids in Obesity
  2072. Evaluation of Indonesian Anti-obesity Traditional Medicinal Plants: A Systematic Review and Meta-analysis on Pancreatic Lipase Inhibition Activity
  2073. Lipid-Lowering and Anti-Obesity Properties of Resveratrol-Enriched Peanut Sprouts
  2074. MON-LB104 Update on Anti-Obesity Medical Devices
  2075. THE ANTI-OBESITY EFFECT OF ALLIUM CEPA L. LEAVES ON HIGH FAT DIET INDUCED OBESITY IN WISTAR RATS
  2076. Evaluation of Anti-Obesity Potential of Commiphora Mukul the Indian Bdellium Plant
  2077. Anti-obesity effects of cultivated ginseng,-wild ginseng and-red ginseng extracts
  2078. Overview of Anti-Obesity Medications for Weight Management.
  2079. A REVIEW OF HERBS MENTIONED IN BHAVPRAKASH NIGHANTU WSR TO ITS MEDOHARA ACTIVITY (ANTI OBESITY ACTIVITY) ACCORDING TO ITS …
  2080. Anti-obesity public health vs. fat acceptance: impacts on’fat’as a marginalized identity
  2081. Anti-Obesity Activity Tin Leaf Extract (Ficus carica Linn) on the Rats given High Fat Diets
  2082. Physiological and Anti-obesity Effects of Melatonin and Niacin Supplements in Rat Models
  2083. Ischemic stroke, obesity, and the anti‐inflammatory role of melatonin
  2084. Anti-obesity Effects of Treatment with Air-classified Brassica juncea L. Extract in High-Fat Diet-Induced Obese C57BL/6J Mice
  2085. Phytochemicals with potential anti-obesity properties
  2086. Synergistic anti-obesity effects of red cabbage and chromium administration on obese rats
  2087. A612 Anti-Obesity Pharmacotherapy: Putting Guidelines into Action
  2088. Effect of anti-obesity activity of Setaria italica on rats by using food induced obesity method
  2089. Anti-obesity Effects of Mulberry Leaf and Yacon Extract in Obese Rats
  2090. Abstract# 995159: Individualized Anti-obesity Pharmacotherapy Enhances Weight Loss in Patients with Diabetes Mellitus Type 2
  2091. Anti-Obesity Effect of CTFV in HFD-Fed Obesity Mice
  2092. Antimicrobial and anti-obesity properties of phenolic compounds
  2093. Anti Obesity Action of Omega-3 Supplementation in Wistar Rats
  2094. Anti-Obesity Properties of Jin-Chang-Mi in High-Fat Diet-Fed C57BL/6 Mice.
  2095. Anti-obesity Activity of Each of Green Coffee and Moringa oleifera Beverages Compared to Some Commercial Drugs and Their Possible Effects on Insulin Receptors …
  2096. Anti-Obesity Effects of Arum maculatum, Nasturtium officinale Plant Extracts and Exercise in High Fat Diet-Induced Obese Rats
  2097. Anti-obesity Effect of Quercetin by Activation of Non-shivering Thermogenesis in Adipose Tissues
  2098. Current and investigational anti-obesity drugs help reduce weight and offer additional benefits, but more effective options are needed
  2099. Real-World Primary Nonadherence to Long-Term Anti-Obesity Medications
  2100. EVALUATION OF ANTI-OBESITY AND ANTI-DIABETIC EFFECT OF HISTIDINE DIHYDROCHLORIDE IN ZEBRAFISH MODEL
  2101. Research progress on the anti-obesity effect and mechanism of plant polyphenols.
  2102. Anti-Obesity Drugs: Still in Evolution Stage
  2103. Study D: evaluation of anti-obesity drug treatment in children and adolescents
  2104. Anti-Obesity Effect of Mixed Probiotics of Bifidobacterium animalis subsp. Lactis CP-9 and Lactobacillus rhamnosus bv-77 in High-Fat Diet-Induced Obese …
  2105. Benefit-Risk Value Assessment of Long-Term Anti-Obesity Drugs
  2106. Evaluation of the anti-obesity potential of polyphenols through pancreatic lipase inhibition
  2107. Anti-obesity Agents Formulary Exception with Quantity Limit Program Summary
  2108. A BRIEF REVIEW ON CURRENT SCENARIO OF ANTI-OBESITY AYURVEDIC TREATMENT MODALITIES
  2109. Anti-oxidant, Anti-inflammatory, and Anti-obesity Effects of Ethanol Extracts from Ulmus divididiana var. japonica
  2110. … EVALUATION OF HYDROALCOHOLIC EXTRACT OF BARK OF PONGAMIA GLABRA VENT. FOR ANTI-OBESITY ACTIVITY AND EFFECT ON LIPID PROFILE AND …
  2111. Inorganic nitrate, a natural anti-obesity agent
  2112. Exploration of Possible Anti-Obesity Activity of Urolithins
  2113. The efficacy of an energy-restricted anti-inflammatory diet for the management of obesity in younger adults
  2114. Identification of a Dual-Action Small Molecule with Potent Anti-diabetic and Anti-obesity Activity
  2115. MON-593 Single-Dose Effects of Anti-Obesity Drugs on Human Basal Metabolic Rate
  2116. Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment
  2117. Suppressing Fat Accumulation and Anti-Obesity Effects of Imyo-San
  2118. Front Cover: Anti‐Obesity Effect of T. Chebula Fruit Extract on High Fat Diet Induced Obese Mice: A Possible Alternative Therapy
  2119. Antidiabetic and anti-obesity acylated flavonol diglucoside from Ammannia baccifera L. subsp. aegyptiaca (Willd.) Koehne Waste
  2120. Exploring Interactional Metadiscourse in Anti-Obesity Advertisements on Egyptian Facebook Pages Promoting Sleeve Gastrectomy: A Multimodal Approach
  2121. Comparative Studies on FDA Approved Anti-Obesity Drugs: A Review
  2122. Going too far? How the public health anti-obesity drives could cause harm by promoting eating disorders
  2123. AMP-activated protein kinase (AMPK) contributes to the anti-obesity effects and adipose tissue browning of alpha-lipoic acid in ovariectomized rats
  2124. Anti-obesity and anti-diabetic effect of Radish leaves extracts on high fat diet induced obesity in mice
  2125. Anti-Obesity Pharmacotherapy After Bariatric Surgery
  2126. Crude microcystins extracted from Microcystis aeruginosa exert anti-obesity effects by downregulating angiogenesis and adipogenesis related signaling …
  2127. An Anti-Obesity Formulation with AMPK upregulative and UCP-1 mRNA expression Enhancement Properties
  2128. The Effect of Sensitization Lectures on Anti-Obesity Attitudes in Undergraduate Medical Students
  2129. OPTIFAST: Long-Term Weight Loss from OPTIFAST Program by Anti-Obesity Medication Use at UPMC
  2130. Optimization of Kimchi Function and Anti-Obesity/Anti-Inflammatory Effect
  2131. Utilizing C. elegans to Study Effects of Natural and Pharmaceutical Anti-Obesity Medications.
  2132. Clinical Understanding of Udvarthana (Massage with Powdered Herbs) and Its Medohara (Anti-Obesity) Property
  2133. Exposure of anti-obesity drugs during pregnancy and their teratogenicity
  2134. … Patch Delivery: Microneedle Patch Delivery of Capsaicin‐Containing α‐Lactalbumin Nanomicelles to Adipocytes Achieves Potent Anti‐Obesity Effects (Adv. Funct …
  2135. Fermentation Characteristics and Anti-Obesity Effects of Cheonnyuncho (Oputia Humifusa) Fruit Fermented with Lactobacillus plantarum in 3T3-L1 Cells
  2136. Functional Verification of Probiotics with Anti-Obesity Activity in Chicken Fertilized Eggs
  2137. Physiological Characteristics and Anti-Obesity Effect of Weissella cibaria KI35
  2138. Allium cepa L. var. Tropea: a source of nutraceuticals with anti-obesity potential
  2139. The Expression Of Heme Oxygenase 1 In Skeletal Muscle Of Diet Induced Obese Mice In Response To Anti‐obesity Treatment
  2140. Anti-Obesity and Antihypertensive Peptides: Its Relationship to Adipose Tissue
  2141. Impact of obesity on anti-Mullerian hormone (AMH) levels in women of reproductive age
  2142. Evaluation of awareness about requirement of anti-obesity pharmacotheraphy before weight loss surgery in a tertiary outpatient Endocrine Clinic in Turkey
  2143. Anti‐obesity and Anti‐diabetes Effects of Silk Peptide in 3T3‐L1 Adipocytes.
  2144. A novel anti-obesity medication method using photodynamic therapy
  2145. A new anti-obesity medication with photodynamic therapy
  2146. Application of zebrafish model for screening of anti-obesity substances
  2147. Partition Coefficient of the Anti-Obesity Health Supplement Raspberry Ketone
  2148. Anti-obesity Effect of Date Palm Pith in High-Fat Induced Obese Rats
  2149. Effects of Deep Sea Water on Anti-Obesity Properties in Induction of Beige Adipocytes
  2150. Antioxidant and Anti-obesity Properties of Pectolinarin-Rich Brassica juncea fine powder extract
  2151. Anti-Obesity Effect of Extract from FCVG in 3T3-L1 Adipocytes
  2152. Anti‐obesity Effects of Ecklonia stolonifera Extract in 3T3‐L1 Cells
  2153. Anti-obesity Effect of Centella asiatica Hot-Water Extract in 3T3-L1 Preadipocytes
  2154. Development of ultrasound-assisted extraction process for production of bio-active compounds and evaluating anti-obesity effects from peanut shells
  2155. Bioactive compounds of fruit peel extract in prebiotic fermentation and anti-obesity activity
  2156. Adequacy of anti-obesity effects of Barley sprout
  2157. ANTI-OBESITY EFFECTS OF THE METHANOL EXTRACT OF MOMORDICA FOETIDA (CUCURBITACEAE) IN MALE WISTAR RATS
  2158. Anti-obesity effect of Chrysanthemum morifolium in a high fat diet-induced obese rats
  2159. Anti-obesity and Hypolipidemic Effects of GymnemaSyylvestre Leaves on Rats Fed on High Fat Diet
  2160. ANTI-OBESITY ACTIVITY OF THE AQUOEUS EXTRACT OF MORINGA OLIFERA HERBAL TEAS FAMILY MORINGACEAE (RSPG2. 6)
  2161. Potential sources of anti-obesity compound–hydroxycitric acid among some of the underutilized fruits in the Philippines
  2162. Maternal Use of Anti-Obesity Drugs and Infant Congenital Malformations
  2163. Anti-obesity Effect of chamomileand Camel’s hey in-Induced Obese Rats
  2164. Anti-obesity Activity of Standardized Ecklonia stolonifera Extract in 3T3-L1 Adipocytes
  2165. Obesity Among College Students of a Higher Education Institution in Northern Philippines: Focusing on the University’s Anti-Obesity Program
  2166. Associations between obesity and the effectiveness of anti–tumor necrosis factor-α agents in inflammatory bowel disease patients: a literature review and meta …
  2167. The Improvement of skin barrier function and anti-obesity effect of Codonopsis lanceolata by supercritical carbon dioxide extraction
  2168. Anti-obesity activity of the aqueous extract of Moringa Olifera herbal teas family Moringaceae (RSPB2. 1)
  2169. A Study on the Anti-obesity Effect of Caffeoylquinic Acids From the Cell Culture of Saussurea Involucrata
  2170. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds
  2171. Anti-diabetic and anti-obesity potentials of Hesperetin
  2172. Anti-obesity effect of Mongolian medicine Lomatogonium rotatum on high fat diet induced obese rats
  2173. ANTI-OBESITY, COGNITIVE ENHANCING, NEUROBEHAVIORAL, ANTIOXIDANT EFFECTS AND PHYTOCHEMICAL PROFILE OF DICHLOROMETHANE …
  2174. Anti-obesity effects of ethanol extract Plocamium Telfairiae in the C57BL/6 mice fed a high-fat diet
  2175. Protective effects of anti-obesity and anti-diabetic activities of date pits powder on alloxan Induced diabetic rats
  2176. Comparison of in vitro anti-obesity effect of raw garlic and processed garlic
  2177. Anti-Obesity Properties Of Katuk Leaves (Sauropus Androgynus) Extract To Reduce Risk Factor Diabetes Type 2
  2178. Anti-obesity effect of Spiraea prunifolia f. simpliciflora Nakai (SSN) extract in diet-induced obesity mice model
  2179. Anti-obesity activity of Jinmutang-hap-banggihwanggi-tang Gagam in High-Fat Diet-Induced Obese Mice Model
  2180. Glucagon-Like Peptide 1 Receptor Agonists, the Past, and Now–Focus on Its Anti-Obesity Effect
  2181. Early Hepatic Gene Expression Profile of Lipid Metabolism of Mice on High Fat Diet after Treatment with Anti‐Obesity Drugs
  2182. SUN-591 PAPP-A Inhibition-a Novel Anti-Obesity Therapeutic Approach
  2183. Anti-obesity and Hypolipidemic Effects of GymnemaSyylvestre Leaves on Rats Fed on High Fat Diet
  2184. Anti-Obesity effects of extract from wild edible greens in 3T3-L1 Preadipocytes
  2185. Anti-obesity Effect of Asparagus and Broccoli in Induced Rats
  2186. Anti-obesity effects of Gastrodia elata extracts on high-fat diet-induced model in C57BL/6 mice
  2187. Anti-obesity activity of broccoli sprout and mustard seed mixture during differentiation of 3T3-L1 preadipocytes
  2188. Anti-obesity Effect of Extracts of Morus alba L. and Aronia Melanocarpa (Michx.) Elliott
  2189. … REVIEW AND NETWORK META-ANALYSIS OF THE EFFECT OF NALTREXONE/BUPROPION COMPARED WITH OTHER ANTI-OBESITY DRUGS IN OVERWEIGHT …
  2190. Antioxidant and Anti-Obesity Effects of Polygonum cuspidatum in 3T3-L1 Adipocytes
  2191. … Study of the Antioxidant and Anti-Inflammatory Effects of Leaf Extracts from Four Different Morus alba Genotypes in High Fat Diet-Induced Obesity in Mice
  2192. Hepatoprotective and anti-obesity effects of Novel Peptide from Allomyrina dichotoma Larvae in high-fat diet (HFD)-fed mice
  2193. The Anti-Obesity Effect of Jeju Magma Sea Water In Vitro and In Vivo
  2194. Anti-obesity efficacy of some enzymes derived from grains in high-fat diet induced mice
  2195. Effects of sprouted turnips seeds as a hypolipidemic and anti-obesity agents on adult human females
  2196. Study of anti-obesity effect of Rumex japonicus Houttuyn ethanol extracts in 3T3-L1 preadipocytes cells.
  2197. ANTI-OBESITY POTENTIAL OF GAVEDHUK (Coix lacryma-jobi Linn.): A REVIEW
  2198. Caffeic acid phenethyl ester and its fluorinated derivative as natural anti-obesity agents
  2199. In Vitro and In Vivo Anti-obesity Activity of Nano Formulation of a Standardized Extract of Oolong Tea, White Tea, and Green Tea Together with their Metabolic Profiling
  2200. The anti-obesity effect of GRHE on adipogenesis and lipogenesis in 3T3-L1 Cell
  2201. … MODELLING OF OMEGA-3 DERIVATIVES WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AS AN ANTI-OBESITY AGENT
  2202. Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
  2203. Anti-obesity effect of Colocasia esculenta water extract and glucose precipitate using high-fat diet and Cholesterol diet
  2204. Metabolic and hepatic effects of energy-reduced anti-inflammatory diet in younger adults with obesity
  2205. Antioxidant and Anti-Obesity Effects of Rosa rugosa Roots in 3T3-L1 Adipocytes
  2206. Anti-obesity Effect of Silk Peptide in High-fat Dietinduced Obese Mice
  2207. Anti-Obesity Effects of Stevia Standardized Steviosides and Rebaudiosides Mixture by Attenuating Adipogenesis and Lipogenesis via Downregulation and …
  2208. Obesity and CD8 T cell metabolism: implications for anti‐tumor immunity and cancer immunotherapy outcomes
  2209. Anti-obesity effects of an ethanol extract of red seaweed Plocamium telfairiae in C57BL/6 mice fed a high-fat diet
  2210. Anti-obesity Effects of Cardamonin in 3T3-L1 Cells
  2211. Anti-obesity Effect of Vegetable Juice Fermented using Lactic Acid Bacteria from Kimchi in High-fat Diet-induced Obese Mice
  2212. The study of the anti-obesity effects of aronia vinegar in mice model
  2213. UPLC-ESI-MS profile, antioxidant, cytotoxic, antidiabetic and anti-obesity activities of the aqueous extracts of three different Hibiscus species
  2214. Olfactory stimulation by fennel essential oil upregulated central nervous system: focus on metabolic health and anti-obesity
  2215. Anti-Obesity Effect of Rottlerin by Inhibiting Adipogenesis and de novo Lipogenesis via LRP6/mTOR/SREBP Pathway in 3T3-L1 Adipocytes
  2216. … expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
  2217. Exploring Novel Anti-Obesity Strategies: Nutritional and Pharmacological Interventions to Induce Browning and Brown Adipogenesis
  2218. Antioxidant Effects of Pine (Pinus densiflora) Needle Steam Distillation Extract and its Anti-obesity Effects on 3T3-L1 Adipocytes
  2219. Anti-obesity effect of the enzymatic hydrolyzed extract derived from Meretrix lusoria using the animal model (high fat-fed mice or ob/ob mice)
  2220. Anti-obesity effect of unripe citrus extract and its flavonoids in 3T3-L1 cells
  2221. Anti-obesity effect of micro-current stimulation by activating Wnt/β-Catenin signaling in ob/ob mice model
  2222. Peripheral cannabinoid–1 receptor blockade potentiates the anti–obesity and anti–diabetic effects of GLP–1 mimetics
  2223. Anti-Obesity Effect of Lactobacillus plantarum BK-021 in Diet-Induced Obese Rats
  2224. Ginger Rhizomes as Anti-Obesity Agent in MSG–Exposed Female Rats: Anti-Hypothyroidic Effect versus Satiety Stimulation as Possible Mechanisms
  2225. Retraction: Ling, W. et al. Evaluation of Anti-Obesity Activity, Acute Toxicity, and Subacute Toxicity of Probiotic Dark Tea. Biomolecules 2018, 8(4), 99
  2226. Anti-obesity effect of blueberry fermented liquid for companion animals using blueberry by-products
  2227. Anti-obesity effects of MPP, a mixed formulation of platycodin and the Aureobasidium-derived β-glucan polycan, in db/db mice.
  2228. Purification and Evaluation of Anti-Obesity Activity of Enzymatic Protein Hydrolysates from Allomyrina Dichotoma Larvae
  2229. Analytical Method Development and Investigation of Caffeine Content from Coffea arabica and Anti-Obesity Formulation as per ICH Q2 (R1) Protocol of …
  2230. Anti-adipogenic signals at the onset of obesity-related inflammation in white adipose tissue
  2231. Fermented Rice Bran Using Lactobacillus plantarum EM or Weissella koreensis DB1 Exerts Cholesterol-Lowering and Anti-obesity Effects in Mice Fed a High-Fat and …
  2232. Anti-obesity and Gut Health Effects of Molokhia (Corchorus olitorius L.) Extract in 3T3-L1 Adipocytes and C57BL/6J Obese Mice
  2233. Anti-Obesity Effect of Ramulus Mori and Its Bioactive Substances on High Fat Diet-Fed C57BL6/J Mouse
  2234. Anti-obesity and hypolipidemic effects of a novel inhibitor of Nur77 in high-fat diet-induced obese mice
  2235. Research update on the association between SFRP5, an anti‐inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease
  2236. Anti-obesity Effect of Autumn Olive Berry in Mice Fed a High-fat, High-sucrose Diet
  2237. Anti-NAFLD effect of Djulis hull and its major compound, rutin, in mice with high-fat diet (HFD)-induced obesity
  2238. Anti-obesity effect of broccoli leaf extract on 3T3-L1 adipocyte and ob/ob mice
  2239. Anti-obesity effect of organic cold pressed perilla oil in high-fat-diet-induced obese C57BL/6 mice
  2240. … of Secondary Metabolites and its Antioxidant Activities of Various Fractions of Albizia myriophylla Bark and Evaluations of Anti-Obesity Effect of Methanolic Extract of …
  2241. Evaluation of potential anti-obesity agents of seaweed ethanol extract of Jeju on 3T3 pre-adipocytes and obese mice fed a high-fat diet
  2242. The Anti-obesity Effects of Direct Delivery of Resveratrol-encapsulated Liposomes to Inguinal White Adipose Tissue in Male APOE* 3Leiden. CETP …
  2243. Anti-Obesity Effects of P. cocos wolf, A. chiisanensis, E. cortex, A. annua L., G. Cambogia on Obese Mice Induced by High-Fat-Diet
  2244. Microbiome, bile acids, and obesity: how microbially modified metabolites shape anti‐tumor immunity
  2245. Anti-obesity Effect of Fermented Rice Bran Powder by Weissella koreensis DB1 on High-fat and High-cholesterol Diet-induced Obese Mice
  2246. Tamarind multifunctional protein: Safety and anti-inflammatory potential in intestinal mucosa and adipose tissue in a preclinical model of diet-induced obesity
  2247. 241-LB: Positive Regulation of JAK/STAT at Signaling with SOCS3-Derived Cell-Permeable Binding Domain to ObR Induces Anti-obesity Effect
  2248. Anti-inflammatory components from functional foods for obesity
  2249. Chronic treatment with anti-GIPR mAb alone and combined with DPP-4 inhibitor correct obesity, dyslipidemia and nephropathy in rodent animals
  2250. Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma
  2251. Gum Arabic modifies anti-inflammatory cytokine in mice fed with high fat diet induced obesity
  2252. Potential role of anti-inflammatory HDL subclasses in metabolic unhealth/obesity
  2253. Role of anti‐inflammatory interventions in high‐fat‐diet‐induced obesity
  2254. … of prototypical oxidative phosphorylation uncoupler 2, 4-dinitrophenol (DNP) has been explored to support its development as an anti-obesity agent. The specific aims …
  2255. Systematic review and meta-analysis on the effect of obesity on recurrence after laparoscopic anti-reflux surgery
  2256. 2030-P: BS-016, a Novel Oleanolic Acid Derivative, Exerts Antidiabetic and Anti-Obesity Effects in Preclinical Studies
  2257. Therapeutic potential of novel combination of a long-acting glucagon analog (HM15136) and anti-diabetic drugs for the treatment of obesity
  2258. Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with …
  2259. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties
  2260. Anti-adipogenic effects of viscothionin in 3T3-L1 adipocytes and high fat diet induced obesity mice
  2261. Anti-inflammatory effect of β2 adrenergic stimulation on circulating monocytes with a pro-inflammatory state in high-fat diet-induced obesity
  2262. Herbal medicines attenuate PD-L1 expression to induce anti-proliferation in obesity-related cancers
  2263. … receiving a second dose of ChAdOx1 nCov-19 (AZD1222) vaccine in healthcare workers: lack of association with age, sex, obesity, and adverse reactions
  2264. Anti-diabetic and An ti-obesity effects of Sulforaphane in Broccoli leaf extract
  2265. It’s time to stop thinking about obesity treatment as an anti-vaxxer
  2266. Systemic anti-oxidant capacity is inversely correlated with systolic blood pressure and pulse pressure in children with obesity
  2267. … of Extra‐Virgin Olive Oil Produces a Better Postprandial Gut Hormone Response, Lipidic, and Anti‐Inflammatory Profile that Sunflower Oil: Effect of Morbid Obesity
  2268. Garcinia atroviridis pastilles with anti-obesity potential
  2269. … A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist—Caffeine does not reduce diet-induced obesity …
  2270. Analysis of Brazilian guidelines for obesity: pathologization of fat bodies, an approach focused on weight loss and anti-fat bias
  2271. Does Low Dose Of Piper Nigrum Extract Exert Anti-Obesity Activity?
  2272. More than a “monstrous obesity”! Time to overcome the “anti‐fat” bias
  2273. Obesity-associated metabolic disturbances reverse the antioxidant and anti-inflammatory properties of high-density lipoproteins in microglial cells
  2274. Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF …
  2275. Obesity and remission rates in Japanese patients with rheumatoid arthritis requiring anti-tumor necrosis factor alpha therapy
  2276. Investigating the Potential Anti-inflammatory Effects and Mechanisms of Apple Consumption in Overweight and Obesity
  2277. Folate and vitamin B12 in morbid obesity: the influence of folate on anti-atherogenic lipid profile
  2278. Overexpression of Growth Differentiation Factor 15 Reduces Blood Pressure and Produces Anti‐neuroinflammatory Effects in Mice with Diet‐induced Obesity
  2279. A double pandemic: the impact of anti-Covid measures on obesity
  2280. ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
  2281. The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism
  2282. … an energy-restricted anti-inflammatory diet on weight loss, body composition, cardiometabolic risk factors and immune system response in younger adults with obesity …
  2283. Understanding the Impact of Diet and Obesity on Anti-tumor Immunity and Therapeutic Efficacy in Kidney Cancer
  2284. Comparative Study of the Antioxidant and Anti-Inflammatory E ects of Leaf Extracts from Four Di erent Morus alba Genotypes in High Fat Diet-Induced Obesity in Mice
  2285. Anti-incretin Effect: A Missing Link between Obesity, Diabetes, and Metabolic Surgery
  2286. Obesity-Induced Immune Dysfunction: Implications for Anti-tumor Immunity and Immunotherapeutic Efficacy
  2287. RELATIONSHIP BETWEEN OBESITY AND ANTI MULLERIAN HORMONE IN WOMEN ABOVE (35) YEARS OLD
  2288. New Zealand spinach (Tetragonia tetragonoides) as a functional food alternative for anti-obesity and anti-hyperuricemia
  2289. [論文摘要] Harnessing Anti-obesity Gut Microbiota for Improved Cardiovascular Risk Management
  2290. Evaluation of Lipid Lowering Activity and Anti-Oxidant Status of Pithecellobium dulce in Obesity Induced Rats.
  2291. Assessing CD8+ cytotoxic T-cell dysfunction in obesity and its implications in anti-PD-1 blockade therapy
  2292. High-fat diet-induced oxidative stress links increased colonisation of Lactobacillus sakei with its anti-inflammatory properties in obesity
  2293. Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines’ expression in …
  2294. Protective effects of curcumin in high fat diet (HFD)-induced obesity include anti-inflammatory effects in adipose tissue and changes in gut microbiome (P06-075-19)
  2295. … OF PRO-INFLAMMATSORY/ANTI-INFLAMMATORY CYTOKINES AND MALONDIALDEHYDE IN PATIENTS WITH ALCOtHOL-INDUCED OR OBESITY OR …
  2296. Evaluation of relationship between obesity biomarker and Anti mullerian Hormone in obese infertile woman.
  2297. The procancer effects of obesity can be reversed by moderate weight loss or an anti-inflammatory drug in a mouse model of colon cancer
  2298. weight/obesity concerns, 51, 68, 221 anti-sperm antibodies (ASA) alternative testing procedures, 92
  2299. ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
  2300. Anti‑adipogenic signals at the onset of obesity‑related inflammation in white adipose tissue
  2301. SUN-104 The Anti-Rheumatic Drug Auranofin Improves The Metabolic Phenotype Of Obesity
  2302. Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in …
  2303. Effects of A 12 Week Walking Intervention on Exercise Barriers in Obesity Using an Anti-Gravity Treadmill
  2304. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
  2305. A study of antiobesity, hypolipidemic and anti-atherogenic activity of poly herbal formulation against high fat diet-induced obesity in albino rats
  2306. Supplement Figure 1∣ The anti-obesity effects of resveratrol is associated with metabolic benefits in NASH mice. water (A, mL/wk) and food (B, kcal/wk)
  2307. Obesity is associated with increased quantity but no difference in quality of oocytes and embryos in women with low anti-mullerian hormone level
  2308. Tomato-Oleoresin Anti-Inflammatory Effect Recovers Obesity-Induced Cardiac Dysfunction by Modulating Myocardial Calcium Handling.
  2309. THE IMPACT OF OBESITY ON ANTI-MULLERIAN HORMONE (AMH) AND AMH TRAJECTORIES: A LONGITUDINAL STUDY AMONG REPRODUCTIVE AGED …
  2310. Obesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions
  2311. The dopamine receptor D2 antagonist ONC201 has anti-tumorigenic activity in obesity-driven epithelial ovarian cancer
  2312. … сахара. The history of the South African sugar industry illuminates deeply rooted obstacles for sugar reduction anti-obesity interventions/Myers A., Fig D …
  2313. THU0107 OBESITY PREDICTS RESPONSE TO NOT ALL BUT CERTAIN BIOLOGICAL/TARGETED DISEASE MODIFYING ANTI-RHEUMATIC DRUGS FOR …
  2314. Modulating effect of vitamin D status on serum anti-adenovirus 36 antibody amount in children with obesity: National Food and Nutrition Surveillance
  2315. … ANTI-INFLAMMATORY PATHWAY IN THE HYPOTHALAMUS AND WHITE ADIPOSE TISSUE OF OFFSPRING MICE WITH OBESITY INDUCED BY MATERNAL …
  2316. Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity
  2317. Effects of anti-inflammatory treatment on fibroblast growth factor-21 in obesity and metabolic syndrome
  2318. Abstract LB-183: Anti-PD1 blunts obesity associated triple negative breast cancer progression
  2319. Preventive Effects of Co-administration of IL-2/anti-IL-2 Complex and Hyperbaric Oxygen on Obesity-related Parameters in High-fat Diet-induced Obese Mice
  2320. … . Barriers and facilitators to managing patients with class II and III obesity in primary care: a qualitative study20. The Edmonton Obesity Staging System predicts risk of …
  2321. Anti-infective treatment in obesity—“just double it?”
  2322. Anti-obesity drug discovery: advances and challenges
  2323. Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022
  2324. Anti-obesity natural products and gut microbiota
  2325. Anti-obesity carbonic anhydrase inhibitors: Challenges and opportunities
  2326. Antioxidant, anti-obesity, nutritional and other beneficial effects of different chili pepper: A review
  2327. Anti-obesity medications for the management of nonalcoholic fatty liver disease
  2328. Anti-obesity properties and mechanism of action of flavonoids: A review
  2329. Anti-diabetic and anti-obesity: Efficacy evaluation and exploitation of polyphenols in fruits and vegetables
  2330. Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: a mini-review
  2331. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
  2332. Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults
  2333. Bioactive dietary components—Anti‐obesity effects related to energy metabolism and inflammation
  2334. A natural anti-obesity reagent derived from sea buckthorn polysaccharides: Structure characterization and anti-obesity evaluation in vivo
  2335. Anti‐obesity effects of Chenpi: an artificial gastrointestinal system study
  2336. A review on rhubarb-derived substances as modulators of cardiovascular risk factors—a special emphasis on anti-obesity action
  2337. Anti-obesity weight loss medications: Short-term and long-term use
  2338. Anti-obesity public health advertisements increase risk factors for the development of eating disorders
  2339. Anti-obesity effects of traditional and commercial Kochujang in overweight and obese adults: A randomized controlled trial
  2340. Obesity Pillars roundtable: excessive weight reduction with highly effective anti-obesity medications (heAOMs)
  2341. An historical review of steps and missteps in the discovery of anti-obesity drugs
  2342. Cinnamon, an effective anti‐obesity agent: Evidence from an umbrella meta‐analysis
  2343. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
  2344. Beneficial flavonoid in foods and anti-obesity effect
  2345. Different dietary fibers unequally remodel gut microbiota and charge up anti-obesity effects
  2346. Integrated network pharmacology and cellular assay for the investigation of an anti-obesity effect of 6-shogaol
  2347. Critical review on anti-obesity effects of phytochemicals through Wnt/β-catenin signaling pathway
  2348. Anti-Obesity Effects of Ecklonia cava Extract in High-Fat Diet-Induced Obese Rats
  2349. Recent advances in anti-obesity drugs
  2350. Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience
  2351. Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: a population-based study
  2352. The anti-obesity effects of a water-soluble glucan from Grifola frondosa via the modulation of chronic inflammation
  2353. Influence of anti-obesity strategies on brain function in health and review: A review
  2354. Ulvophyte Green Algae Caulerpa lentillifera: Metabolites Profile and Antioxidant, Anticancer, Anti-Obesity, and In Vitro Cytotoxicity Properties
  2355. Comparative study of the anti-obesity and gut microbiota modulation effects of green tea phenolics and their oxidation products in high-fat-induced obese mice
  2356. Anti-obesity effects of metformin: A scoping review evaluating the feasibility of brown adipose tissue as a therapeutic target
  2357. Butyrylation meets adipogenesis-probed by a p300-catalyzed acylation-specific small molecule inhibitor: implication in anti-obesity therapy
  2358. Composition, Microbiota, Mechanisms, and Anti-Obesity Properties of Rice Bran
  2359. Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
  2360. In silico and in vitro analysis of PPAR–α/γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat
  2361. Anti-obesity effect of sulforaphane in broccoli leaf extract on 3T3-L1 adipocytes and ob/ob mice
  2362. BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
  2363. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance
  2364. Metabolomics based biomarker identification of anti-diabetes and anti-obesity properties of Malaysian herbs
  2365. Nicotinamide riboside supplementation exerts an anti–obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity …
  2366. Metabolomic Assay, Computational Screening, and Pharmacological Evaluation of Caulerpa racemosa as an Anti-obesity With Anti-aging by Altering Lipid …
  2367. A narrative review of anti-obesity medications for obese patients with osteoarthritis
  2368. The anti‐obesity and gut microbiota modulating effects of taxifolin in C57BL/6J mice fed with a high‐fat diet
  2369. Carotenoids Composition of Green Algae Caulerpa racemosa and Their Antidiabetic, Anti-Obesity, Antioxidant, and Anti-Inflammatory Properties
  2370. Anti-obesity properties of probiotics; a considerable medical nutrition intervention: findings from an umbrella meta-analysis
  2371. Microbiota modulation and anti-obesity effects of fermented Pyrus ussuriensis Maxim extract against high-fat diet-induced obesity in rats
  2372. Anti‐obesity effect of fermented lemon peel on high‐fat diet‐induced obese mice by modulating the inflammatory response
  2373. Anti-obesity effects of multi-strain probiotics in mice with high-carbohydrate diet-induced obesity and the underlying molecular mechanisms
  2374. Plantain flour: A potential anti-obesity ingredient for intestinal flora regulation and improved hormone secretion
  2375. Three lactic acid bacteria with anti-obesity properties: In vitro screening and probiotic assessment
  2376. Non-stigmatising alternatives to anti-obesity public health messages: Consequences for health behaviour and well-being
  2377. Bioactive peptides from food proteins as potential anti-obesity agents: Mechanisms of action and future perspectives
  2378. Anti-obesity potential of ponciri fructus: effects of extracts, fractions and compounds on adipogenesis in 3T3-L1 preadipocytes
  2379. Novel avocado oil-functionalized yogurt with anti-obesity potential: Technological and nutraceutical perspectives
  2380. Anti-Obesity Effect of Nostoc commune Ethanol Extract In Vitro and In Vivo
  2381. Biosynthesis and biotechnological production of the anti-obesity agent celastrol
  2382. Grape seed and skin extract, a potential prebiotic with anti-obesity effect through gut microbiota modulation
  2383. Anti-obesity, anti-hyperglycaemic, anti-antipyretic and analgesic activities of Globularia alypum extracts
  2384. Potential Prebiotic and Anti-Obesity Effects of Codium fragile Extract
  2385. Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates
  2386. Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications
  2387. Anti-obesity potential of heat-killed Lactiplantibacillus plantarum K8 in 3T3-L1 cells and high-fat diet mice
  2388. Anti-obesity effects of Laminaria japonica fucoidan in high-fat diet-fed mice vary with the gut microbiota structure
  2389. The anti‐obesity and anti‐diabetic effects of the edible seaweed Gloiopeltis furcata (Postels et Ruprecht) J. Agardh in mice fed a high‐fat diet
  2390. In Vitro Anti-Obesity Effect of Shenheling Extract (SHLE) Fermented with Lactobacillus fermentum grx08
  2391. Evaluation of the Anti-Obesity Effect of Zeaxanthin and Exercise in HFD-Induced Obese Rats
  2392. Combination anti‐obesity medications to effectively treat bariatric surgery weight regain at an academic obesity center
  2393. Anti-obesity effect of escin: a study on high-fat diet-induced obese mice.
  2394. Antidiabetic, antioxidant, and anti-obesity effects of phenylthio-ethyl benzoate derivatives, and molecular docking study regarding α-amylase enzyme
  2395. Microbiome-metabolomics insights into the feces of high-fat diet mice to reveal the anti-obesity effects of yak (Bos grunniens) bone collagen hydrolysates
  2396. The anti-obesity effect of Allium cepa L. leaves on high fat diet induced obesity in male wistar rats
  2397. Anti-obesity effect of theabrownin from dark tea in C57BL/6J mice fed a High-Fat diet by metabolic profiles through gut microbiota using untargeted metabolomics
  2398. Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different …
  2399. Uncovering the effect of Moringa oleifera Lam. leaf addition to Fuzhuan Brick Tea on sensory properties, volatile profiles and anti-obesity activity
  2400. In Vivo and In Silico Investigation of the Anti-Obesity Effects of Lactiplantibacillus plantarum Combined with Chia Seeds, Green Tea, and Chitosan in Alleviating …
  2401. It makes you not want to eat’: Perceptions of anti‐obesity public health campaigns in individuals diagnosed with an eating disorder
  2402. Investigation of antioxidant, hypoglycemic and anti-obesity effects of Euphorbia Resinifera L.
  2403. Anti-oxidative, anti-hyperglycemic and anti-obesity properties of selected edible leafy plants of Sri Lanka
  2404. Development of Functional Kiwifruit Jelly with chenpi (FKJ) by 3D Food Printing Technology and Its Anti-Obesity and Antioxidant Potentials
  2405. Anti-Obesity and Anti-Hyperglycemic Effects of Meretrix lusoria Protamex Hydrolysate in ob/ob Mice
  2406. (20R)-panaxadiol as a natural active component with anti-obesity effects on ob/ob mice via modulating the gut microbiota
  2407. Food-grade microgel capsules tailored for anti-obesity strategies through microfluidic preparation
  2408. Antioxidant, Anti-Obesity, and Hypolipidemic Effects of Polyphenol Rich Star Anise (Illicium verum) Tea in High-Fat-Sugar Diet-Induced Obesity Rat Model
  2409. The Anti-Obesity Potential of Cyperus rotundus Extract Containing Piceatannol, Scirpusin A and Scirpusin B from Rhizomes: Preclinical and Clinical Evaluations
  2410. Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice
  2411. N-Trimethylated chitosan coating white adipose tissue vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol
  2412. Hyperphagia of female UCP1-deficient mice blunts anti-obesity effects of FGF21
  2413. Chemical constitutes and anti-obesity potential of seedlings of purple-leafed rice in high-fat diet induced obese mice
  2414. Comparison of the anti-obesity effect of enriched capsanthin and capsaicin from Capsicum annuum L. fruit in obesity-induced C57BL/6J mouse Model
  2415. Equisetin is an anti-obesity candidate through targeting 11β-HSD1
  2416. Development and characterization of a fucoidan-based nanoemulsion using Nigella sativa oil for improvement of anti-obesity activity of fucoxanthin in an obese rat …
  2417. Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview
  2418. System-level investigation of anti-obesity effects and the potential pathways of Cordyceps militaris in ovariectomized rats
  2419. The Anti‐Obesity and Anti‐Inflammatory Capabilities of Pterostilbene and its Colonic Metabolite Pinostilbene Protect against Tight Junction Disruption from Western …
  2420. Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages
  2421. Anti-obesity effect of Lythri herba water extracts in vitro and in vivo
  2422. Antioxidant, Anti-Diabetic, Anti-Obesity, and Antihypertensive Properties of Protein Hydrolysate and Peptide Fractions from Black Sesame Cake
  2423. Bioactivity‐based molecular networking‐guided identification of guttiferone J from Garcinia cambogia as an anti‐obesity candidate
  2424. Anti-obesity effects of dark tea extracts by down-regulation of C/EBPα and PPARγ
  2425. Anti-obesity and anti-diabetic effect of ursolic acid against streptozotocin/high fat induced obese in diabetic rats
  2426. Anti-Obesity Efficacy of Pediococcus acidilactici MNL5 in Canorhabditis elegans Gut Model
  2427. Ephedra alata extracts exerts anti-obesity, anti-hyperglycemia, anti-antipyretic and analgesic effects
  2428. “Healthy” food and the production of differentiated bodies in “anti-obesity” discourses and practices
  2429. Ulva prolifera polysaccharide exerts anti-obesity effects via upregulation of adiponectin expression and gut microbiota modulation in high-fat diet-fed C57BL/6 …
  2430. Bioconverted Fruit Extract of Akebia Quinata Exhibits Anti-Obesity Effects in High-Fat Diet-Induced Obese Rats
  2431. A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
  2432. Anti-obesity and gut microbiota regulation effects of phospholipids from the eggs of crab, portunus trituberculatus, in high fat diet-fed mice
  2433. Ultrasonic assisted extraction, characterization and gut microbiota-dependent anti-obesity effect of polysaccharide from Pericarpium Citri Reticulatae’ …
  2434. Anti-obesity effects of red pepper (Capsicum annuum L.) leaf extract on 3T3-L1 preadipocytes and high fat diet-fed mice
  2435. Pomegranate Oil’s Potential as an Anti-Obesity Ingredient
  2436. Untargeted metabolomics of fermented onion (Allium cepa L) using UHPLC Q-TOF MS/MS reveals anti-obesity metabolites and in vivo efficacy in Caenorhabditis …
  2437. A novel anti-obesity mechanism for liraglutide by improving adipose tissue leptin resistance in high-fat diet-fed obese mice
  2438. Anti-Obesity Effects of Polymethoxyflavone-Rich Fraction from Jinkyool (Citrus sunki Hort. ex Tanaka) Leaf on Obese Mice Induced by High-Fat Diet
  2439. Anti-Obesity Effect of Chitoglucan in High-Fat-Induced Obesity Mice
  2440. Extra virgin coconut oil (Cocos nucifera L.) exerts anti-obesity effect by modulating adiposity and improves hepatic lipid metabolism, leptin and insulin …
  2441. Hypolipidemic and anti‐obesity effects of hydroalcoholic extract of Brazilian red propolis in a rodent model of Dyslipidemia
  2442. Anti-Obesity Effect of Auricularia delicate Involves Intestinal-Microbiota-Mediated Oxidative Stress Regulation in High-Fat-Diet-Fed Mice
  2443. Isoquercitrin from Apocynum venetum L. produces an anti-obesity effect on obese mice by targeting C-1-tetrahydrofolate synthase, carbonyl reductase, and …
  2444. Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances
  2445. Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives
  2446. Antioxidant, anti-inflammatory and anti-obesity potential of extracts containing phenols, chlorophyll and carotenoids from Mexican wild populations of Bacopa …
  2447. Transcriptomics reveals the anti-obesity mechanism of Lactobacillus plantarum fermented barley extract
  2448. The anti-obesity effect of mulberry leaf (Mori Folium) extracts was increased by bioconversion with Pectinex
  2449. Assessment of Anti-Obesity Potential and Techno-Functional Properties of Bougainvillea spectabilis Willd. Bracts
  2450. Anti-obesity effect of vegetable juice fermented with lactic acid bacteria isolated from kimchi in C57BL/6J mice and human mesenchymal stem cells
  2451. D-Limonene Promotes Anti-Obesity in 3T3-L1 Adipocytes and High-Calorie Diet-Induced Obese Rats by Activating the AMPK Signaling Pathway
  2452. Anti-Obesity Effects of a Mixture of Atractylodes macrocephala and Amomum villosum Extracts on 3T3-L1 Adipocytes and High-Fat Diet-Induced Obesity in …
  2453. Anti-obesity effects of heat-transformed green tea extract through the activation of adipose tissue thermogenesis
  2454. Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic
  2455. Anti-Obesity Effects of Aqueous Extracts of Sunbanghwalmyung-Eum in High-Fat-and High-Cholesterol-Diet-Induced Obese C57BL/6J Mice
  2456. Effect of anti-obesity and antioxidant activity through the additional consumption of peel from ‘Fuji’pre-washed apple
  2457. Spermine Suppresses Adipocyte Differentiation and Exerts Anti-Obesity Effects In Vitro and In Vivo
  2458. Anti-Obesity Evaluation of Averrhoa carambola L. Leaves and Assessment of Its Polyphenols as Potential α-Glucosidase Inhibitors
  2459. Anti-obesity effects of Ishophloroglucin A from the brown seaweed Ishige okamurae (Yendo) via regulation of leptin signal in ob/ob mice
  2460. The inhibition mechanisms of pancreatic lipase by apigenin and its anti-obesity mechanisms revealed by using network pharmacology
  2461. Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/STAT-3/SOCS-3 pathway
  2462. Anti-Obesity Activity in 3T3-L1 Cells of Cornus officinalis Fruits Harvested at Different Times
  2463. Exogenous spraying of sucrose improves sensory quality, bioactive components content and anti-obesity activity of Tieguanyin oolong tea
  2464. Metabolome and transcriptome signatures shed light on the anti-obesity effect of Polygonatum sibiricum
  2465. Oral bioavailability-enhancing and anti-obesity effects of hydroxysafflor yellow A in natural deep eutectic solvent
  2466. Anti-obesity effect of rice bran extract on high-fat diet-induced obese mice
  2467. Anti-Obesity and Anti-Adipogenic Effects of Administration of Arginyl-Fructose-Enriched Jeju Barley (Hordeum vulgare L.) Extract in C57BL/6 Mice and in 3T3 …
  2468. In vitro anti‐obesity activity by pancreatic lipase inhibition ‐ Simple HPLC approach using EVOO as natural substrate
  2469. Brown algae and barley-based anti-obesity food and its safety in C57BL6 mice
  2470. Ephedra alata subsp. alenda (Ephedraceae) leaf extracts: phytochemical screening, anti-diabetic, anti-obesity and anti-toxic activities on diabetic-induced liver …
  2471. Current Research on Antioxidant, Anti-Inflammatory and Anti-Obesity Potential of Food Extracts
  2472. Kadsura japonica fruits exert immunostimulatory and anti-obesity activity in RAW264.7 and 3T3-L1 cells
  2473. Anti-Obesity Effects of Formulated Biscuits Supplemented with Date’s Fiber; Agro-Waste Products Used as a Potent Functional Food
  2474. Anti-obesity and lipid-lowering mechanism of Corydalis Bungeanae Herba: Based on intestinal microflora and metabolomics
  2475. Dipterocarpus tuberculatus as a promising anti-obesity treatment in Lep knockout mice
  2476. Structural characteristics of mixed pectin from ginseng berry and its anti-obesity effects by regulating the intestinal flora
  2477. Anti-obesity effect of the bacterial product nisin in an NIH Swiss mouse model
  2478. In vitro screening and probiotic evaluation of anti-obesity and antioxidant lactic acid bacteria
  2479. Hibiscus increases functional capacity and the anti-obesity effect in trained obese rats
  2480. Assessment of two potential probiotic strains as anti-obesity supplements under high-fat feeding conditions
  2481. The anti-obesity effects of resveratrol on the 3T3-L1 adipocytes
  2482. Ethanol Extracts of Eriobotrya japonica (Loquat) Seeds, Leaves, and Fruits Have Anti-obesity and Hypolipidemic Effects in Rats
  2483. Anti-obesity effects of Lactiplantibacillus plantarum SKO-001 in high-fat diet-induced obese mice
  2484. Knowledge anduse of anti-obesity medications among students at Basrah University
  2485. Person-centered choice of anti-obesity pharmacotherapy.
  2486. Anti-Adipogenic and Anti-Obesity Effects of Gongmi Tea and Gongmi So Extract
  2487. The Relative Value of Anti-Obesity Medications Compared to Similar Therapies
  2488. Jatrorrhizine from Rhizoma Coptidis exerts an anti-obesity effect in db/db mice
  2489. Chios Mastiha Essential Oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults–A randomized controlled trial
  2490. Flowers of Allium cepa L. as Nutraceuticals: Phenolic Composition and Anti-Obesity and Antioxidant Effects in Caenorhabditis elegans
  2491. Collagen Peptide Exerts an Anti-Obesity Effect by Influencing the Firmicutes/Bacteroidetes Ratio in the Gut
  2492. High-throughput screening of lipase inhibitors as anti-obesity drugs on liquid crystal-infused porous surfaces
  2493. Anti-obesity effect and UHPLC-QTOF-MS/MS based metabolite profiling of Solanum nigrum leaf extract
  2494. Probiotic Property and Anti-Obesity Effect of Lactiplantibacillus plantarum KC3
  2495. Investigation of Selected Medicinal Plants for Their Anti-Obesity Properties
  2496. Evaluating anti‐obesity potential, active components, and antioxidant mechanisms of Moringa peregrina seeds extract on high‐fat diet‐induced obesity
  2497. Antioxidant and anti-obesity effects of in vitro digesta of germinated buckwheat
  2498. Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells
  2499. The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK/mTOR/lipogenesis Pathways
  2500. … step gradient ethanol precipitation indicate potential anti-obesity and anti-hepatic steatosis in vitro 3T3-L1 and HepG2 cells and in vivo high-fat diet-induced obesity …
  2501. Anti-obesity Properties of Phytochemicals: Highlighting Their Molecular Mechanisms Against Obesity
  2502. Metagenomic Insights into the Anti-Obesity Effect of a Polysaccharide from Saccharina japonica
  2503. … Effect of Ethanolic Extract from Tabebuia rosea (Bertol.) DC., Quercetin, and Anti-Obesity Drugs in Adipose Tissue in Wistar Rats with Diet-Induced Obesity
  2504. A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform
  2505. Mechanistically acting anti-obesity compositions/formulations of natural origin: a patent review (2010–2021)
  2506. Edible seeds with potential anti-obesity impact: a review
  2507. Government must proceed with landmark anti-obesity regulations in England
  2508. Anti-obesity effects of agar (Gelidium amansii)-derived oligosaccharides in high-fat diet-treated C57BL/6N mice due to differential regulations of lipogenesis and …
  2509. … extractions for improving the recovery of phenolics and charantin from bitter melon and for increasing the antioxidant, antidiabetic and anti-obesity activities of its …
  2510. Glucagon-modified Liposomes Delivering Thyroid Hormone for Anti-obesity Therapy
  2511. Myostain is involved in ginsenoside Rb1-mediated anti-obesity
  2512. Anti-Obesity and Anti-Inflammatory Synergistic Effects of Green Tea Catechins and Citrus β-Cryptoxanthin Ingestion in Obese Mice
  2513. One‐Pot Controllable Assembly of a Baicalin‐Condensed Aptamer Nanodrug for Synergistic Anti‐Obesity
  2514. Anti-Obesity Effects of Dietary Fibers Extracted from Flaxseed Cake in Diet-Induced Obese Mice
  2515. Pu-erh tea intake enhances the anti-obesity effect of intermittent fasting via modulating follicle-stimulating hormone and gut dysbacteriosis in female high-fat …
  2516. The Differences of Mechanisms in Antihypertensive and Anti-Obesity Effects of Eucommia Leaf Extract between Rodents and Humans
  2517. Adipose stromal/stem cell-derived extracellular vesicles: potential next-generation anti-obesity agents
  2518. Chemo-structural diversity of anti-obesity compound database
  2519. Evaluation of antioxidant and anti-obesity potential of Sargassum extracts
  2520. Anti-obesity effects of kimchi with red yeast rice in 3T3-L1 adipocytes and high-fat diet-induced obese mice
  2521. Evaluation of Body Changes and the Anti-Obesity Effect after Consumption of Korean Fermented Food, Cheonggukjang: Randomized, Double-Blind Clinical …
  2522. Anti-obesity effects of galacto-oligosaccharides in obese rats
  2523. The Anti-Obesity Potential of Superparamagnetic Iron Oxide Nanoparticles against High-Fat Diet-Induced Obesity in Rats: Possible Involvement of Mitochondrial …
  2524. An Innovative Mei-Gin Formula Exerts Anti-Adipogenic and Anti-Obesity Effects in 3T3-L1 Adipocyte and High-Fat Diet-Induced Obese Rats
  2525. Inhibitory Potential of Synthetic Amino Acid Derivatives against Digestive Enzymes as Promising Hypoglycemic and Anti-Obesity Agents
  2526. Anti-obesity effects of aerobic exercise along with Rosa canina seed extract supplementation in rats: The role of irisin and adipolin
  2527. Anti-Obesity Action of Boerhavia diffusa in Rats against High-Fat Diet-Induced Obesity by Blocking the Cannabinoid Receptors
  2528. Anti-obesity effect of simvastatin and omega-3 and its combination on obese model male Wistar rats: Effect of simvastatin, omega-3 and their combination on UCP1
  2529. Fermentation of ascorbic acid-elicited alfalfa sprouts further enhances their metabolite profile, antioxidant, and anti-obesity effects
  2530. Surface display of pancreatic lipase inhibitor peptides by engineered Saccharomyces boulardii: Potential as an anti-obesity probiotic
  2531. Lentinus squarrosulus Mont. Mushroom: Molecular Identification, In vitro Anti-Diabetic, Anti-Obesity, and Cytotoxicity Assessment
  2532. Immunostimulatory and anti‑obesity activities of Adenocaulon himalaicum leaves in RAW264.7 and 3T3‑L1 cells
  2533. Target identification of anti-diabetic and anti-obesity flavonoid derivative (Fla-CN)
  2534. Anti-Inflammatory and Neuroprotective Effect of the Anti-Obesity Dietary Supplement Dekosilhue® in an In Vitro Model of Neuroinflammation
  2535. Potential anti-obesity effect of fermented adzuki beans and their untargeted metabolomics using UHPLC-QTOF-MS
  2536. Foodomics Reveals Anti‐Obesity Properties of Cannabinoids from Hemp Oil
  2537. … and Characterization of Contaminating Bacteria from Garcinia cambogia Extract: Methods to Reduce Microbial Load and Its Anti-Obesity Effect in Wistar Rats
  2538. Affinity screening of potential anti-obesity and anti-diabetic component from pomegranate peel by co-immobilization of lipase and α-amylase using carbon nanotube …
  2539. Effect of superfine grinding on physical properties, bioaccessibility, and anti‐obesity activities of bitter melon powders
  2540. Variation in the anti-oxidant, anti-obesity, and anti-cancer potential of different polarity extracts of saffron petals
  2541. RNA-seq reveals that anti-obesity irisin and triiodothyronine (T3) hormones differentially affect the purinergic signaling transcriptomics in differentiated human …
  2542. Oral delivery of GLP-1R agonist by an engineered probiotic yeast strain has anti-obesity effects in mice
  2543. Perilla, sunflower, and tea seed oils as potential dietary supplements with anti-obesity effects by modulating the gut microbiota composition in mice fed a high-fat diet
  2544. Liver lipidomics analysis reveals the anti-obesity and lipid-lowering effects of gypnosides from heat-processed Gynostemma pentaphyllum in high-fat diet fed mice
  2545. Efficacy and safety of anti-obesity herbal medicine focused on pattern identification: A systematic review and meta-analysis
  2546. Gut microbiota mediates the anti-obesity effect of intermittent fasting by inhibiting intestinal lipid absorption
  2547. Effects of resistant starch on anti-obesity status and nutrient digestibility in dogs
  2548. Lipidome remodeling activities of DPA-EA in palmitic acid-stimulated HepG2 cells and the in vivo anti-obesity effect of the DPA-EA and DHA-EA mixture …
  2549. Anti‐obesity effect of Auricularia heimuer fruiting body alcohol extraction on obese mice and crucial metabolite pathway analysis by liquid chromatography‐tandem …
  2550. Anti-Obesity and Anti-Dyslipidemic Effects of Salicornia arabica Decocted Extract in Tunisian Psammomys obesus Fed a High-Calorie Diet
  2551. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program
  2552. Systematic review and meta-analysis of the anti-obesity effect of cupping therapy
  2553. Anti-obesity effects of corn peptide on 3T3-L1 preadipocytes and C57BL/6J obese mice
  2554. Anti-Obesity Potential through Regulation of Carbohydrate Uptake and Gene Expression in Intestinal Epithelial Cells by the Probiotic Lactiplantibacillus …
  2555. Insoluble Dietary Fiber from Soybean Residue (Okara) Exerts Anti-Obesity Effects by Promoting Hepatic Mitochondrial Fatty Acid Oxidation
  2556. KSK-74: Dual Histamine H3 and Sigma-2 Receptor Ligand with Anti-Obesity Potential
  2557. Bifidobacterium lactis IDCC 4301 Exerts Anti‐Obesity Effects in High‐Fat Diet‐Fed Mice Model by Regulating Lipid Metabolism
  2558. The Anti-Obesity Effect of Porous Silica Is Dependent on Pore Nanostructure, Particle Size, and Surface Chemistry in an In Vitro Digestion Model
  2559. Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo
  2560. Novel Anti-Obesity Pharmacotherapies
  2561. Anti-Obesity Effect of Porcine Collagen Peptide in 3T3-L1 Adipocytes and High-Fat Diet-Fed Mice by Regulating Adipogenesis
  2562. Antioxidant, Antidiabetic, and Anti-Obesity Properties of Apple Pulp Extracts (Malus domestica Bork): A Comparative Study of 15 Local and Commercial …
  2563. Total Phenolic, Flavonoids, and Carotenoids Content and Anti-Obesity Activity of Purslane Herb (Portulaca oleracea L.) Ethanol Extract
  2564. Molecular mechanism of anti-obesity effect of total lutein oxidized products (LOPs) in diet-induced obese mice
  2565. Evaluation of drug-drug interactions via inhibition of hydrolases by orlistat, an anti-obesity drug
  2566. Reduction of NADPH oxidase 4 in adipocytes contributes to the anti-obesity effect of dihydroartemisinin
  2567. Phytochemical Screening, Anti-obesity and Hepatoprotective Activities of Ethanol Leaf Extract of Jatropha tanjorensis in Wistar Rats
  2568. Rhamnose Displays an Anti-Obesity Effect Through Stimulation of Adipose Dopamine Receptors and Thermogenesis
  2569. Evaluation of Some Safety Parameters of Dual Histamine H3 and Sigma-2 Receptor Ligands with Anti-Obesity Potential
  2570. Radical Scavenging-Linked Anti-Obesity Effect of Standardized Ecklonia stolonifera Extract on 3T3-L1 Preadipocytes and High-Fat Diet-Fed ICR Mice
  2571. Solanum nigrum show anti-obesity effects on high-fat diet-fed Sprague Dawley rats in a randomized study
  2572. Antioxidant, anti-inflammatory and anti-obesity effects of onion and its by-products in high-fat fed rodents: a systematic review
  2573. Hydroethanolic Cyperus rotundus L. extract exhibits anti-obesity property and increases lifespan expectancy in Drosophila melanogaster fed a high-fat diet
  2574. Anti-Obesity Effects of SPY Fermented with Lactobacillus rhamnosus BST-L.601 via Suppression of Adipogenesis and Lipogenesis in High-Fat Diet-Induced …
  2575. FORMULATION OF HERBAL TEA USING CYMBOPOGON CITRATUS, FOENICULUM VULGARE AND MURRAYA KOENIGII AND ITS ANTI-OBESITY …
  2576. Can homeopathic medicine Chelidonium majus serve a dual role of an anti-obesity and anti-diabetic agent?
  2577. Increasing inosine/decreasing ENT1: promising strategies for anti-obesity therapy
  2578. A small-molecule lycorine derivative reveals Na+/K+-ATPase α3 as an anti-obesity target
  2579. Anti-Obesity Actions of Two Separated Aqueous Extracts From Arbutus (Arbutus unedo) and Hawthorn (Crataegus monogyna) Fruits Against High-Fat Diet in Rats …
  2580. Effect of multi-strain probiotics as an anti-obesity among overweight and obese Saudi adults
  2581. In silico elucidation of plausible anti-obesity activity by Withaferin-A compound targeting alpha-amylase.
  2582. Anti-obesity effect of collagen peptides obtained from Diplulmaris antarctica, a jellyfish of the Antarctic region
  2583. Inhibition of Serum Lipase as a Mechanism of Action for Anti-Obesity Potentials of Dioscorea bulbifera Extracts on Wistar Rats
  2584. Anti-Obesity Effects and the Regulation of Energy Metabolism in Skeletal Muscle Tissues of Allii Fistulosi Bulbus Extract in High Fat Diet-Induced Obesity …
  2585. A Comprehensive Review on Anti-obesity Potential of Medicinal Plants and their Bioactive Compounds
  2586. The anti-obesity compound Asperuloside reduces inflammation in the liver and hypothalamus of high-fat-fed mice
  2587. Anti-obesity effects of isoacteoside on 3T3-L1 adipocytes
  2588. Non‐Cardiotoxic Tetradecanoic Acid‐2, 4‐Dinitrophenol Ester Nanomicelles in Microneedles Exert Potent Anti‐Obesity Effect by Regulating Adipocyte Browning and …
  2589. … Docking Analysis of Some New Thiazole and Thiazine Derivatives as Three Armed Molecules with a Triazine Ring as a Core Component: A Search for anti-Obesity …
  2590. Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs
  2591. Anti-obesity activity of polyherbal formulation Divya-Medohar-Vati by inhibition of pancreatic lipase activity and triglyceride translocation through enterocytes
  2592. Flowers and Leaves Extracts of Stachys palustris L. Exhibit Stronger Anti-Proliferative, Antioxidant, Anti-Diabetic, and Anti-Obesity Potencies than Stems and …
  2593. Evaluation of antidiabetic and anti-obesity potential and safety of a polyherbal remedy
  2594. Anti-obesity effect of eucalyptus leaf extract containing oenothein B in healthy Japanese adults: a randomized, placebo-controlled, double-blind, parallel-group study
  2595. Anti-Obesity Activity of Guava Branch Extract in the Co-Culture System of Adipocytes and Macrophages
  2596. EE72 The Relative Value of Anti-Obesity Medications Compared to Similar Therapies
  2597. Anti-Obesity Effect of Dyglomera® Is Associated with Activation of the AMPK Signaling Pathway in 3T3-L1 Adipocytes and Mice with High-Fat Diet-Induced …
  2598. Anti-obesity potential of bioactive guided fractions of Annona squamosa linn. leaves extract: a combination of in-vitro, in-vivo and in-silico studies along with profiling of …
  2599. Anti-obesity potential of Capparis spinosa flower bud extracts in 3T3-L1 adipocytes and in high fat diet induced obese rats.
  2600. Acute and sub-acute toxicity study of anti-obesity herbal granules in Sprague Dawley rats
  2601. Pharmacokinetics and Metabolism of Phytochemicals Having Anti-obesity and Antidiabetic Activity
  2602. Anti-obesity effects of fucoidan from Sargassum thunbergii in adipocytes and high fat diet induced obese mice through inhibiting adipogenic specific …
  2603. Edible insects and their potential anti-obesity effects: a review
  2604. … and in vitro evaluation of some N5-(1H-pyrazol-3-yl)-3H-benzo[d]imidazole-2,5- diamine derivatives as potential pancreatic lipase inhibitors for anti-obesity …
  2605. New insight on antioxidants and anti-obesity properties of two Indonesian seagrass Thalassia hemprichii and Zostera marina: an …
  2606. Assessment of redox state and biochemical parameters of salivary glands in rats treated with anti-obesity drug sibutramine hydrochloride
  2607. Headspace gas chromatography/mass spectrometry analysis Endorses melaleuca species as abundant source of medicinal eucalyptol and its proposed anti-obesity …
  2608. Anti-Obesity Potential of Natural Products
  2609. … digestibility and bioavailability in an F2 mouse cross between the selected fat mouse line and an M2 congenic line carrying the anti‐obesity and anti‐diabetic Tst allele
  2610. Pharmacology of Anti-Obesity and Antidiabetic Phytochemicals Isolated from Various Natural Sources (Plants, Seaweeds, Mushrooms, Marine Animals, and …
  2611. Natural Products as Novel Anti-Obesity Agents: Insights into Mechanisms of Action and Potential for Therapeutic Management
  2612. Anti-Obesity Activity of Ethanol Extract of Veronica peregrina L.
  2613. SELECTED POTENTIAL ANTI-OBESITY N-ACYLETHANOLAMIDES
  2614. Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
  2615. Effect of heat processing conditions on the anti-obesity activity of kombu in diet-induced obese mice
  2616. Role of Samyoga and Samskara on Antihyperlipidaemic/Anti-obesity activity of Honey-An Experimental Study
  2617. PLA-PEG Diblock Copolymer Micelle as Nanocarrier for Anti-Obesity Drug Delivery System
  2618. Anti-diabetic and anti-obesity activity of Caralluma adscendens var. gracilis and Caralluma pauciflora
  2619. Review of upcoming and currently available anti-obesity drugs in Europe
  2620. Mulberry Leaf Supplements Effecting Anti-Inflammatory Genes and Improving Obesity in Elderly Overweight Dogs
  2621. Tirzepatide: A new anti-obesity medication
  2622. Butchering the fat body: Enacting and engaging fatness in an American “anti-obesity” campaign
  2623. Anti-inflammatory, anti-lipogenesis, and anti-obesity benefits of fermented Aronia vinegar evaluated in 3T3-L1 cells and high-fat diet induced C57BL/6 mice
  2624. Immunostimulatory and Anti-Obesity Activity of Lonicera insularis Nakai Extracts in Mouse Macrophages RAW264. 7 Cells and Mouse Adipocytes 3T3-L1 Cells
  2625. The effectiveness of sea lettuce (Ulva lactuca) water extract from Aceh Waters as an anti-obesity
  2626. Anti-obesity effect of Microalga, Melosira nummuloieds ethanolic extract in high-fat-diet-induced obesity C57BL/6J mice
  2627. Anti-obesity Effects of Some Plant Extracts in Rats Fed with High-Fat Diet
  2628. Childhood obesity and curcumin: a possible effective anti-obesity adjunct
  2629. A 10‐Year Nationwide Pharmacovigilance Assessment on Anti‐Obesity Medications and Factors Associated with Serious Adverse Events
  2630. Phytochemical screening and anti-obesity, anti-diabetic and anti-oxidant properties of Scoparia dulcis leaf decoction (crude)
  2631. Metabolites of oregano (Origanum vulgare) seed and their anti-obesity effects on 3T3-L1 adipocytes through down-regulated adipogenesis
  2632. Weight Loss From Combination Anti-Obesity Medication Regimens Can Approach that Achieved From Bariatric Surgery
  2633. The potential anti-obesity, anti-diabetic and anti-oxidant effects of Vitamin A in streptozotocin-induced diabetic mice.
  2634. Anti-Obesity Effect of Pinus densiflora Leaf Extracts
  2635. Will Tirzepatide Become a Game-Changer Anti-Obesity Drug?
  2636. Integration of systematic review and data mining techniques to reveal core anti-obesity medicinal plants
  2637. In vitro anti-obesity effect of Aloe vera extract through transcription factors and lipolysis-associated genes
  2638. Anti-Obesity Effects of Black Barley Ferment Extract in 3T3-L1 Adipocytes and Obese Mice Induced by High Fat Diet
  2639. Anti-obesity effects of the n-butanol fraction of the methanolic leaf extract of Artemisia campestris from Tunisian pharmacopeia in male Wistar rats
  2640. Synthesis, Cannabinoid Receptor Targeted Molecular Docking of Some New Pyrazole Derivatives as Hypolipidemic and Anti-Obesity Agents.
  2641. Anti-Obesity Effects of Imyo-san on High Fat Diet Induced Obese Mice
  2642. Anti-Obesity Effect of Boscia senegalensis in Rabbits
  2643. A small-molecule lycorine derivative reveals Na+/K+-ATPase α3 as an anti-obesity target
  2644. Anti-obesity, slimming, biochemical and genotoxic effects of Cordia ecalyculata in diet-induced obese rats
  2645. Effect of Centella asiatica extract on anti-obesity suppression via inhibition of adipogenesis-related gene expression in preadipocyte
  2646. Anti-Obesity Activities of Probiotics and Dairy Based Ingredients
  2647. Inquiry on a Potential Anti-Obesity Agent: Investigating Pancreatic Lipase Inhibitors in Seed Extracts
  2648. Anti-Obesity Effect of Promod 278P Hydrolysate of Allomyrina dichotoma Larvae in Diet-induced Obese Mice
  2649. Antioxidant, Anti-inflammatory and Anti-obesity Properties of Tea Foods
  2650. Estimation of Anti-Obesity Potential of Tribulus terrestris in Wistar Rats (High Fat Diet Inducted Obesity)
  2651. Anti-obesity drugs: from previous disappointments to new hopes
  2652. Anti-obesity and anticancer activity of Solanum xanthocarpum leaf extract: An in vitro study
  2653. Anti-Obesity Effect of Parthenocissus tricuspidata (Siebold & Zucc.) Planch Stem Extracts
  2654. Anti-obesity Effects of SCOBY Jackfruit Beverages and Their Influence on Gut Microbiota
  2655. DIFFERENTIAL EXPRESSION OF MICRORNAS BY ANTI-OBESITY TREATMENT SULFORAPHANE IN SKELETAL MUSCLE OF DIET-INDUCED OBESITY IN MICE
  2656. Pharmacology of Anti-Obesity Medications: Current Status and Future Needs
  2657. Correction: Uncovering the effect of Moringa oleifera Lam. leaf addition to Fuzhuan Brick Tea on sensory properties, volatile profiles and anti-obesity activity
  2658. In Vitro Pancreatic Lipase Inhibition by Marine Fungi Purpureocillium lilacinum Associated with Stylissa sp. Sponge as Anti-obesity Agent
  2659. Evaluation of the effectiveness and safety of anti-obesity drugs-an update on the current state of knowledge on available and investigational drugs
  2660. Evaluation of Water and Ethanol Extracts of 13 Hallasan Native Plants as Sources of Anti-Obesity Ingredients
  2661. CO52 Modelling Long-Term Outcomes of Tirzepatide Compared to Lifestyle Modification and Other Anti-Obesity Medications As Treatment for Overweight and Obesity
  2662. Anti-Obesity Effect of Nostoc Commune Ethanol Extract In Vitro and In Vivo. Nutrients 2022, 14, 968
  2663. Anti-Obesity Dendritic Cell Vaccine Therapy Targeting Neovascular Vessels in High-Fat-Diet-Fed Mice
  2664. The orchestration of Cornus kousa fruit and gut microbiota for anti-obesity via integrated pharmacological analysis based on metabolomics
  2665. Anti-Obesity Effects of Gastrodia elata Extracts on High Fat Diet-Induced Obese Mice
  2666. Investigation of the anti-obesity effects of citrate-capped gold nanoparticles on 3T3-L1 cells and their genetic profiling
  2667. The Anti-obesity Agent d-norpseudoephedrine Protects Against Rotenone-induced Parkinson’s Disease in Mice
  2668. Anti-obesity effect of the bacterial product, nisin
  2669. Anti-obesity molecules of natural origin.
  2670. Anti-diabetic and Anti-obesity effects of flavonoids in Premature citrus extract
  2671. Assessment of anti-obesity activity of Tamarindus leaves on butter induced hyperlipidemia in mice
  2672. … and thermogenic potency of Padina tetrastromatica bioactives in hypertrophied 3T3-L1 cells and their efficacy based thermogenic food supplement to mitigate obesity
  2673. Corrigendum to” Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/STAT-3/SOCS-3 pathway”[Eur. J …
  2674. Cardiovascular Outcomes of Bariatric Surgery and Anti-Obesity Medications in Patients With New Onset Heart Failure and Obesity
  2675. EVALUATION OF ANTI-OBESITY POTENTIAL OF CYPERUS ROTUNDUS IN ALBINO RATS
  2676. PSUN113 Evaluating The Efficacy Of Anti-Obesity Medications In a Multidisciplinary Weight Management Clinic At a VA Medical Center
  2677. Obesity Care in Adolescents: Are We Screening for Comorbidities and Providing Anti Obesity Medications?
  2678. Anti-Obesity Effect of Methanolic Extracts of Local Punica granatum in High-Fat Diet-Induced Obese Rats.
  2679. Anti-Obesity Effect of Carom Seeds (Trachyspermum Ammi) Tea on Bmi and Lipid Profile Leading to Cardiovascular Diseases
  2680. Are GLP-1 agonists the first group of pharmaceutical agents with a promising future as anti-obesity drug?
  2681. 1156: A COMPARISON BETWEEN REAL WORLD WEIGHT LOSS OUTCOMES WITH ANTI-OBESITY MEDICATIONS BEFORE AND DURING COVID-19 PANDEMIC
  2682. Anti-Obesity Effect Of Bark Of Ficus Racemosa In High Fat Diet Induced Obese Rats
  2683. Anti-inflammatory nutrients and obesity-associated metabolic-inflammation: state of the art and future direction
  2684. A long-term anti-inflammation markedly alleviated high-fat diet-induced obesity by repeated administrations of overexpressing IL10 human umbilical cord …
  2685. One‐Pot Controllable Assembly of a Baicalin‐Condensed Aptamer Nanodrug for Synergistic Anti‐Obesity (Small 6/2023)
  2686. Nanotechnology-Based Strategies for Treatment of Obesity, Cancer and Anti-microbial Resistance: Highlights of the Department of Science and Innovation/Mintek …
  2687. Anti-obesity effect of Bioengineered Silver Nanoparticles synthesized from Persea americana on obese albino rats.
  2688. Potential Anti-Obesity Effects of Matcha Tea in Rats Fed on a High Fat Diet
  2689. Beneficial effects of anti-inflammatory diet in modulating gut microbiota and controlling obesity
  2690. Back Cover: Bifidobacterium lactis IDCC 4301 Exerts Anti‐Obesity Effects in High‐Fat Diet‐Fed Mice Model by Regulating Lipid Metabolism
  2691. … of Evaluation of Prebiotic and Anti-Obesity Properties of Persian Gulf Brown Seaweeds on Induced Obese Male Ratsand anti-obesity properties of Persian …
  2692. Anti-obesity Potency of Chili Extract in Male White Rat
  2693. Hydrolyzed proteins and vegetable peptides: anti-inflammatory mechanisms in obesity and potential therapeutic targets
  2694. In vitro and in vivo antidiabetic and anti-obesity activities of two methanolic pulp extracts of Malus domestica Borkh
  2695. Anti-obesity Effect of Some Herbal Mixtures (Anise, Fennel, Mint, and Black Seed) in a high-fat diet-Induced Obese Rats
  2696. Antidiabetic and anti‑obesity properties of a polyphenol‑rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages
  2697. Prescribing and Managing Anti-Obesity Drugs
  2698. PROFILE OF LONG NON-CODING RNA IN RESPONSE TO SULFORAPHANE ANTI-OBESITY TREATMENT IN SKELETAL MUSCLES OF DIET INDUCED OBESITY …
  2699. AOS: Anti-Obesity System with Deep Learning-Based Classification Model Using a Novel Data Augmentation Technique
  2700. Effect of Anti-Obesity Medications (AOMs) Education on Prescription for Obesity Management in Diabetic Patients.
  2701. ANTI-OBESITY MEDICATION USE IN THE ADOLESCENT BARIATRIC POPULATION: A SYSTEMATIC REVIEW
  2702. Anti-obesity-induced inflammation treatment study using adipose tissue homing glycyrrhizin derivative
  2703. Effect of heat processing conditions on the anti-obesity activity of kombu in diet-induced obese mice
  2704. # 175 Anti-obesity activity of Annona squamosa (Linn.) leaves extract on monosodium glutamate-High fat diet-induced obese mice model
  2705. Characteristics of Yogurt Ice Cream Fortified with Red Dragon Fruit Puree as Anti-Obesity Functional Food
  2706. Identification of a plant-derived small molecule with potent anti-obesity and anti-diabetic activities in type 2 diabetic mice
  2707. A clinical and computational study on anti-obesity effects of hydroxycitric acid
  2708. Anti-obesity effects of Erythrina abyssinica stem bark extract in flies exposed to a high fat diet
  2709. Chemical isolation of novel compounds from Spirulina with anti-obesity activity as future nutraceuticals
  2710. Structure-Activity Studies of α-Melanotropin and Ultra-Short GLP-1 Analogs to Benchmark the Development of Improved Anti-obesity Drugs
  2711. Alteration of Circulating levels of BDNF, SPARC, FGF-21, and GDF-15 after 1 Year of Anti-Obesity Treatments and Their Association with 1-Year Weight Loss
  2712. Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management
  2713. CLINICAL PHARMACISTS CAN PROVIDE ANTI-OBESITY MEDICATIONS TO PATIENTS ANTICIPATING BARIATRIC SURGERY: A NEW PARADIGM
  2714. Anti-Obesity Effect of Simvastatin and/or Omega-3 on Obese Male Wistar Rats
  2715. PSUN124 Weight Loss from Combination Anti-Obesity Medications Including Glucagon-Like Peptide-1 Receptors Agonists can Approach that Achieved from Bariatric …
  2716. Anti‐obesity effect of Premature Citrus Extract in high‐fat diet induced obesity mice
  2717. Efficacy of Anti-Obesity Drugs and Metabolic Surgeries as Add-On to Lifestyle Intervention in Obesity with Metabolic Complications: A Network Metanalysis
  2718. … Catalase Enzyme Activity and Anti-Obesity Effects of the Stem Bark Extract of Erythrinaabyssinica on Drosophila Melanogaster Model of Diet Induced Obesity.
  2719. Anti-obesity Effects of Extracts from Irvingia gabonensis on High Fat Diet-induced Obese Mice
  2720. Vitamin d effects on selected anti-inflammatory and pro-inflammatory markers of obesity-related chronic inflammation
  2721. Addendum to: Anti-obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of …
  2722. Anti-adipogenic and anti-obesity activity of bovine milk bioactives in 3T3L1 preadipocytes and in diet-induced obese mice.
  2723. Spermine Suppresses Adipocyte Differentiation and Exerts Anti-Obesity Effects In Vitro and In Vivo
  2724. Cost-effectiveness analysis of five anti-obesity medications from a US payer’s perspective
  2725. Anti-obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1 (vol 30, pg …
  2726. The anti-obesity potential of Ulvan from the green seaweed Ulva
  2727. Profile of insulin resistance in adipose tissue of diet induced obese mice in response to anti‐obesity treatment
  2728. Orlistat, an anti‐obesity remedy as a competitive lipase inhibitor, enhanced inflammatory reaction in the intestine
  2729. Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
  2730. Exposure to anti-Black Lives Matter movement and obesity of the Black population
  2731. Corchorus olitorius extract exhibit anti-hyperglycemic and anti-inflammatory properties in rodent models of obesity and diabetes mellitus
  2732. SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity
  2733. Anti-hyperlipidemic and ameliorative effects of chickpea starch and resistant starch in mice with high fat diet induced obesity are associated with their multi-scale …
  2734. Anti-Inflammatory Mechanisms of Dietary Flavones: Tapping into Nature to Control Chronic Inflammation in Obesity and Cancer
  2735. Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity
  2736. Comparison of anti-factor Xa levels in female and male patients with obesity after enoxaparin application for thromboprophylaxis
  2737. Nanoparticles Containing Tamarind Isolate Protein Potentiate the Satiety without Promoting the Anti-Inflammatory Effect in a Preclinical Model of Diet-Induced Obesity
  2738. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies
  2739. The Allium Derivate Propyl Propane Thiosulfinate Exerts Anti-Obesogenic Effects in a Murine Model of Diet-Induced Obesity
  2740. … reticulum stress by modulating CHOP and empowers favorable anti-inflammatory adipose tissue immune-metabolism in HFD fed mice model of obesity
  2741. Association Between Sleep Time and Pro-and Anti-Inflammatory Biomarkers Is Mediated by Abdominal Obesity Among Adolescents
  2742. Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers
  2743. A direct and simple immobilization route for immunosensors by CNBr activation for covalent attachment of anti-leptin: obesity diagnosis point of view
  2744. Association between High Normal TSH Levels and Obesity in Women with Anti-Thyroid Autoantibodies (ATAs)
  2745. … Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity
  2746. Association between Anti-DENV IgM Serum Prevalence and CD11b Expression by Classical Monocytes in Obesity
  2747. Prescription trends for anti-obesity drugs and patterns in prescriber information between 2017 and 2022 in the United States.

Related Posts

Shopping Cart
Scroll to Top